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Abstract 
 
The small intestinal permeability barrier is dependent on tight 
junction (TJ) complexes that separate the external lumen from the 
underlying mucosa. Apical TJs consist of integral transmembrane 
proteins including occludin, claudins and ZO-1 as well as the cytoplasmic 
plaque of TJ-associated adaptor, scaffolding and signalling proteins. 
Although the function of occludin at the TJ remains unclear, the dynamic 
mobility of occludin, claudins and ZO-1 to and from the TJ suggests 
occludin may play a key role in regulation of TJ structure and function, 
regulated by occludin phosphorylation status. Defects in TJ barrier 
function have been implicated in a range of inflammatory diseases such 
as inflammatory bowel disease (IBD) and pathogens such as Toxoplasma 
gondii target this complex as a route of infection. As oral infection is the 
primary cause of toxoplasmosis, the first point of contact between T. 
gondii and the host is the small intestinal epithelium and studies by 
Weight, 2012 show occludin may be involved in T. gondii paracellular 
transmigration of the small intestinal epithelium.  
The aim of this research was to investigate T. gondii paracellular 
transmigration using an in vitro model of the small intestinal epithelium 
and elucidate the role of occludin both in regulation of the TJ barrier and 
as a receptor for T. gondii infection. The results presented in this thesis 
demonstrate that T. gondii infects the small intestinal epithelium via the 
paracellular pathway and occludin was shown to play a key role both in 
regulation of the TJ paracellular barrier and as a receptor for T. gondii 
infection by parasite-mediated modulation of the occludin C-terminus 
phosphorylation status and direct binding to occludin ECL1; suggesting T. 
gondii interactions with occludin are a potential mechanism of 
paracellular transmigration of the small intestinal epithelium.  
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1 Introduction 
 
The human gastrointestinal tract (GIT) comprising of the 
oesophagus, stomach, small intestine, large intestine, rectum and anus, 
fundamentally forms a route through which food enters the body, is 
digested and then waste is excreted. The GIT lumen is also home to a 
diverse microbiota that varies in density and composition along the GIT 
[Hooper et al, 2012; O’Hara and Shanahan, 2006]. It is estimated that the 
human microbiota contains 1014 bacteria with 70% residing in the colon 
(1011—1012 bacteria per gram of colonic content) [O’Hara and Shanahan, 
2006; Sekirov et al, 2010]. With the exception of the oesophagus, the GIT 
has a conserved architecture throughout, consisting of an internal lumen, 
epithelial lining and underlying stratified layers of the mucosa and 
submucosa.  The epithelium is specialised along the length of the GIT, 
reflecting a diverse range of functions from resisting highly acidic 
digestive enzymes in the stomach to water absorption in the colon whilst 
providing an effective barrier between microbes and host. This thesis 
focuses on the small and large intestine. 
The intestinal epithelium is the largest of the body’s mucosal 
surfaces, covering 400m2. It creates a highly effective barrier between the 
GIT lumen and the body even though it is formed from only a single 
continuous layer of columnar epithelial cells [Peterson and Artis, 2014]. 
These cells within the mucosa rest on the basement membrane and 
connective tissue of the lamina propria, supported by a thin layer of 
smooth muscle termed the muscularis mucosa. The underlying 
submucosa is composed of connective tissue, nerves, blood vessels and 
lymphatics and is lined by a thicker muscle layer, surrounded by the 
serosa, which separates the intestine from the peritoneal cavity (Figure 
3.1B)  [Mowat and Agace, 2014; Turner and Turner, 2010].  
 The small intestine (SI) measures 6-7m in length and 
approximately 2.5cm in diameter and is divided into three anatomically 
distinct sections; the duodenum, the jejunum and the ileum, with specific 
absorptive capabilities whereas the large intestine (LI), comprising the 
 16 
ascending and transverse sections (proximal colon) and descending and 
sigmoid sections (distal colon), is shorter in length at ~1.5m and much 
wider in diameter [Mowat and Agace, 2014].  The SI is the primary site 
for nutrient and water absorption [Montrose, 2003] and is specialised to 
maximise absorption by increasing the available surface area to 
approximately 200m2 by ordered folding of the submucosa and further 
folding of the epithelium into finger-like villi and invaginated crypts of 
Lieberkühn [Barker et al, 2007; Hooper et al, 2012; Kim and Ho, 2010; 
Neiss and Reinecker, 2006]. The epithelial brush border of ~1μm 
microvilli further increases the surface for enhanced nutrient absorption 
and the gradient of solute exchange across the basement membrane also 
encourages water absorption via the network of closely residing 
capillaries. In contrast, villi are absent from the colon, it has limited 
digestive capability and functions to extract water and solutes from solid 
waste [Mowat and Agace, 2014]. 
 Along the SI crypt-villus axis and colonic crypt, there is a dynamic 
system of constant renewal; under normal conditions, the progeny of 
stem cells in the base of the crypt proliferate, differentiate and migrate 
upwards, where they are eventually shed into the lumen at an 
approximate rate of 1400 cells from the villus tip per day [Potten and 
Loeffler, 1990]. Importantly, the SI epithelial barrier is preserved even 
during the high turnover cell shedding from the villus tip, a potential site 
of barrier loss [Duckworth and Watson, 2011].  In inflammatory GI 
diseases such as inflammatory bowel disease (IBD), cell turnover is 
accelerated and the potential for barrier loss is increased [Marchiando et 
al, 2011; Meddings, 2008]. Despite the evidence of gaps in the epithelium 
possibly created during shedding, the barrier is consistently maintained 
[Kiesslich et al, 2007; Watson et al, 2005 and 2009].  
The predominant cell type along the SI villus are absorptive 
enterocytes (over 80%), adapted for metabolic and digestive functions, 
which alongside specialised intestinal epithelial cells (IECs) such as 
hormone-secreting enteroendocrine cells, mucus-secreting goblet cells, 
Paneth cells and M (microfold) cells, form a dynamic SI epithelial barrier 
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[Karam, 1999; Sancho et al, 2003; van der Flier and Clevers, 2009].  
Paneth cells are only found in the SI where they migrate to the crypt base 
and secrete antimicrobial peptides such as lysozyme, defensins and other 
factors [Bevins and Salzman, 2011; Elphick and Mahida, 2005]. In the 
colon, the number of goblet cells is increased, comprising 25% of all 
epithelial cells in the distal colon compared to 10% in the SI [Mowat and 
Agace, 2014]. This difference in goblet cell number correlates with mucus 
production; a thin layer is present in the SI whereas a thick double layer 
consisting of a dense, sterile inner layer and loose outer layer where 
bacteria reside is present in the LI [Johansson et al, 2013; Pelaseyed et al, 
2014].  
The continuous layer of IECs forms the body’s largest interface 
with the external environment and creates an effective barrier to luminal 
bacteria, pathogens, toxins and antigens from entering the lamina propria 
[Marchiando et al, 2010; Suzuki, 2013]. This thesis focuses on the SI 
epithelial barrier and its role in T. gondii infection. 
 
 
1.1 Small Intestinal Epithelial Barrier 
 
 
As well as creating an effective barrier to luminal microorganisms, 
the SI epithelium permits the absorption of nutrients by selective 
permeability through the transcellular (through cells) and paracellular 
(between cells) pathways. The transcellular absorption of sugars, amino 
acids, peptides, fatty acids, minerals and vitamins is mediated by 
transporters and channels in the apical and basolateral cell membranes 
[Broer, 2008; Ferraris and Diamond, 1997; Kiela and Ghishan, 2009]. The 
paracellular pathway, regulated by apical cellular junctions, forms a 
barrier to harmful luminal contents whilst allowing the selective 
transport of ions, solutes and water across the epithelium [Shen, 2012]. 
Crucially, without this paracellular barrier, absorbed solutes would 
simply diffuse back across the concentration gradient of the epithelium 
[Turner, 2009].  
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Breakdown of the epithelial barrier has been implicated in the 
pathogenesis of various intestinal and systemic diseases including 
ischemic retinopathy, pulmonary edema, IBD, oeliac disease, rheumatoid 
arthritis, psoriasis, cancer, diabetes, allergic disorders and HIV [Harhaj 
and Antonetti, 2004; Shen et al, 2009; Suzuki 2013]. The common factor 
of all these diseases is altered epithelial permeability but this connection 
is only beginning to be understood.  
At steady state, cellular junctions regulate the permeability of the 
epithelial barrier in response to stimuli including nutrients, cytokines and 
bacteria [Ivanov, 2008; Turner, 2009; Nusrat et al, 2000]. However, under 
inflammation conditions the epithelial barrier is disrupted [Ivanov et al, 
2010; Turner, 2009] and an increase in permeability leads to the 
symptoms experienced with IBD of reduced solute transport [Simon et al, 
1999], leak-flux diarrhoea [Sandle, 2005] and a ‘leaky gut’ that allows the 
translocation of large luminal antigens that are normally prevented from 
entry, which may initiate the immune response and cause or maintain 
intestinal inflammation [Al-Sadi et al, 2011; Buschmann et al, 2013; 
Odenwald and Turner, 2013]. Clinical data has confirmed a positive 
correlation between the decline of intestinal barrier function and the 
degree of mucosal inflammation in patients with CD and UC and 
increased epithelial permeability often precedes relapse of CD in patients 
[Arnott et al, 2000; D’Incà et al, 1999; Wyatt et al, 1993]. In addition to 
the widespread barrier loss caused by severe intestinal inflammation in 
IBD, targeted barrier loss occurs during pathogen infection [Balda and 
Matter, 2000; Capaldo and Nusrat, 2009], as discussed later in this 
chapter. 
The economic costs associated with GI diseases is continuing to 
expand, the latest reported annual costs of IBD to the UK NHS are 
estimated at £470 million or £631-762 per patient [Buchanan et al, 2011; 
Cummings et al, 2008; Luces and Bodger, 2006; Molodecky et al, 2012]. 
These figures reflect lifelong healthcare costs such as medication, anti-
TNFα therapy, hospitalisation and surgery a well as productivity losses 
associated with sick leave and work disability which amount to almost 
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50% of the total costs [Bassi et al, 2004; Mowat et al, 2011; van der Valk 
et al, 2014]. Clearly it is important to elucidate the mechanism of 
epithelial barrier loss to potentially treat these diseases. 
 
 
1.2 Epithelial Cellular Junctions 
 
 In order to investigate SI epithelial barrier function during T. gondii 
infection, it is essential to understand the molecular architecture of 
cellular junctions. Epithelial cell sheets such as the SI lining are formed by 
tightly connected adjacent cell membranes held together by a series of 
intercellular junctions termed the epithelial junctional complex. This was 
first visualised at the ultrastructural level over 50 years ago by Farquhar 
and Palade using transmission electron microscopy (TEM). The authors 
used thin sections of epithelial cells and identified points of cell-cell 
contact and regions between epithelial cells where the paracellular space 
was completely eliminated [Farquhar and Palade, 1963].  
 They identified three distinct morphological structures of the 
epithelial junctional complex: the apical tight junction (TJ), followed by 
lateral adherens junctions (AJ) and basolateral desmosomes  (Figure 
1.1A) and their TEM images revealed the junctional complex as a 
continuous ring, completely encircling the cell and interconnecting 
neighbouring cells [Farquhar and Palade, 1963]. Early studies confirmed 
the epithelial TJ as the point of complete membrane occlusion through 
the use of tracer molecule diffusion across the paracellular space 
[Goodenough and Revel, 1970]. The TJ is also responsible for intercellular 
sealing whereas lateral AJ and desmosomes provide the adhesive force to 
maintain cell-cell contacts [Gumbiner, 1993; Schneeberger and Lynch 
1992].  
 In some tissues intercellular pore-forming gap junctions are also 
associated with the junctional complex and allow small molecules to pass 
between the cytoplasm of neighbouring cells [Goodenough and Paul, 
2003].  
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  The AJ is formed by cadherins, a family of glycoproteins that form 
homotypic adhesive contacts between adjacent cells [Gumbiner, 2005; 
Perez-Moreno, 2006]. E-cadherin, for example, binds to the catenins 
p120, β and α, which connect the cadherin complex to the actin 
cytoskeleton and signalling pathways [Niessen, 2007]. Loss of the AJ 
results in loss of cell-cell adhesion, ineffective polarisation, differentiation 
and subsequent apoptosis [Hermiston and Gordon, 1995]. Dysregulation 
of E-cadherin expression and cellular localisation has also been linked to 
carcinogenesis and IBD [Hartsock and Nelson, 2008; Mehta et al, 2014]. 
Formation of the AJ appears to precede the localisation and assembly of 
the TJ protein complex [Ikenouchi et al, 2007; Rajasekaran et al, 1996; 
Siliciano and Goodenough, 1988] although the exact order of assembly 
and disassembly of the TJ molecules remains unknown.  
  TJs are found in a variety of tissues besides the intestinal 
epithelium, including the vascular endothelium of the blood-brain, blood-
retinal and blood-placental barriers. The SI epithelial TJ located at the 
boundary between the apical and basolateral plasma membranes forms a 
selectively permeable barrier that drives passive paracellular absorption 
and secretion [Turner, 2009]. Early freeze-fracture electron microscopy 
(EM) offered a lateral view of the intercellular space by fracturing along 
hydrophobic planes. The TJ was observed by TEM just below the apical 
microvilli as a series of continuous anastomosing strands that form small 
punctae or ‘kissing points’ between the outer leaflets of neighbouring cell 
membranes, essentially forming paired TJ strands that occlude the 
paracellular space between adjacent cells (Figure 1.1B) [Cereijido 1989; 
Farquhar and Palade, 1963; Shen et al, 2011; Tsukita et al, 2001]. When 
visualised by immunofluorescence, TJ proteins create a chicken-wire 
pattern in sections parallel to the monolayer, mirroring cellular borders 
(Figure 1.1C) and display a distinct apical punctate pattern when viewed 
laterally, perpendicular to the monolayer [Matter and Balda, 2003; 
Tsukita et al, 1996]. 
The number of TJ strands loosely correlates to barrier function 
and varies both between tissues and within epithelia, for example ‘leaky’ 
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epithelia such as the gallbladder often have only a single strand whereas 
‘tight’ epithelia such as the urinary bladder have at least five strands 
[Claude and Goodenough, 1973; Marcial et al, 1984; Naftalin and Tripathi, 
1985]. The SI has a relatively leaky epithelium for unidirectional nutrient 
and solute absorption [Anderson and Van Itallie, 2009]. Along the SI 
crypt-villus axis a permeability gradient forms between the ‘tight’ villus 
epithelium, which allows a flux of molecules ~6-10Å, and the relatively 
‘leaky’ crypt epithelium, which is permeable to larger molecules of ~60Å. 
[Fihn, 2000]. 
Now, 50 years since its discovery the TJ is known to be more 
dynamic than the original perception as a static, rigid structure that 
simply sealed the paracellular space and much progress has been made in 
the field of TJ structure, function and regulation.  
 
 
1.2.1 Tight Junction Structure 
 
The first TJ-associated proteins were identified in the 1980’s as 
zonula occludens-1 (ZO-1) [Stevenson et al, 1986], followed by Cingulin 
[Citi et al, 1988] and other related peripheral membrane proteins [Jesaitis 
and Goodenough, 2004; Ohnishi et al, 2004]. With the discovery of the 
pore-forming function of the TJ, subsequent studies sought to identify 
integral membrane proteins.  
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Figure 1.1: The epithelial junctional complex. A) Schematic representation of 
the apical tight junction, lateral adherens junction and basolateral desmosomes. 
B) Transmission electron microscopy image from Shen et al, 2011 showing 
junctional complexes between two villous enterocytes. The tight junction (TJ) is 
just below the microvilli (Mv), followed by the adherens junction (AJ). The 
desmosomes (D) are located basolaterally [Shen et al, 2011].. C) Classic ‘chicken-
wire’ junctional staining pattern of β-catenin in IEC-6 cell line. Scale bar 20μm. 
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Two main classes of transmembrane proteins have now been 
discovered: firstly, tetraspanning proteins including occludin, tricellulin, 
marvelD3, the claudins, and tetraspanin [Fujimoto, 1995; Furuse, 1993; 
Furuse and Tsukita, 2006; Ikenouchi et al, 2005, Van Itallie and Anderson, 
2006] and secondly, members of the single membrane spanning 
junctional adhesion molecule (JAM) family [Ebnet et al, 2004].  
The list of known TJ components (Figure 1.2) is likely to be 
incomplete as the molecular architecture of the TJ and functional 
interactions of the TJ proteins are still to be defined.  
 
 
TAMP Family 
 
Occludin, tricellulin and MarvelD3 are part of the TJ Associated 
MARVEL Protein (TAMP) family that contain a conserved four 
transmembrane MARVEL domain [Sanchez-Pulido et al, 2002].  
Occludin and MarvelD3 are preferentially located at bicellular TJs 
(bTJs) and tricellulin exclusively at tricellular TJs (tTJ) where it forms a 
barrier to macromolecules [Ikenouchi et al, 2005; Raleigh et al, 2010; 
Steed et al, 2009]. Occludin and tricellulin have long carboxyl terminus 
(C-terminus) tails that share a similar RNA-polymerase II elongation 
factor (ELL) domain whereas MarvelD3 has a short C-terminus tail 
[Raleigh et al, 2010].  
The TAMPs have distinct but overlapping functions at the TJ and 
share no sequence homology with the claudins [Krause et al, 2008]. 
Tricellulin can partially compensate for occludin loss as upon occludin KD 
it is redistributed to bicellular junctions [Ikenouchi et al, 2005 and 2008]. 
However, its contribution to TJ barrier function is still undefined [Raleigh 
et al, 2010; Van Itallie et al 2010].  
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Figure 1.2: Epithelial tight junction structure. Schematic representation of 
the apical tight junction. Transmembrane occludin, JAMs and claudins seal the 
paracellular space between adjacent epithelial cells and the cytoplasmic plaque 
of peripheral scaffolding, adaptor and signalling proteins connect the 
transmembrane proteins with the structural cytoskeleton and regulate cell 
polarity, proliferation and differentiation, although the molecular architecture of 
the TJ is still to be defined. This image is a modification of QIAGEN’s original, 
copyrighted image by Jones, 2015. The original image may be found at 
www.QIAGEN.com. © 2009 QIAGEN, all rights reserved. 
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Krug et al, discovered that when tricellulin was only expressed at 
tTJs, permeability to macromolecules was reduced and when tricellulin 
was overexpressed and localised to both tTJs and bTJs, permeability to 
both macromolecules and ions was reduced [Krug et al, 2009]. This 
suggests tricellulin has an important role in macromolecule permeability 
associated with the leak pathway. With the knowledge that occludin 
knockdown (KD) induces the relocalisation of tricellulin to bTJs and 
remedial occludin expression removes bTJ tricellulin [Ikenouchi et al, 
2008], it is likely that tricellulin normally only regulates the leak pathway 
at tTJs but upon relocalisation to bTJs, partially compensates for occludin 
regulation of the pore and leak pathways [Furuse, 2010; Krug et al, 2009; 
Liang and Weber, 2014; Raleigh et al, 2011]. Recently it was shown that 
the cytoplasmic domain of lipolysis-stimulated lipoprotein receptor (LSR) 
recruits tricellulin to tTJs [Masuda et al, 2011]. 
The recently discovered MarvelD3 protein partly co-localises with 
occludin at bTJs [Steed et al, 2009] and it also immunoprecipitates with 
both occludin and tricellulin so it seems likely that their functions are also 
overlapping [Raleigh et al, 2010]. Clearly, all the TAMPs are important for 
barrier maintenance and further functional analyses are required. This 
thesis will focus exclusively on occludin.  
 
 
Occludin 
 
Occludin was discovered by Furuse et al in chicken liver as a 60-
65kDa four transmembrane protein and its structure has since been 
elucidated [Furuse et al, 1993]. 
Figure 1.3 illustrates that occludin is a 521 amino acid (aa) 
polypeptide in mouse or 522 aa polypeptide in humans, consisting of two 
extracellular loops (ECL), a short intracellular loop (IL), four hydrophobic 
transmembrane domains (TM), a short cytoplasmic N-terminal domain 
and a long cytoplasmic C-terminal domain [Furuse et al, 1994]. 
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Both ECL are enriched in tyrosine residues and in ECL1 ~60% of 
the residues are tyrosine and glycine but the functional significance of 
this is unclear [Furuse et al, 1993]. In vitro studies have demonstrated 
that post-translational modifications, especially phosphorylation and 
dephosphorylation of the occludin C-terminus regulate occludin 
localisation to the TJ as well as paracellular permeability [Balda and 
Matter, 2008; Rao, 2009].  
Many mammalian homologs of the chicken occludin discovered by 
Furuse et al have since been identified and they all conserve the tetra-
span structure along with other distinct structural domains [Ando-
akatsuka, 1996; Feldman et al, 2005].  Although the occludin protein 
structure is well described, the role of differential occludin isoforms is not 
understood. The Saitou group originally discovered multiple occludin 
isoforms due to post-translational alternative mRNA splicing [Saitou et al, 
1997]. Subsequently, at least four occludin splice variants have been 
described, which differ in their subcellular distribution and molecular 
mass [Ghassemifar et al, 2002; Gu et al, 2008; Mankertz et al, 2002; 
Muresan et al, 2000]. It is thought they may regulate the adhesive 
properties of the TJ but further investigations are needed to explain their 
functions. 
Since its discovery over 20 years ago, many aspects of occludin 
structure and function have been studied although its functional role still 
remains elusive. Occludin has been shown to be a functional component 
of TJs using in vitro epithelial cell lines and in vivo models. TJ disruption 
occurs as a consequence of occludin siRNA KD [Al-Sadi et al, 2011; 
Raleigh et al, 2010], occludin C-terminus deletion [Balda et al, 1996; 
Furuse et al, 1994] or occludin overexpression [Balda et al, 1996; Furuse 
et al, 1993; McCarthy et al, 1996; Wong and Gumbiner, 1997].   
 
 
 
 
 
 
 
 
 27 
 
 
 
 
 
 
Figure 1.3: Molecular structure of occludin. A) Murine occludin is a 521 aa 
polypeptide. B) Predicted occludin topology consisting of two extracellular loops 
(ECL), a short intracellular loop (IL), four hydrophobic transmembrane domains 
(TM), a short cytoplasmic N-terminal domain and a long cytoplasmic C-terminal 
domain. Occludin topology predicted by http://bioinfo.si.hirosaki-
u.ac.jp/~ConPred2/.Image adapted from www.zonapse.net. 
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With the knowledge that occludin alone cannot form TJ strands 
the question of whether occludin is required for TJ assembly and function 
was raised [Saitou et al, 1998]. In vivo studies by Saitou et al 
demonstrated occludin knockout (KO) mice express TJ strands, which are 
morphologically similar to wild-type mice with no measurable barrier 
dysfunction in the intestinal epithelium. However, they do present with 
complex phenotypes such as growth retardation, testicular atrophy, brain 
calcification and chronic inflammation and hyperplasia of the GI 
epithelium [Saitou et al, 2000].  
These studies suggest occludin is not essential for TJ strand 
formation but is likely required for paracellular TJ barrier regulation, 
which explains the disruption of Ca2+ absorption in the GI epithelium and 
gastritis in the occludin KO mice [Saitou et al, 2000; Schulzke et al, 2005]. 
Similarly, occludin may not be crucial for TJ structure and function, since 
in its absence, other TJ proteins such as tricellulin or MarvelD3 can 
partially compensate [Raleigh, 2010; Schulzke et al, 2012].  
 
 
Claudins 
 
The presence of TJ strands in occludin-deficient cells led to the 
discovery of claudins, the principle family of integral membrane proteins 
and the main determinants of the barrier property of the TJ. Claudins-1 
and -2 were the first to be identified by Furuse et al and since then 27 
claudin family members have been identified in mammals and 
categorised depending on their function; either pore forming (increase 
permeability) or barrier sealing (decrease permeability) [Furuse et al, 
1998; Krug et al, 2014; Mineta et al, 2011; Schulzke et al, 2012; Tamura 
and Tsukita, 2014]. In the mouse, claudins -1, -3, -4, -5, -11, -14, -18 and -
19 are described as barrier-forming whereas -2, -7, -10, -15, -16 and -17 
as pore-forming [Tamura and Tsukita, 2014].  Claudins are expressed in 
both a homotypic and heterotypic manner in single TJs [Tsukita et al, 
2001] and TJ permeability appears to be dependent on this pattern of 
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claudin expression along the length of the GIT. In the small intestine and 
colon claudins -3, -7 and -15 are the most highly expressed although 
claudins -2, and -15 appear to control the paracellular pore pathway in 
the intestine [Tamura and Tsukita, 2014; Wada et al, 2013] as confirmed 
by claudin -2 and -15 double KO mice, which die in infancy as a result of 
fatal defects in intestinal Na+-nutrient transport and ultimately 
malnutrition [Wada et al, 2013]. Interestingly, SI expression of claudins -2 
and -15 alters with age. In infant mice, claudin -2 levels are higher than 
claudin -15 whereas in adult mice this is reversed [Tamura et al, 2011].  
Even along the crypt-villus axis claudins are spatially separated; in 
adult mice claudin -2 is restricted to the crypt whereas claudin -4 is 
expressed exclusively at the villus [Fujita et al, 2006; Rahner et al, 2001; 
Tamura et al, 2011; Van Itallie et al, 2001]. These differences in claudin 
expression and localisation seem to reflect the different barrier 
properties of intestinal tract. At the villus tip, claudin-4 forms relatively 
tight paracellular ion barriers and its removal from the TJ by Clostridium 
perfringens enterotoxin for example, causes a loss of barrier function 
[Saitoh et al, 2015; Sodona et al, 1999; Van Itallie et al, 2001 and 2008; 
Winkler et al, 2009; Zeissig et al, 2007].  While at the more ‘leaky’ crypt, 
claudins-2 or -15 increase TJ ion permeability but maintain a barrier to 
macromolecules [Amasheh et al, 2002; Wada et al, 2013]. Increased 
claudin -2 expression has also been implicated in bacterial 
transmigration of the SI epithelium [Zhang et al, 2013]. Similarly, 
significantly increased TJ expression of claudin -2 alongside 
downregulation or redistribution of claudin -4 away from the TJ is 
observed in both CD and UC patients. This leads to an increased number 
of pores that allow paracellular flux of Na+, which contribute to decreased 
paracellular permeability and may explain the symptoms of leak-flux 
diarrhoea [Prasad et al, 2005]. Increased claudin-1 expression has been 
linked to IBD as well as tumour growth and metastasis in experimental 
models, suggesting changes in claudin expression may have undesired 
consequences [Turner, 2009]. In addition to expression changes, some 
groups suggest TJ permeability could be regulated simply by 
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displacement of pore-forming claudins by barrier-forming claudins, as 
demonstrated by the displacement of claudin-2 from the TJ by claudin-8 
and subsequent increase in barrier function [Angelow et al, 2007; Shen et 
al, 2011]. However, it remains poorly understood how different claudins 
interact with other TJ proteins such as occludin in the intestinal 
epithelium.  
Recently, pioneering work by Suzuki et al solved the crystal 
structure of claudin-15, which gave an insight into the architecture of the 
TJ [Suzuki et al, 2014]. Linear claudin polymers were proposed to 
assemble into the membrane in double rows and associate with claudin 
polymers on an adjacent cell membrane, forming strands of charge-
selective ion pores parallel with the membrane plane and punctuating the 
paracellular space (Figure 1.4) [Suzuki et al, 2015]. A disulphide bond 
between conserved extracellular cysteines appeared to be important for 
this pore formation but it is still not clear how the extracellular domains 
of different claudin molecules coordinate to assemble pores [Li et al, 
2013; Suzuki et al, 2014 and 2015]. 
 
 
Junctional Adhesion Proteins 
 
The JAM family of proteins has at least four members including 
JAM-A, -B, and –C and the more distantly related JAM-4, JAM-L and 
coxsackie and adenovirus receptor (CAR) [Coyne and Bergelson, 2005; 
Liu et al, 2000; Mandell and Parkos, 2005].  
They are all part of the immunoglobulin family of adhesion 
proteins with a long extracellular domain consisting of two 
immunoglobulin (Ig) loops formed by disulphide bonds and a short 
intracellular C-terminal domain containing a PDZ (The post-synaptic 
density 95/Drosophila discs large/ZO-1) binding motif [Martin-Padura et 
al, 1998]. It seems these proteins are not directly responsible for TJ 
permeability but may contribute to TJ assembly and modulation 
[Monteiro and Parkos, 2012; Van Itallie and Anderson, 2014]. 
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Figure 1.4: Architecture of claudin paracellular pores.  Schematic model of 
the proposed paracellular TJ structure. Claudins dimers in trans on 
neighbouring cell membranes and in cis on the same cell membrane form 
polymers within TJ strands and create paracellular pores that regulate the 
paracellular ion flow. Claudin polymers (blue). Cell membranes (grey). Putative 
charged β-barrel pores (purple). Arrows indicate the proposed paracellular ion 
flow. Image adapted from Suzuki et al, 2015. 
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For example siRNA KD of JAM-A increased permeability of 
epithelial cells and inhibited TJ reassembly [Liu et al, 2000; Mandell et al, 
2004]. JAM-A KO mice presented increased GI permeability and 
developed intestinal inflammation [Laukoetter et al, 2007; Vetrano et al, 
2008] whereas JAM-4 overexpression in mice decreased paracellular 
permeability to dextran [Hirabayashi et al, 2003]. 
Similarly, CAR overexpression leads to an increase in TJ barrier 
function [Cohen et al, 2001], although it should be noted that these 
findings are yet to be confirmed in vivo. 
 
 
1.2.2 Tight Junction Function  
 
The two established functions of the epithelial TJ are widely 
described as resembling a ‘gate’ and ‘fence’.  Firstly, the ‘gate’ function 
refers to the TJ barrier that regulates the selective transport of ions and 
solutes (e.g. nutrients) and water through the paracellular pathway and 
prevents the transmigration of microorganisms (commensal and 
pathogenic) and antigens (bacterial or food) [Cereijido et al, 2008; 
Diamond, 1977; Gumbiner, 1987; Schneeberger and Lynch, 1992]. As TJs 
are incapable of active transport, as achieved by transcellular 
transporters, the TJ forms a gradient to drive passive paracellular 
transport in the appropriate direction across the lumen [Turner et al, 
2014]. Secondly, the ‘fence’ function maintains polarity of the plasma 
membrane by restricting the diffusion of lipids and proteins between the 
apical and basal membrane domains. [Tsukita et al, 2001]. 
A direct measurement of the TJ barrier or ‘gate’ function in vitro is 
the measurement of transepithelial electrical resistance (TEER) or ion 
flux across the epithelium of cells grown on porous supports. To obtain 
these measurements a continuous current is applied via two electrodes 
either side of the monolayer, passing through both the transcellular and 
paracellular pathways [Powell 1981]. The transcellular resistance 
pathway is predominantly controlled by apical and basolateral 
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membrane transporters whereas the paracellular resistance results from 
cell-substrate or cell-cell contacts, primarily the TJ [Shen et al, 2011]. 
Although TEER reflects both transcellular and paracellular resistance, the 
paracellular pathway exhibits a significantly lower electrical resistance 
than the transcellular route and accounts for the majority of the 
measured resistance, between 74-95% of total passive ion flux across the 
SI epithelium [Fanning et al, 1998; Matter and Balda, 2003; Reuss, 1991]. 
It should be noted that our ability to study the specific barrier 
function of the TJ at the ultrastructural level is limited as it is currently 
not possible to isolate single TJs; therefore TEER reflects averaged 
resistance measurements across the cultured epithelial monolayer [Liang 
and Weber, 2014]. Additionally, as TEER is only a measure of ion flux and 
does not assess size selectivity, the paracellular diffusion of molecular 
tracers of various sizes is used to evaluate average TJ pore size. For 
example, the flux of 5kDa FITC-dextran across epithelial monolayers 
grown on transwell inserts is commonly used as a measure of TJ barrier 
function. To ensure measured changes in the TJ barrier are not due to loss 
of TJ function such as collapse of the paracellular pathway, high 
resolution morphological analysis should be assessed alongside TEER 
and tracer flux. 
Despite their limitations, both TEER and tracer flux measurements 
are widely used and have resulted in important discoveries, notably that 
the TJ barrier is not absolute; it is selectively permeable to certain ions 
and molecules [Anderson et al, 2004; Goodenough and Revel, 1970; 
Machen et al, 1972]. Significantly, upon discovery that the number of TJ 
strands was not proportional to TEER, Claude proposed a model in which 
the TJ strands are punctuated by pores that are either open or closed to 
regulate paracellular ion flux [Claude, 1978]. More recent high-resolution 
studies have described at least two pathways of TJ molecule flux: a ‘pore’ 
pathway that allows the passage of small uncharged solutes and ions of 
~4Å and the ‘leak’ pathway that regulates the passage of larger 
uncharged macromolecules across the epithelium [Van Itallie et al, 2008; 
Watson et al, 2005].  These pathways are also distinct in their capacity; 
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the ion-selective ‘pore’ pathway transports large quantities of small 
solutes and ions whereas the size-selective leak pathway only transports 
small volumes of larger molecules across the epithelium [Anderson and 
Van Itallie, 2009; Van Itallie et al, 2009; Weber et al, 2010]. Studies have 
indicated these two distinct TJ pathways are differentially regulated and 
there is no correlation between permeability to small ions such as Na+ 
and Cl- or larger macromolecules such as glucose [Heller et al, 2005; 
Prasad et al, 2005; Turner et al, 1997; Wang, et al, 2005; Weber et al, 
2010]. Interestingly, Al–Sadi et al recently suggested occludin expression 
in vitro and in vivo is important for specific maintenance of the leak 
pathway as occludin depletion increased flux of macromolecules, 
including bacterial antigens, which lead to an inflammatory response [Al-
Sadi et al, 2011]. This possible mechanism of TJ opening requires further 
investigation. 
Although a wealth of information about the pore and leak 
pathways has been obtained over the last 25 years, it has not been 
possible to confirm the pore opening and closing events due to the 
resolution required to isolate single TJs. Once these mechanisms have 
been elucidated, TJ opening and closing events may present novel targets 
for oral drug delivery to control conditions such as IBD, which are 
associated with compromised TJ barriers.  
In addition to the barrier or ‘gate’ function, TJs also function as a 
molecular ‘fence’ dividing the epithelial cell plasma membrane into apical 
and basolateral domains and limiting the lateral diffusion of lipids and 
integral proteins between these domains [Tsukita et al, 2001]. The 
polarised localisation of lipids was originally confirmed by insertion of 
fluorescently labelled lipids into the apical membrane of cultured Madin-
Darby canine kidney (MDCK) cells, where they remained [Dragsten et al, 
1981; van Meer and Simon, 1986].  
Interestingly, occludin has a possible involvement in the lipid 
diffusion barrier. Fluorescently labelled apical phospholipid 
sphingomyelin was added to the apical membrane of MDCK cells 
expressing C-terminally truncated occludin and rather than remaining at 
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the apical membrane, it was redistributed to the basolateral membrane 
[Balda et al, 1996]. Highlighting the potential for occludin to be involved 
in TJ structural integrity. 
 
 
1.2.3  Tight Junction Regulation 
 
As well as the transmembrane integral proteins described above, 
peripheral cytoplasmic structural or signalling proteins arrange into 
multiprotein complexes termed the ‘TJ plaque’, of which at least 40 
components have currently been described. This signal transduction to 
and from the TJ is important for TJ regulation and cross-talk between the 
TJ and nucleus coordinates gene expression, proliferation and 
differentiation [Farkas et al, 2012; Matter and Balda 2003]. Figure 1.2 
schematically outlines these known adaptor and scaffold proteins that 
link the integral TJ proteins to the actin cytoskeleton and depicts the 
types of signalling molecules recruited to the complex [Aijaz et al, 2006; 
Matter and Balda, 2003; Schneeberger and Lynch, 2004; Tsukita et al, 
2001].  
 The cytoplasmic plaque proteins are divided into two groups, those 
with and without PDZ domains. The PDZ proteins include ZO-1, -2 and -3 
[Beatch et al, 1996; Fanning and Anderson, 2009; Guillemot et al, 2008; 
Haskins, 1998; Van Itallie et al, 2009; Willott et al, 1993], Par3 and Par6 
[Joberty et al, 2000], Pals1 [Straight et al, 2004], PATJ [Shin et al, 2005], 
GOPC [Lu et al, 2015], Dlg, Scrib and Lgl [Humbert et al, 2003], MUPP-1 
[Hamazaki et al, 2002] and the MAGI proteins [Dobrosotskaya et al, 
1997]. Structural protein-protein interactions occur between multiple 
PDZ domains to form a complex molecular scaffold between the integral 
membrane proteins, cytoskeletal components and signalling molecules at 
the TJ [Kim et al, 1995]. Non-PDZ proteins include cingulin [Citi et al, 
1989], heteromeric G proteins [Balda et al, 1991; Denker et al, 1996], 
Rab-13 and PTEN [Matter et al, 2005], kinases [Dorfel and Huber, 2012], 
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phosphatases, Rho GTPases [Matter and Balda, 2003] and NACos [Matter 
and Balda, 2009]. 
Some TJ adaptor proteins form connections with AJ proteins, 
connecting components of the epithelial junctional complex. For instance, 
TJ-associated ZO-1 interacts with AJ-associated β–catenin and afadin 
[Aijaz et al, 2006; Itoh et al, 1997; Rajasekaran et al, 1996; Yokoyama et 
al, 2001]. Other more peripheral membrane proteins such as cingulin 
bind directly to adaptor proteins such as ZO-1 or JAM-A and perform both 
structural and signalling roles at the TJ [Bazzoni et al, 2000; Ebnet et al, 
2000; Yano et al, 2013].  
Numerous other interactions occur at the TJ between the 
transmembrane proteins, adaptor proteins and cytoplasmic plaque and 
these have been reviewed in detail by both Gonzalez-Mariscal et al, and 
Matter and Balda [Gonzalez-Mariscal, 2003; Matter and Balda, 2003]. 
These complex multimeric protein interactions are thought to be 
necessary for correct assembly and organisation of the integral TJ 
proteins and correct TJ barrier function but their physiology and 
mechanisms of regulation are still to be elucidated [Fanning and 
Anderson, 2009; Köhler and Zahraoiu, 2005; Matter and Balda, 2003; 
Steed et al, 2010; Vogelmann and Nelson, 2005]. 
 The cytoskeleton forms a complex structure of protein filaments 
that extends into the cytoplasm to maintain cell structure. As viewed by 
EM, an apical belt-like ring of actin, α-actinin and non-muscle myosin II 
filaments is located immediately beneath the TJ in epithelial cells to allow 
contraction of the epithelial sheet and these proteins clearly play a critical 
role in TJ architecture and paracellular permeability [Drenckhahn and 
Dermietzel, 1988; Glotfelty et al, 2014; Madara, 1987; Mooseker, 1985; 
Turner and Madara, 1995]. For instance in cultured epithelial cells 
paracellular permeability is linked to phosphorylation of myosin light 
chain (MLC) by myosin II light chain kinase (MLCK) or rho-associated 
protein kinase (ROCK), which activates myosin contractility [Anderson 
and Van Itallie, 1995; Turner et al, 1997]. Several bacterial toxins also 
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specifically target the actin cytoskeleton to disrupt the TJ barrier, the best 
studied being cholera toxin ZOT [Fasano et al, 1995]. 
TJ connections with the perijunctional cytoskeleton are also 
essential for assembly of the TJ and maintenance of the TJ barrier and 
accordingly there are a large number of cytoskeletal proteins associated 
with the TJ [Van Itallie and Anderson, 2014]. These include a number of 
actin polymerising proteins including Arp2/3, N-WASP, cortactin and 
VASP [Ivanov et al, 2005; Katsube et al, 1998; Lawrence et al, 2002; Zhou 
et al, 2013]. Many cytoplasmic plaque proteins are involved in linking the 
transmembrane TJ proteins to the actin cytoskeleton, often via binding to 
ZO proteins [Aijaz et al, 2005; Wittchen et al, 1999]. Examples are the 
actin-crosslinking protein α-actinin-4, vinculin, α-catenin, anillin and 
shroom2 [Chen et al, 2006; Etournay et al, 2007; Hildebrand, 2005; Itoh 
et al, 1997; Reyes et al, 2014; Zemljic-Harpf et al, 2014].  
The protein structure of the TJ is known to regulate the TJ 
permeability barrier by the formation of ion-selective pores and size-
selective leak pathways and an insight into this relationship between TJ 
structure and function was originally provided by studies using 
latrunculin A to induce barrier loss. As a result of treatment, TJ proteins 
were redistributed away from the TJ and rapid occludin endocytosis was 
associated with barrier loss whereas claudin-1 and ZO-1 redistribution 
occurred much later [Shen and Turner, 2005]. This constant assembly 
and disassembly of TJ components demonstrates the pronounced 
plasticity of the TJ. Recently studies using MDCK cells further evaluated 
occludin trafficking [Fletcher et al, 2014]. The authors discovered a 
continuous and rapid cycle of occludin endocytosis, recycling and 
degradation and following internalisation, intracellular occludin was lost 
from the cytoplasm. Their analysis demonstrated that this loss was due to 
lysosomal degradation and although ~20% of occludin was recycled back 
to the plasma membrane via recycling endosomes, the remainder was 
replaced by newly synthesised occludin [Fletcher et al, 2014; Fletcher 
and Zappoport, 2014]. Occludin internalisation pathways include 
clathrin-mediated endocytosis, caveolar endocytosis and macro-
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pinocytosis. In vitro occludin at the MDCK cell membrane has only a brief 
half-life of ~15 minutes with very rapid endocytosis and recycling rates 
of <1 minute although degradation is much slower at ~53 minutes 
[Fletcher et al, 2014].  
 A breakthrough in visualising this rapid turnover came with the 
use of fluorescence recovery after photobleaching (FRAP) and 
fluorescence loss in photobleaching (FLIP) techniques used to monitor 
the trafficking of TJ-associated proteins at steady state. In MDCK cells, TJ 
proteins were N-terminally tagged with enhanced green fluorescent 
protein (EGFP) and their mobility assessed [Capaldo and Macara, 2007; 
Shen et al, 2008]. The study by Shen et al was key in understanding the 
correlation between TJ barrier function and mobility of the TJ proteins. 
Figure 1.5 is a schematic depicting the technique used to monitor the 
exchange of proteins between three cellular compartments, the TJ, the 
lateral membrane and the cytoplasm. During microscopy, a laser 
transiently photobleaches the tight junction region of the cell and 
fluorescence recovery or loss patterns are monitored [Shen et al, 2008].   
The mobility of ZO-1, occludin and claudin-1 is distinct and 
recovery of each occurs from a different pool of unbleached fluorescent 
proteins. FRAP demonstrated occludin is highly mobile at the TJ and 
using FLIP, occludin diffused within the TJ and lateral membrane rather 
than between a cytoplasmic pool [Shen et al, 2008]. When the TJ was 
photobleached continuously, occludin was progressively lost from 
around the bleached area and subsequent occludin recovery at the 
photobleached area was fast and began at the edges of the region and 
progressed towards the centre (Figure 1.5B) [Shen et al, 2008]. 
Continuous photobleaching of the cytoplasm further confirmed occludin 
diffusion occurs only within the membrane, as fluorescence was not lost 
at the TJ [Shen et al, 2008]. The authors also discovered claudin-1 
recovery at the TJ was slow and exchange occurred exclusively within the 
TJ. In contrast, ZO-1 recovery was simultaneous at the centre and edges 
of the photobleached region and continuous bleaching of the cytoplasmic 
region caused progressive loss of ZO-1 fluorescence at the TJ, suggesting 
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ZO-1 exchange occurs between the TJ and a cytoplasmic pool [Shen et al, 
2008]. This constant ZO-1 exchange suggests the TJ proteins do not 
always form a stable protein complex with ZO-1 [Shen, 2012].  
Raleigh et al discussed whether ZO-1 could be an intermediate 
between occludin and claudins -1 and -2 [Raleigh, 2011]. The C-terminus 
of occludin interacts with the SH3-hinge-GuK unit of ZO-1 [Bal et al, 2012] 
and subsequently the ZO-1 PDZ domains bind to the C-terminus of 
claudins [Itoh et al, 1999]. However, Cording et al dismissed this 
interaction as in their study the C-terminus of the claudins was 
inaccessible to ZO-1 due to a fluorescent tag yet there were still claudin 
co-polymerisation with occludin. In fact, the authors presented 
quantitative fluorescence resonance energy transfer (FRET) evidence for 
direct molecular interactions between all the TAMPs and claudins 
[Cording et al, 2013]. The TAMPs themselves were able to form 
homophilic and heterophilic complexes as well as heterophilic complexes 
with members of the claudin family and a particularly strong interaction 
was observed between claudin-1 and all TAMPs which drastically 
reduced their membrane mobility [Cording et al, 2013]. Co-
immunoprecipitation between recombinant occludin and claudin-1 
confirmed the occludin C-terminus coiled-coil domain mediates these cis-
interactions but the interaction sites were not identified [Cording et al, 
2013]. Clearly, the mechanisms that anchor claudin-1 to the TJ remain to 
be determined.  
The exact correlation between dynamic exchange of proteins at 
the TJ and barrier regulation at steady state is still being investigated and 
in silico computer modelling will be a useful tool for mechanistic analysis 
of TJ structure and assembly as it has so far been difficult to study at a 
molecular level [Rossa et al, 2015; Zhang et al, 2013]. It is probable that 
stimuli which alter the TJ barrier within minutes such as inflammatory 
cytokines or pathogen infection may also influence the exchange of TJ 
proteins in order to open the TJ barrier without changing levels of protein 
expression and this will be investigated as part of this thesis. 
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A common pathway of TJ regulation in response to these stimuli is 
MLCK activation of the perijunctional actomyosin ring [Turner, 2009]. 
Similar to Na+-nutrient co-transport, cytokine induced MLCK activation 
appears to rapidly and reversibly increase paracellular flux through the 
leak pathway [Clayburgh et al, 2004; Turner et al, 1997] but not the pore 
pathway regulated by claudins, consistent with the fact that claudins do 
not directly interact with actin [Turner, 2009]. Of interest here, increased 
MLCK activation has been associated with IBD [Blair et al, 2006] as well 
as pathogenic infection by E. coli, H. pylori and Giardia [Scott et al, 2002; 
Wroblewski et al, 2009].  
However, the mechanism of TJ regulation by MLCK is not defined; 
MLCK phosphorylation of MLC within the perijunctional actomyosin ring 
activates myosin ATPase and causes changes to circumferential 
cytoskeletal tension and contraction but how this opens the paracellular 
pathway is unclear [Turner, 2009]. Interactions between perijunctional 
actin and ZO-1, occludin, claudins and other TJ proteins are likely to play 
an important role alongside mediators such as myosin ATPase, Rho 
kinases and AMP-activated kinases [Scharl et al, 2009; Shen et al, 2006; 
Van Itallie et al, 2009]. 
Although in progress, much work is still to be done to fully 
understand the connection between TJ architecture, barrier function and 
paracellular permeability of the pore and leak pathways. This is an area 
of great interest at present and considerable research is currently being 
undertaken to piece together a high-resolution three-dimensional model 
of the TJ molecular structure. Molecular characterisation of TJ barrier 
regulation will also be essential for the development of novel therapies 
for intestinal infectious and inflammatory diseases. 
 
 
 
 
 
 
 41 
1.3 Tight Junction Interactions with the Immune System  
 
The SI TJ forms a dynamic barrier between the external contents of 
the lumen and the internal tissues. However, the large surface area and 
selectively permeable barrier of the SI, required for nutrient and water 
absorption, means the SI epithelium is exposed to a vast array of luminal 
food antigens and pathogens [Turner, 2009]. Although bacterial 
colonisation of the SI is low in comparison to the colon, diverse 
interactions also occur with commensal microbiota [Salzman et al, 2007; 
Yurist-Doutsch et al, 2014]. Consequently, the SI epithelium is the 
primary site of contact between luminal antigens and the underlying 
mucosa-associated lymphoid tissue (MALT) [Turner, 2009]. 
The dynamic cross-talk between IECs and the underlying immune 
system protects the host from potentially harmful pathogens whilst 
maintaining ‘tolerance’ to food antigens or commensal microbiota 
[Turner, 2009]. This is essential as an inappropriate immune response 
can lead to allergy or chronic inflammatory disease when directed 
towards dietary antigens or the microbiota [Mayer, 2003; Mowat, 2003].  
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Figure 1.5: Tight junction dynamics assessed by fluorescence recovery 
after photobleaching. A) Before laser pulse. B) A laser is used to transiently 
photobleach a region of labelled TJ proteins. C-D) Time-course of fluorescence 
recovery after photobleaching. E) Recovery occurs from within three cellular 
compartments: TJ, lateral membrane and cytoplasm. Claudin-1 is largely fixed at 
the TJ, occludin exchanges with a small lateral pool (20% of total) and ZO-1 is 
immobile at the TJ and exchanges with an intracellular pool. Image adapted 
from Weber, 2012. 
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The first line of SI defence against infection is the physical barrier 
of the TJ as well as mucus from goblet cells, which traps bacteria, viruses 
and pathogens, which are subsequently expelled from the SI by peristalsis 
[Juge, 2012; Lamont, 1992; Pelaseyed et al, 2014].  
Mucus also contains antimicrobial peptides (AMPs) such as 
defensins, cathelicidins and C-type lectins secreted from Paneth cells, 
which directly kill luminal bacteria, as well as proteolytic enzymes that 
facilitate digestion of polypeptides and IgA that limits bacterial 
association with IECs [Hooper and Macpherson, 2010; Mayer, 2003; 
Salzman et al, 2007].  
The second line of defence is created by leukocytes such as 
macrophages, dendritic cells (DCs), B cells, T cells and intra-epithelial 
lymphocytes (iIELs), which are distributed throughout the SI epithelium, 
within the lamina propria and as organised aggregate follicles such as 
Peyer’s patches [Brandtzaeg et al, 2008; McGhee and Fujihashi, 2012; 
Mowat et al, 2003].  
As part of the rapid innate immune response, intestinal 
macrophages and immature DCs act as phagocytes to clear 
transmigrating commensal and pathogenic bacteria [Banchereau et al, 
2000; Neiss et al, 2005; Schultz et al, 2009; Stagg et al, 2003]. Rescigno et 
al, also described immature DCs as expressing TJ proteins such as 
occludin, claudin-1 and ZO-1, which establish TJ-like structures with 
neighbouring epithelial cells [Rescigno et al, 2001]. By forming these TJ-
like structures in vivo, the authors suggest DCs open TJs, extend dendrites 
through the paracellular space to directly sample bacteria from the lumen 
then shuttle them across the epithelium, whilst maintaining the epithelial 
barrier [Niess et al, 2005; Rescigno et al, 2001; Rimoldi et al, 2004]. Of 
interest here, the presence of occludin in these dendrites appears to be 
sufficient to loosen the TJ contacts, allowing DCs to compete with TJ 
occludin and open up the TJ like a zip [Rescigno et al, 2001], a mechanism 
used by Entamoeba histolica to alter epithelial barrier function [Goplen et 
al, 2013] that could potentially be utilised by T. gondii. Subsequent DC 
acquisition of bacterial antigens from the lumen also causes occludin 
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disappearance from DCs, detachment from TJs and migration to draining 
lymph nodes [Rescigno et al, 2001], a mechanism that is exploited by 
pathogens such as T. gondii to disseminate through the body. It should be 
noted that the existence and purpose of these trans-epithelial dendrites 
remains controversial [Knoop et al, 2013; Nicoletti et al, 2009].  
The SI epithelium also contains intestinal intraepithelial 
lymphocytes (iIELs) located at the basolateral membrane between IECs, 
which form another line of defence against pathogens and maintain 
intestinal homeostasis through immune surveillance and regulation of 
the mucosal immune system [Allison and Havran, 1991; Guy-Grand et al 
1991; Inagaki-Ohara et al, 2005; Kaufmann, 1996]. iIELs include 
conventional T cells as well as subsets of cells expressing a restricted 
repertoire of T cell receptors including γδ T cells and αβ T cells 
[Cheroutre et al, 2011; Ismail et al, 2011] but their function is poorly 
understood [Edelblum et al, 2012].  
γδ iIELs constitutively express occludin, JAM-A and ZO-1 as well as 
AJ β-catenin and E-cadherin which may play a role in preservation of the 
TJ during pathogen infection, although unlike DCs, they do not cross the 
epithelial TJ [Alexander et al, 1998; Cepek et al, 1996; Edelblum et al, 
2012; Inagaki-Ohara et al, 2005]. The lateral location of γδ iIELs between 
epithelial cells suggests they are an important constituent of the TJ 
barrier and their absence or depletion is associated with increased 
susceptibility to infection by enteric pathogens [Andrew and Carding, 
2005; Mixter et al, 1994]. Understanding the mechanism of γδ iIEL 
interactions with the intestinal epithelium and mucosal immune system 
for the detection and eradication of pathogens, whilst maintaining 
tolerance to the commensal microbiota, will be important for 
development of therapeutics against intestinal pathogen infection. Other 
immune cells in the SI include eosinophils and mast cells, which are 
involved in allergic reactions and responses to parasitic worms and 
natural killer cells (NK cells) that recognise and eradicate abnormal cells 
such as tumour cells and virus infected cells [Mowat and Agace, 2014].  
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As described earlier in this chapter, the TJ is affected by stimuli 
such as cytokines [Turner, 2009; Van Itallie et al, 2008; Watson et al, 
2005]. An increase in TNF, IL-1β and IL-16 leads to TJ disruption [Turner, 
2009]. TNF-induced MLCK activation in IBD and CD causes increased 
paracellular flux through the leak pathway as well as immune cell 
activation, including increased lamina propria T cells and DC migration to 
the lamina propria as well as enhanced mucosal IFNγ, TNF and IL-10 
[Baert et al, 1999; Blair et al, 2006; Clayburgh et al, 2006; Su et al, 2009; 
Turner et al, 1997; Wang et al, 2005]. However, the link between TJ 
barrier loss and intestinal inflammation remains controversial. Data from 
both patients and mouse models confirm that defects in the TJ barrier 
alone are not sufficient to cause intestinal inflammation [Turner, 2009]. 
Watson recently raised the question of whether a breech in the TJ barrier 
causes inflammation or if barrier loss is actually a consequence of 
inflammation [Watson, 2015]. This is of clinical relevance because 
intestinal permeability is increased in CD and celiac disease patients as 
well as their apparently healthy or presymptomatic relatives [Hollander 
et al, 1986; Katz et al, 1989; Ukbam et al, 1983]. It appears that an 
increase in TJ barrier permeability, possibly due to an abnormal immune 
response to food and microbiota-associated antigens, and immune cell 
activation are both required to promote the onset of IBD. This is further 
illustrated by both antibiotic use in controlling CD and the absence of the 
microbiota preventing intestinal disease in animal models of IBD [Balish 
and Warner, 2002; Ewaschuk et al, 2006]. 
The diverse interactions between epithelial TJs and the immune 
system in response to stimuli such as cytokines, luminal antigens and 
pathogens highlights the importance of understanding the mechanisms of 
TJ regulation. This indicates a key requirement for further investigation 
of the barrier function of the epithelial TJ to both aid our understanding 
of IBD pathogenesis and to elucidate the role during T.gondii infection. 
Therefore, the in vitro model of the SI utilised in this study provides an 
important insight into this mechanism as it eliminates the immune cells 
in order to strictly observe T. gondii interactions with the TJ.  
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1.4 Toxoplasma gondii  
 
In 1908 Splendore, Nicolle and Manceaux simultaneously isolated a 
new parasite from rabbits and the African rodent Ctenodactylus gundi 
that was subsequently named Toxoplasma gondii in recognition of its 
bow-like shape [Kim and Weiss, 2008]. It is a ubiquitous protozoan 
obligate intracellular parasite of the phylum Apicomplexa that infects all 
warm-blooded animals from mammals to birds and causes toxoplasmosis 
in humans [Su et al, 2003].  
T.gondii is recognised as a significant worldwide zoonotic being one 
of the most significant sources of food-borne disease worldwide 
[Kortbeek et al, 2009] and the most common food-bourne parasitic 
infection requiring hospitalisation [Vaillant et al, 2005].  
T.gondii infection is also associated with considerable economic 
consequences including production losses due to abortion and stillbirth 
in livestock, equating to the loss of 1.5-2 million animals per year in 
Europe in 2007 [Buxton et al, 1998; da Silva and Langoni, 2009; Innes et 
al, 2009; Wang and Yin, 2014]. In France, a national programme for 
detection and treatment of toxoplasmosis in pregantant women has 
reduced the rate and severity of congenital infections but the assays have 
been proven to be poorly reliable and not cost effective [Hill and Dubey, 
2002; Villard et al, 2013]. Other significant human pathogen species in 
the phylum Apicomplexa include Plasmodium, cryptosporidium and 
Neospora [Carruthers, 2002].  
The success of T.gondii in global pathogenesis is linked with its 
broad host range and ability to rapidly cross the restrictive biological 
barriers of the intestine, blood-brain, blood-retina and placenta 
[Barragan and Sibley 2002; Smith, 1995].  
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1.4.1 Toxoplasma gondii Life Cycle and Unique Morphology 
 
T.gondii undergoes both a sexual life cycle that occurs only in the 
feline (definitive host) and an asexual cycle that occurs in all infected 
hosts (intermediate hosts). A brief overview is presented below and 
outlined in Figure 1.6. The primary cat host is infected by any of the three 
infective forms of T.gondii, tachyzoites, bradyzoites or sporozoites and 
ultimately parasites are released as oocytes into the environment [Dubey 
et al, 1998]. One cat can shed 100 million parasites into the environment 
per day during acute infection, effectively increasing the likelihood for 
infection of the next host [Mittal and Ichhpujani, 2011]. Once ingested by 
intermediate hosts such livestock, mice or humans, the oocysts resist 
degradation in the stomach and eventually rupture and release 
bradyzoites into the intestinal lumen [Dubey et al, 1998]. After invasion 
of SI epithelial cells, the parasites convert into proliferative, motile 
tachyzoites. These tachyzoites then undergo an asexual lytic cycle [Hoff 
and Carruthers, 2002] of intracellular growth and multiplication within 
epithelial cells by endodyogeny before cell rupture and egress of 
tachyzoites into both the lamina propria and lumen followed by invasion 
of surrounding SI epithelial cells and dissemination to secondary sites of 
infection, activating an immune response (acute phase). This immune 
response causes conversion from tachyzoites to bradyzoite cysts in 
muscles and the brain (chronic phase) [Blader and Saeij, 2009; Courret et 
al, 2006]. These slow-replicating dormant cysts persist for the life-time of 
the host without causing disease but in rare cases, such as if the 
individual becomes immunocompromised, the cysts rupture causing 
conversion back to tachyzoites that cause systemic disease and possibly 
death of the host [Lyons et al, 2002]. 
Tachyzoites, bradyzoites and sporozoites are morphologically 
similar although they present specific surface antigens and their polar 
composition of organelles and inclusion bodies are distinctive. T.gondii 
tachyzoites and bradyzoites express a number of 
glycophosphatidylinositol (GPI)-anchored surface proteins [Nagel and 
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Boothroyd 1989; Tomavo et al, 1989], the most abundant of which are 
members of the surface antigen-1 (SAG1) or SAG2 families [Boothroyd et 
al, 1998; Burg, 1988; Kasper et al, 1983; Lekutis et al, 2000; Manger et al, 
1998] which are differentially expressed during the different T.gondii life 
stages [Lekutis et al, 2001]. In vitro bradyzoites primarily express SAG2 
whereas tachyzoites primarily express SAG1 and SAG3 [Lekutis et al, 
2000 and 2001]. Interestingly, SAG1 has been demonstrated as a critical 
ligand for promoting tachyzoite attachment and invasion of host cells 
[Grimwood and Smith, 1992; Mineo et al, 1993; Mineo and Kasper, 1994]. 
It has also been suggested that SAG2 and SAG3 facilitate rapid parasite 
invasion [Burg et al, 1988; Cesbron-Delauw et al, 1994; Dzierszinski et al, 
2000; Prince et al, 1990; Tomavo, 1996]. 
T.gondii ultrastructure [Dubey et al, 1998] reveals many 
specialised polar organelles and inclusion bodies as illustrated in Figure 
1.7. These include the outer pellicle membranes, apical microtubule-
containing conoid, secretory rhoptries and micronemes, dense granules 
and the plastid-like apicoplast [Dubey et al, 1998]. All parasite life forms 
possess similar numbers of rhoptries (ROPs) whereas tachyzoites have 
few micronemes compared to bradyzoites and more dense granules 
[Dubey et al, 1998].  
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Figure 1.6 Toxoplasma gondii life Cycle. Oocysts containing sporozoites shed 
from the feline gut are ingested by intermediate hosts such as livestock, mice or 
humans. Proliferative, motile tachyzoites undergo replication and 
dissemination, activating an immune response and causing the initial acute 
stage of infection.  Immune activation induces conversion to the bradyzoites and 
cyst formation during the chronic stage of infection. Re-activation of the acute 
stage of infection can occur following immune suppression such as experiences 
by individuals with AIDS. If the cysts are re-ingested by the primary feline host, 
sexual reproduction can occur within the feline intestine.  
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Figure 1.7: T. gondii bradyzoite and tachyzoite ultrastructure. Schematic 
drawings of T. gondii tachyzoites (left) and bradyzoites (right). Bradyzoites are 
slender with a pointed apical conoid and rounded posterior end. Various 
organelles and inclusion bodies including rhoptries, micronemes and dense 
granules are present and the nucleus is situated towards the posterior end. The 
nucleus is situated towards the centre of the cell and the rhoptries are electron 
dense. Tachyzoites are structurally similar with a crescent shape, more a 
centrally located nucleus and fewer, less dense rhoptries. Tachyzoites measure 
approximately 6μm by 2μm. Image adapted from Dubey et al, 1998. 
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1.4.2 Toxoplasmosis 
 
Toxoplasmosis is widespread throughout the world and in the 
United States and the United Kingdom it is estimated that 16–40% of the 
population are infected, whereas in Central and South America and 
continental Europe, estimates of infection range from 50-80% [Cook et al, 
2000; Dubey and Beattie, 1988; Jones et al, 2001].  
T.gondii infection arises by various routes in both humans and 
veterinary hosts. The highly virulent tachyzoite stage undergoes vertical 
transmission across the placenta barrier during pregnancy and is thus 
frequently associated with abortion, especially in sheep [Lindsay and 
Dubey, 2011]. Rarely, humans are infected by blood transfusion or organ 
transplantation from an infected donor [Derouin et al, 2008]. Most 
commonly, infection is acquired by oral ingestion of bradyzoite tissue 
cysts in raw or undercooked meat, particularly pork or lamb [Tenter et al, 
2000], similarly by oral ingestion of sporulated oocysts from cat faeces 
infected soil, food or water that is dependent on water quality and 
hygiene [Bahia-Oliveira et al, 2003; Bouzid et al, 2008; Isaac-Renton et al, 
1998; Jones and Dubey, 2012]. The occurrence of waterborne infection 
led to the classification of T.gondii as a National Institute of Allergy and 
Infectious Diseases (NIAID) category B priority agent [Kim and Weiss, 
2009]. 
Increased awareness of the hazard to pregnant women caused by 
contaminated cat faeces as well as the risk of undercooked meat has seen 
a decrease in worldwide toxoplasmosis [Kim and Weiss 2008]. Improved 
animal husbandry has also played an important role [Tenter et al, 2000]; 
keeping cats away from pig houses for example drastically reduced 
T.gondii infection of pork in the USA [Dubey, 2009]. 
Immunocompetent individuals usually present no signs of 
infection other than mild flu-like symptoms due to host immune system 
evasion by the parasite and 80-90% of T.gondii infections go 
unrecognised [Mittal and Ichhpujani, 2011]. In the immunocompromised, 
particularly those with HIV/AIDS, infection is associated with severe 
 52 
pathology including ulceration, encephalitis and systemic infection 
caused by breakdown of the epithelial barrier and bacterial translocation 
from the lumen to the lamina propria [Dupont et al, 2012; Heimesaat et 
al, 2006; Kim and Weiss, 2008; Montoya and Lissenfeld, 2004].  
If treated quickly with drugs such as pyrimethamine and 
sulfadiazine before tissue destruction occurs, clinical symptoms can be 
reduced but no drugs currently available eradicate all parasites [Weiss 
and Dubey, 2009]. Despite its clinical importance, relatively few drugs 
against T.gondii are currently available and only one vaccine Toxovax is 
available for use in sheep and goats, although it requires cold storage and 
has a short shelf life [Garcia, 2009; Innes et al, 2011]. 
The most common clinical pathologies presented in association 
with acquired immunodeficiency include ocular toxoplasmosis and 
infection of the central nervous system (CNS) [Montoya and Remington, 
1996; Porter and Sande, 1992]. Interestingly, recent studies have also 
detected possible rodent behavioural changes associated with chronic 
T.gondii infection. Infection influences the behaviour of mice and rats in 
order to heighten their contact with cats, thereby increasing the 
likelihood of parasite transmission to the primary cat host by carnivorism 
[Vyas et al, 2007]. The effect on human behaviour has been a subject of 
great interest. A number of reports have linked T.gondii infection with 
neurological disorders such as schizophrenia [Derouin et al, 2002; Hinze-
Selch et al, 2007; Yolken et al, 2001] or increased risk of being in a car 
accident [Flegr et al, 2002], although verifying this connection may prove 
a challenge.  
Clearly the propagation of parasites across the intestinal TJ barrier 
to secondary tissues is a critical factor in T.gondii pathogenesis and 
elucidating these mechanisms will be critical for development of targeted 
therapeutics preventing parasite spread.  
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1.4.3 Toxoplasma gondii Host Infection and Dissemination  
 
As the most common route of human infection is through oral 
ingestion, the first point of contact between parasites and host is the GIT. 
Therefore, although T.gondii infects most cell types, the SI epithelium is 
the primary target for parasite invasion before tachyzoites ultimately 
enter the host circulation and disseminate to secondary tissues [Dubey et 
al, 1997; Jones and Dubey, 2012; Speer et al, 1998]. T. gondii use a variety 
of strategies to quickly disseminate through the SI, often taking only 15-
40 seconds [Carruthers and Boothroyd, 2007; Egarter et al, 2014; Werk, 
1985]. Using mouse models tachyzoites rapidly disseminate to all organs 
of the body and are detected in the Peyers patches and lymph nodes 
within two days post infection (p.i), in the ilium within five days p.i, and 
in the brain and heart by ten days p.i [Courret et al, 2006; Dubey et al, 
1997]. Importantly, T.gondii tachyzoites transmigrate across epithelial 
cells in vitro within minutes, providing a valuable laboratory model of SI 
epithelial infection [Barragan and Sibley, 2003; Lei et al, 2005; Weight 
and Carding, 2012].  
The crucial step for T.gondii establishment of infection and 
subsequent parasite survival and proliferation is parasite attachment to, 
and invasion of host cells, thus evading host defences [Lei et al, 2005]. For 
over 20 years it has been known that host cell laminin, lectins and SAG1 
act as receptors for tachyzoite attachment and invasion [Furtado et al, 
1992; Kasper and Mineo, 1994; Robert et al, 1991]. Since then various 
mechanisms of host cell infection have been described and it is likely 
T.gondii disseminate using a combination of strategies. For example, 
some sporozoites and bradyzoites pass completely through host cells 
prior to invasion of neighbouring cells [Dzierszinski et al, 2004; Speer et 
al, 1997]. 
The transcellular or active penetration invasion mechanism has 
been well described for T.gondii tachyzoites, bradyzoites and sporozoites 
[Morisaki et al, 1995] and as T.gondii lacks cilia or flagella, host cell entry 
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involves an unusual form of gliding motility [Dobrowolski et al, 1997; 
Plattner et al, 2008].  
 Transcellular invasion occurs in a series of stages, as depicted in 
Figure 1.8, including host cell attachment, conoid extension, parasite 
reorientation, secretion of organelle contents and moving junction (MJ) 
formation [Carruthers and Boothroyd, 2007]. The parasite then actively 
enters the cell through the MJ into the non-fusogenic parasitophorous 
vacuole (PV) using its actomyosin motor complex before separating from 
the host plasma membrane [Carruthers and Boothroyd, 2007]. 
Ten years ago Barragan et al first described a significant 
proportion of tachyzoites clustering within 5μm of an intercellular 
junction during early infection as well as observing parasites between 
host cells, adjacent to TJs, which suggested parasites utilise the 
paracellular route to actively cross the epithelial barrier, avoiding 
damage to the epithelium and subsequent initiation of an inflammatory 
response as well as bypassing intracellular replication. Further evidence 
was provided by the fact that transmigration of the parasites did not alter 
monolayer barrier integrity. These observations led to the authors to 
investigate parasite- and host-derived molecules involved in T. gondii 
attachment and invasion. Host recombinant ICAM-1 (intercellular 
adhesion protein-1) was first found to be upregulated on cellular barriers 
during transmigration but not cellular invasion, confirmed by human 
ICAM-1 antibodies inhibiting parasite transmigration [Barragan et al, 
2005]. Subsequent ICAM-1 immunoprecipitation identified T. gondii 
MIC2, a microneme adhesion protein secreted from the apical microneme 
organelle onto the parasite surface, to be involved in parasite 
transmigration of the host epithelium in order to disseminate to deeper 
tissues [Carruthers and Tomley, 2008].  
Although parasite-host interactions clearly play a role in parasite 
transmigration, as demonstrated by ICAM-1 interaction with MIC2, it has 
not been confirmed how parasite binding to host molecules facilitates 
paracellular transmigration.  
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Figure 1.8: T. gondii transcellular invasion mechanism. 1) Initial attachment 
to the host cell surface via SAGs precedes 2) conoid extension, release of MICs 
and apical attachment. 3) Invasion is initiated by secretion of RONs and 
association with microneme-derived AMA1, which forms the ring-like MJ. 4) The 
parasite re-orientates and ROPs are discharged from rhoptries into the host 
cytoplasm where they associate with the developing PV or remain soluble. 5) 
The parasite actively invades through the MJ, creating the invaginated PV. 6) 
Once internalised, the PV is closed and 7) the parasite separates from the host 
plasma membrane and dense granules are released and associate with the PVM. 
Steps 2-5 take only 15-20 seconds whereas the final steps 6-7 take 1-2 minutes. 
Magnified view of tachyzoite (inset). Figure adapted from Carruthers and 
Boothroyd, 2007. 
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As the molecular mechanism behind this route of T. gondii transmigration 
of the SI is still not understood, it will be investigated as part of this 
thesis. 
 
1.4.4 Toxoplasma gondii Virulence Factors 
 
Potential disease outcome of T. gondii infection is highly 
dependent on parasite virulence. Surprisingly, T. gondii population 
biology has identified only a few dominant strains; serology samples from 
humans and domestic or farm animals from North America and Europe 
were grouped into clonal lineages termed types I, II and III [Howe and 
Sibley 1995; Sibley and Ajioka, 2008] and the recently discovered 
haplotype 12 [Khan et al, 2011]. The clonal types are closely related [Saeij 
et al, 2005] and possess different virulence within and between host 
species; type I is most virulent in mice, type II in humans, type III in 
livestock and type 12 in wild animals [Boothroyd and Grigg, 2002; Howe 
and Sibley, 1995; Khan et al 2011]. These differences are also reflected in 
human disease; ocular toxoplasmosis in humans is associated with Type I 
but not type II or III strains [Grigg et al, 2001].  
The Institute for Genomic Research (TIGR) has generated near 
complete genomes of the GT1, ME49 and VEG strains of T. gondii (Types I, 
II and III respectively) and the Wellcome Trust Sanger Centre 
complemented this with the sequencing of chromosomes 1A and 1B from 
strain RH (Type I) [Khan et al, 2006]. This data including genome 
sequences is freely available at the genome database ToxoDB available at 
www.toxoDB.org [Gajria et al, 2008]. This wealth of T. gondii genetic 
information has led to many functional genomics studies.  
Although it is unclear how the T.gondii population structure 
evolved, expansion of the lineages dates back ~10,000 years, correlating 
with the domestication of animals by humans [Su et al, 2003]. The 
population profile of T.  gondii also has a clear divide between 
Europe/North America and South America, as the majority of human 
cases of toxoplasmosis in Europe/North America are associated with 
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Type II strains whilst in South America higher incidence of Type I is 
reported. [Ferreira et al, 2008; Howe et al, 1997; Su et al, 2012]. 
Expressed sequence tag (EST) alignment of the three lineages to the 
partial ME49 or whole T. gondii genome gave an insight into parasite 
ancestry. Different Types I and III appear to be derived from type II with a 
very limited number of genetic crosses [Bontell et al, 2009; Boyle et al, 
2006]. Forward-genetics and quantitative trait loci (QTL) mapping 
identified some of the genes responsible for the phenotypic and virulence 
differences between types I, II and III in mice and they appear to be 
closely associated with the host immune response [Sibley et al, 2009]. In 
mice type I are virulent as they cause lethal acute stage infections 
whereas types II and III are associated with formation of chronic 
infections [Appleford and Smith, 2000; Howe et al, 1996; Suzuki et al, 
1989].  
As described above, an important step during T. gondii infection is 
organelle content secretion into the host cell. Consequently, ROP18 has 
been identified as a major contributor to differences in virulence [Saeij et 
al, 2006; Taylor et al, 2006]. ROP18 is a secreted serine-threonine kinase 
that is found on the PV membrane (PVM) surface and expression is high 
in virulent types I and II but low in type III [Khan et al, 2009]. Subsequent 
genetic crosses between types likely led to kinases such as ROP16 and 
ROP5 that differentially regulate host gene transcription [Behnke et al, 
2011; Fentress et al, 2012; Reese et al, 2011; Saeij et al, 2007]. It appears 
that in mice, highly virulent type I strains highly express ROP18 and 
ROP5, which cooperatively phosphorylate host immunity-related 
GTPases (IRGs) to inhibit parasite clearance in IFN-γ activated cells 
[Hunter and Sibley, 2012]. Additionally, T. gondii dense granule protein 
GRA15 is associated with reduced macrophage IL-12 production via 
transcription factor NFκB in virulent type I strains [Robben et al, 2004]. 
In contrast, in type II strains ROP5 is avirulent, leading to reduced IRG 
phosphorylation and less inhibition of parasite clearance. Also, type II 
GRA15 increases macrophage production of IL-12, resulting in more 
effective parasite clearance. Type III strains do not express ROP18 so 
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parasites are effectively cleared [Hunter and Sibley, 2012], which could 
explain why types II and III are less virulent in mice. Consequently, each 
strain appears to be adapted for interactions with specific host cellular 
responses, such as the immune system, in order to propagate infection of 
the primary feline host [Khan et al, 2009].  
In silico approaches are increasingly being used to identify new 
genes of interest or genetic pathways. For example Chen et al identified 
60 candidate T. gondii secretory proteins and using protein-protein 
interaction data, identified potential interactions with the host cell [Chen 
et al, 2008]. Recently, Lorenzi et al used a comparative genomics 
approach with 62 strains of T. gondii and found both large regions of 
conserved genes and specific regions enriched in copy number variation 
(CNV) and tandem duplication. The authors found these regions were 
associated with secretory pathogenicity determinants (SPDs); genes 
encoding secretory proteins in MICs, GRA, ROPs and the SRS superfamily 
that are associated with host transmission and infection. Highly diverse 
regions were particularly linked to GRA, ROP and SAG genes such as 
ROP17, ROP5, GRA3 and SAG3 and SAG2A which have been previously 
implicated in murine virulence differences between strains. In contrast, 
MICs associated with host attachment were found to be highly conserved, 
suggesting T. gondii strains may utilise a similar repertoire of these host 
MIC receptors [Lorenzi et al, 2016].  
 Manipulation of the T. gondii genome has also facilitated the 
creation of KO mutant strains [Saeij et al, 2008] to assess the genetic basis 
of migration, virulence and growth [Saeij et al, 2005]. For example KO of 
SAG3 [Dzierszinski et al, 2000], GRA2 [Mercier et al, 1998], MIC1 and 
MIC3 [Cerede et al, 2005] all decrease T.gondii virulence in mice. Of note, 
incorporation of fluorescent markers such as GFP, YFP or mCherry into 
the T.gondii genome has permitted parasite detection and imaging of 
processes such as stage conversion or phagocytosis both in vitro and in 
vivo [Dupont et al, 2014; Gubbels et al, 2003; Hitziger et al, 2005; Unno et 
al, 2009; Zhang et al, 2013]; a property utilised in this thesis. 
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The work in this thesis aims to further our understanding of 
parasite host interactions by investigating host cell modulation during 
infection using the IEC-6 cell line. 
 
 
1.5 Toxoplasma gondii Interactions with Occludin 
 
 Since Barragan et al, 2005 first described the exploitation of the 
paracellular pathway as a mechanism of infection by T. gondii, the role of 
TJ proteins, particularly the transmembrane proteins, during infection 
has begun to be investigated [Barragan et al, 2005].  
 In 2006, Dalton et al identified an increased susceptibility to 
infection and an in vivo change in occludin distribution in response to T. 
gondii or Salmonella typhimurium infection of mice lacking γδ+ iELs. 
Within one hour of infection of wild type mice there was a striking 
redistribution of occludin and ZO-1 to the apical TJ, whereas in KO mice 
no redistribution occurred. The difference in occludin redistribution 
observed in γδ+ iEL KO mice was linked to an absence of occludin serine 
phosphorylation and lack of claudin-3 and ZO-1 at the TJ [Dalton et al, 
2006]. The authors concluded that γδ+ iELs played a critical role in 
maintaining TJ integrity and barrier function in response to T. gondii 
infection in mice [Dalton et al, 2006]. 
 Following on from this Weight, 2011 confirmed a role for occludin 
in T.gondii infection [Weight, 2011; Weight and Carding, 2012]. The 
authors assessed the previous findings using m-ICc12, a murine SI 
epithelial cell line [Bens et al, 1996]. In accordance with Barragan et al, 
2005, the authors found tachyzoites cluster to cellular junctions and 
transmigrate through the SI epithelial barrier without altering barrier 
function [Weight, 2011]. After establishing that occludin was the only TJ 
protein affected by parasite infection, they found the parasite co-localises 
and interacts with occludin and a route of invasion was speculated: 
parasites cluster to cellular junctions and move between cells, associating 
with the extracellular loops of occludin which aids migration through the 
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paracellular pathway. It was also found that during T. gondii infection, 
occludin was displaced from the TJ to an intracellular compartment, 
suggesting a change in phosphorylation status [Weight, 2011]. 
 The work presented in this thesis will further investigate T.gondii 
infection mechanisms in vitro, with a focus on the role of occludin, using a 
SI epithelial cell line. 
 
 
1.6 Rationale 
 
The small intestinal permeability barrier is dependent on TJ 
complexes that separate the external lumen from the underlying mucosa. 
Apical TJs consisting of integral transmembrane proteins including 
occludin, form a dynamic multimolecular complex that selectively 
regulates the paracellular transport and flux of ions and molecules 
through the small intestinal epithelium. Being the first point of contact 
between host and luminal pathogens and toxins, the small intestinal 
epithelial TJ complex also constitutes a highly resistant barrier, 
preventing chronic infection of the underlying tissues. Occludin forms 
part of a complex that seals the paracellular space between neighboring 
cells and this pathway can be targeted by the pathogenic protozoan 
parasite T. gondii to transmigrate the epithelium, although the 
mechanism of paracellular invasion is unclear. The redistribution of 
occludin to and from the tight junction during T. gondii invasion of the 
small intestine is associated with occludin phosphorylation status. 
Further investigation is required to determine the role of occludin in T. 
gondii transmigration of the small intestine and is presented in this 
thesis. The findings will extend the current understanding of pathogen 
infection of the small intestine and potentially present novel targets for 
future therapeutics. 
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1.7 Hypothesis 
 
T. gondii infects the SI epithelium via the paracellular pathway and 
occludin plays a key role both in regulation of the TJ paracellular barrier 
by acting as a receptor for T. gondii infection by direct binding and by 
parasite-mediated modulation of the occludin C-terminus 
phosphorylation status. 
 
 
 
1.8 Aims 
 
The role of the SI epithelial TJ barrier during T. gondii infection will 
be investigated to increase our current understanding of the molecular 
mechanisms of T. gondii paracellular transmigration of the epithelium. 
Following on from the study by Weight, the importance and role of 
occludin during T. gondii infection will be examined. 
 
 Visualise T. gondii paracellular transmigration of SI epithelial cells 
using an in vitro model  
 Ascertain the involvement of TJ-associated proteins in T. gondii 
infection 
 Identify changes in occludin phosphorylation in response to T. gondii 
infection 
 Determine if T. gondii directly interacts with occludin and if so what 
the molecular basis of the interaction with occludin is 
 
 
 
 
 
 
 
 62 
2 Materials and Methods 
 
2.1 Commercial Suppliers 
 
All general reagents and materials were purchased from Sigma-
Aldrich unless otherwise stated. A full list of reagents, antibodies, cell 
stains and suppliers are provided in Tables 2.1 and 2.2. 
 
 
2.2 Cell Line Culture 
 
Rat SI epithelial cell line (IEC-6) [Quaroni et al, 1979] were 
obtained from the European Collection of Cell Cultures (ECACC) and 
maintained by serial passage in DMEM (Lonza, Basel), supplemented with 
2mM/L L-glutamine, 0.1 IU/ml Insulin and 5% FBS (Biosera) at 37°C in 
5% CO2/95% air atmosphere.  
Murine small intestinal epithelial cell line (m-ICc12) provided by 
Alain Vandewalle (Inserm U246, Paris, France, [Bens et al, 1996]), were 
maintained by serial passage in 1:1 DMEM:HAMSF12 (Lonza) 
supplemented with 2mM/L L-glutamine, 0.1 IU/ml Insulin and 5% FBS 
(Biosera) at 37°C in 5% CO2/95% air atmosphere. 
 
 
2.3 T. gondii Culture 
 
The type 1 RH strain of T. gondii tachyzoites stably expressing YFP 
[Gubbels and Striepen, 2003] were maintained by continuous passage in 
confluent monolayers of Hs27 HFF (European Collection of Cell Cultures) 
in DMEM supplemented with 2 mmol/L l-Glutamine and 10% FBS at 37C 
in 5% CO2. Pelleted parasites were collected after 90% HFF lysis by 
centrifugation at 1000 g for 15 min. 
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Product Supplier 
Catalogue 
No. 
35 mm μ-dishes  IBIDI 81156 
13mm glass coverslips  BDH 631-0149 
660nm Protein Assay kit Pierce 22660 
660nm protein assay kit  Pierce 22660 
Amicon Ultra 0.5ml 1kDa Centrifugal Filter Merck Millipore UFC5003BK 
ATP  NEB P07565 
CellTracker™ Red CMPTX  Molecular Probes C34552 
CKII enzyme  NEB P60105 
CKII peptide substrate Promega V5661 
Collagen I Sigma C7661 
Criterion XT MES BioRad 1610789 
Criterion XT precast Bis-tris gel 10% IPG+1 well 
comb 11cm 
BioRad 3450115 
DePeX BDH 101410-638 
DMEM Lonza BE12-604F 
E. coli Rosetta2 (DE3) pLysS Novagen 71403 
E.Z.N.A Plasmid DNA Mini Kit Omega Bio-tek D6942 
FBS Biosera FBS1000HI 
Fibronectin Sigma F1141 
FITC-dextran 3-5kDa Sigma FD4-100MG 
Float-a-lyzer  Spectrum Labs 
G235027, 
G235065 
GelCode Blue Thermo Scientific 24590 
Glutanyl Endopeptidase Roche Diagnostics 11814021 
Halt protease and phosphatase inhibitor cocktail Thermo Scientific 78441 
HAMSF12 Lonza BE12-719F 
Hs27 HFF  ECACC 94041901 
IEC-6 ECACC 88071401 
Immobiline DryStrip 11cm pH3-11NL GE Healthcare 17-6003-74 
Immobiline DryStrip cover fluid GE Healthcare 17-1335-01 
Immobiline IPG buffer pH3-11NL  GE Healthcare 17-6004-40 
Kinase buffer NEB 9802 
L-Arg-HCl Invitrogen 32460 
L-Lys-HCL Invitrogen 32461 
Matrigel Corning 356237 
Table 2.1 List of reagents. Continued p64. 
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Product Supplier 
Catalogue 
No. 
mem-PER plus membrane protein extraction kit Thermo Scientific 89842 
m-PER mammalian protein extraction kit Thermo Scientific 89842 
Nexterion  Slide H Schott 1070936 
Ni-NTA agarose  Qiagen 30230 
Ni-NTA Superflow Columns  Qiagen 30622 
NuPAGE antioxidant Invitrogen NP0005 
NuPAGE Bis-Tris gels  Invitrogen NP0302 
NuPAGE Bis-Tris gels  Invitrogen NP0342 
NuPAGE Bis-Tris gels  Invitrogen NP0322 
NuPAGE LDS sample buffer  Invitrogen NP0007 
NuPAGE MES  Invitrogen NP0002 
NuPAGE MOPS  Invitrogen NP0001 
NuPAGE reducing agent (10x)  Invitrogen NP0004 
NuPAGE transfer buffer  Invitrogen NP0006 
PBS Lonza 17-517Q 
pET15b  Novagen 69661 
p-NPP NEB P0757S 
ProLong Gold antifade mountant with DAPI  Invitrogen P36935 
ProQ Diamond Invitrogen P33300 
PVDF membranes  Invitrogen LC2002 
Pvu1 restriction enzyme NEB R0150 
Quant-IT protein assay kit  Molecular Probes Q33210 
SILAC Media Kit Invitrogen MS10030 
SpectraGel Absorbant  Spectrum Labs 292600 
SuperSignal West Pico Chemiluminescent 
substrate  
Pierce 34080AB 
SYPRO Ruby Invitrogen S12000 
Transwell 24 well hanging PET Inserts, 8 μm 
pore size 
BD Biosciences CLS3422-48EA 
Trypsin Gold  Promega V5280 
Vectashield anti-fade mounting medium with 
DAPI  
Vector Labs H-1500 
Table 2.1 List of reagents.  
 
 
 
 
 
 
 65 
 
 
 
 
 
 
Product Supplier 
Catalogue 
No. 
Biotin-XX goat anti-rabbit IgG Invitrogen B2770 
CellTracker Red CMPTX dye Molecular Probes C34552 
Cy5 conjugated goat anti-mouse IgG Jackson Immunoresearch 115-175-166 
Donkey anti-goat IgG FITC-conjugate  Santa Cruz Biotechnology sc2024 
Donkey anti-goat IgG HRP-conjugate Santa Cruz Biotechnology sc2020 
Donkey anti-goat IgG Texas Red-
conjugate 
Santa Cruz Biotechnology sc2783 
Donkey anti-mouse IgG HRP-conjugate Santa Cruz Biotechnology sc2314 
Donkey anti-rabbit IgG HRP-conjugate 
Santa Cruz 
Biotechnology  
sc2313 
GAPDH anti-rabbit IgG  Santa Cruz Biotechnology sc25778 
Goat anti-occludin C-terminus   Santa Cruz Biotechnology sc8144 (C19) 
Goat anti-occludin ECL Santa Cruz Biotechnology sc27151 (Y12) 
Goat anti-rat IgG HRP-conjugate 
Santa Cruz 
Biotechnology  
sc2006 
Goat anti-rat IgG-texas red conjugate Santa Cruz Biotechnology sc2782 
Hoechst 33342 Invitrogen H1399 
IgG controls Vector Labs BA-4000 
IgG controls Vector Labs I-5000 
IgG controls Vector Labs I-2000 
IgG controls Vector Labs I-4000 
Mouse anti-β catenin  BD Biosciences 610154 
Rabbit anti-occludin  Invitrogen 71-1500 
Rat anti-ZO-1 Santa Cruz Biotechnology sc33725 
Rhodamine labelled peanut agglutinin Vector Labs RL-1072  
Table 2.2: List of antibodies and cell stains. 
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2.4 Alkaline Phosphatase Assay 
 
 
IEC-6 cells cultured in plastic 25cm2 flasks were rinsed twice with 
1ml 1xPBS, removed from the flask using a cell scraper and transferred to 
a 15ml Falcon tube and centrifuged at 600✕g for 5 minutes and the 
supernatant discarded. The pellet was re-suspended in 100μl p-
Nitrophenyl Phosphate (p-NPP) solution (1mg/ml n-NPP (NEB) in 10mM 
diethanolamine, 0.5mM MgCl2, pH 10.5) for 20 minutes at RT. Adding 
50μl 1N NaOH stopped the reaction and the p-nitrophenol product 
absorbance was read at 405nm and compared to a standard curve of ALP 
activity (U). 
 
 
2.5 Immunocytochemistry  
 
IEC-6 cells plated onto the apical compartment of polyethylene 
terephthalate (PET) cell culture transwell inserts (8µm pore size, BD 
Biosciences) within a 24 well plate were washed in 1xPBS, fixed in either 
2% formaldehyde for 20 minutes or acetone for 5 minutes followed by 5 
minutes in rehydration buffer (1% BSA in 1xPBS). Cells were then 
permeabilised with 0.2% Triton X-100 for 10 minutes and incubated with 
blocking buffer (0.2% Triton X-100, 3% BSA, 3% goat serum, 3% fish skin 
gelatin in PBS) for 1 hour. All reagents were added to both the apical and 
basal compartments of PET inserts. The PET membranes were extracted 
from the insert and incubated with primary antibodies including occludin 
(Invitrogen), ZO-1 (Santa Cruz) and β-catenin (BD Biosciences), diluted in 
blocking buffer for 20 hours at 4°C. Controls consisted of either no 
primary antibody or isotype matched antibodies. Membranes were 
washed 3 times in 1xPBS prior to secondary or tertiary antibody 
incubation for 2 hours at RT in a humidified chamber in the dark. A 1:1 
mixture of Rhodamine-peanut and -wheat germ agglutinin (Vector Labs) 
was used to visualise surface cell carbohydrates. The membrane was 
mounted by placing cell side up on a glass microscope slide with DePeX 
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(BDH), Vectashield with DAPI (Vector Labs) or ProLong Gold with DAPI 
(Invitrogen) and covering with a glass coverslip and storing at 4°C in the 
dark. To visualise intracellular parasites, IEC-6 cells grown on PET inserts 
were infected with T. gondii for 2 hours before removing and washing 
with 1xPBS to remove unattached parasites prior to PET membrane 
extraction, fixation with 2% formaldehyde, permeabilisation, incubation 
and mounting as above.  
 
 
2.6 Fluorescence or Confocal Microscopy 
 
After mounting slides, fluorescence microscopy images were 
viewed using an inverted Zeiss AxioVert 200M microscope with the 40x 
objective unless otherwise stated. Images were analyzed on LSM software 
or AxioVision image viewer. Confocal microscopy images were viewed 
using an upright or inverted LSM510 META on a Zeiss AxioVert 200M 
microscope. Z stacks were composed of 1μm interval sections with the 
40× objective unless stated otherwise. To visualize occludin by Z stack, 
cells were marked for the apical and basal membrane using rhodamine 
labelled surface carbohydrates and the surface of the PET membrane.  
Rhodamine and Texas Red fluorochromes were excited by the 543nm 
laser, YFP-RH T. gondii and Alexa Fluor 488 by the 488nm laser, DAPI, 
Hoechst or Pacific Blue by the 405nm laser and Cy5 by the 633nm laser. 
All laser intensities were consistent within and between experiments.  
 
 
2.7 Immunoblotting 
 
IEC-6 cells cultured in plastic 25cm2 flasks were rinsed with 1ml 
ice-cold 1xPBS, removed from the flask using a cell scraper and 
transferred to a chilled Eppendorf. Cells were lysed using either m-PER or 
mem-PER protein extraction kits (Thermo Scientific) supplemented with 
Halt protease and phosphatase inhibitor cocktail (Pierce) and 50 mmol/L 
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phenylmethysulfonyl fluoride (PMSF) according to the manufacturer’s 
instructions. Protein quantification was determined using the 660nm 
protein assay kit (Pierce). Samples were separated using NuPAGE Bis-
Tris pre-cast gels (10%, 12% or 4-12%, Invitrogen). 10-20μl samples 
were prepared for SDS-PAGE by adding NuPAGE LDS sample buffer (4x), 
NuPAGE reducing agent (10x) and deionized water and heating at 70°C 
for 10 minutes. 1x SDS running buffer was prepared by adding 50ml of 
20x NuPAGE MES or MOPS SDS running buffer (Invitrogen) to 950ml of 
deionized water. The upper chamber of an XCell SureLock mini-cell gel 
running tank (Invitrogen) was filled with 200ml 1xSDS running buffer 
and 500μl NuPAGE antioxidant. The gels were placed in the gel tank and 
the tank filled with 1x running buffer prior to gel loading alongside a pre-
stained molecular marker (10-170kDa, Fermentas). When using MES 
running buffer gels were run for 35 minutes at 200V constant and when 
using MOPS running buffer gels were run for 50 minutes at 200 V 
constant.  
Immunoblotting was carried out using the using the XCell II Blot 
Module (Invitrogen) according to manufacturer’s instructions. Briefly, 
after electrophoresis, proteins were transferred onto pre-cut PVDF 
membranes (Invitrogen) using transfer buffer consisting of 50ml NuPAGE 
transfer buffer (20x), 1ml NuPAGE antioxidant, 100ml methanol and 
849ml deionized water at 30V constant for one hour. Membranes were 
subsequently washed, blocked in 5% BSA in Natt buffer (150 mM NaCl, 
20 mM Tris Base, 0.1% Tween-20, pH 7.4) for one hour at RT, shaking. 
Proteins were detected by incubating in 1% BSA in Natt buffer with 
primary antibodies for 12 h at 4 °C. Membranes were washed 6x for one 
hour in Natt buffer before addition of secondary HRP conjugates (Santa 
Cruz) in 1% BSA in Natt buffer for one hour at RT. Membranes were 
washed as previous before the addition of 1:1 volume of enhanced 
SuperSignal West Pico Chemiluminescent substrate (Pierce) for 5 
minutes and visualisation with a FluorChem E system (ProteinSimple) 
and Digital Darkroom software (ProteinSimple). Membranes were 
washed as previous, stripped by incubating in 1:20 dilution acetic 
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acid:1xPBS for one hour and washed in Natt buffer for one hour prior to 
probing for a second protein. 
 
 
2.8 Transepithelial Electrical Resistance (TEER) and 
Permeability 
 
 IEC-6 cells were plated onto the apical compartment of PET cell 
culture transwell inserts (8µm pore size, BD Biosciences) within a 24 well 
plate. TEER measurements were performed using an Epithelial Tissue 
Volt Ohmmeter 2 and Endohm chamber (EVOM, World precision 
instruments) voltmeter to assess paracellular ion flux across the 
epithelium. TEER values of the cell monolayer were obtained by 
subtracting the contribution of a blank insert and culture medium. . 700μl 
of pre-warmed cell media was placed in the basal Endohm compartment 
and 200μl in the apical insert compartment before being allowed to 
equilibrate to 15 minutes. Ohm’s law was then used to calculate 
resistance using the equation: 
 
𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 =  (𝑅𝑐 − 𝑅𝑖)𝜋𝑟2  
 
Where Rc is the resistance of the cells on the insert, Ri is the resistance of 
the insert and r is the radius of the insert.  
The insert was then placed back in the 24 well plate and barrier 
permeability assessed by measuring the diffusion of 1000μg/ml FITC-
conjugated dextran (3 - 5kDa, 1mg/ml; Sigma-Aldrich) from the apical to 
basal compartment. Apical and basal media were collected in 1ml 
Eppendorf’s and centrifuged at 1000✕g for 10 minutes. The supernatant 
was transferred to a new Eppendorf and 100μl transferred to a black 96 
well microplate. The concentration of FITC-dextran was determined from 
a standard curve (excitation 490nm, emission 520nm). 
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2.9 Recombinant Occludin Peptides 
 
 
2.9.1 Cloning of Occludin EC1, ECL2, ECL1+ECL2 and C-
terminus into the 6xHIS-tagged expression vector 
pET15b 
 
DNA regions coding for extracellular loop (ECL) 1 (residues 85 to 
138) (184bp) ECL2 (residues 191 to 241) (167bp), ECL1+ECL2 (residues 
85 to 241) (485bp) and C-terminus (residues 261 to 521) (800bp) 
murine occludin fragments were PCR amplified from pBABE-FLAG + Occ 
plasmid DNA (Britta Engelhardt, Theodor Kocher Institute, University of 
Bern, Switzerland) [Bamforth et al, 1999] (Appendix A) using the 
following primer pairs: ECL1-F, ATGCCATATGACACTTGCTTGGGACAG-3′ 
and ECL1-R, 5′- AGCAGCCGGATCCTAGCCTTTGGCTGCTCTTGGGT-3′ (full 
length ECL1); ECL2-F, 5′-ATGCCATATGATAATGGGAGTGAACCC-3′ and 
ECL2-R, 5′-ATGGATCCTACTGGGGATCAACCACAC-3′ (full length ECL2); 
ECL1-F, 5′-ATGCCATATGACACTTGCTTGGGACAG-3′ and ECL2-R, 5′- 
ATGGATCCTACTGGGGATCAACCACAC-3′ (full length ECL1+ECL2); and C′-
F, 5′- ATGCCATATGGCTGTGAAAACCCGAAG-3′ and C′-R, 5′- 
ATGGATCCTAAGGTTTCCGTCTG-3′ (full length C-terminus). PCR products 
were cloned into the NdeI and BamHI sites of the expression vector 
pET15b (Novagen) (Appendix A) and sequence-verified prior to 
transforming Escherichia coli Rosetta2 (DE3) pLysS (Novagen). Occludin 
C-terminus, ECL1+ECL2 and ECL2 were previously cloned by Nikki Horn 
(Institute of Food Research) [Weight, 2011] and ECL1 cloned by E. Jones 
and Dr Duncan Gaskin (Institute of Food Research] as part of this thesis. 
The ECL1 sequence was verified by Eurofins (UK) using primers: ECL1-F 
5’-TCACCCTGGATGCTGTAGGCA-3’and ECL1-R 5’-
CGATCTTCCCCATCGGTGAT-3’. 
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2.9.2 Purification of Occludin ECL1, ECL2, ECL1+ECL2 and C-
terminus peptides 
 
E. coli expressing His-tagged-protein products were purified using 
Ni-NTA agarose and Ni-NTA Superflow Columns (Qiagen) under 
denaturing conditions according to the manufacturer's instructions. 10ml 
Luria-Bertani (LB) media supplemented with 200 μg/ml ampicillin and 
35 μg/ml chloramphenicol were inoculated with E.coli containing the 
recombinant plasmids for 20 hours at 37°C shaking at 250rpm. 2.5ml 
culture was subcultured into 250ml pre-warmed LB media supplemented 
with antibiotics in a 2L conical flask and grown at 37°C, 250rpm shaking 
until the optical density at 600nm (OD600) reached 0.6. Expression of 
occludin was induced by adding 2mM of isopropyl-beta D-
thiogalactopyranoside (IPTG) and incubating at 37°C, 250rpm shaking for 
until the OD600 reached 1.0. The cultures were transferred to ice-cold 
50ml falcon tubes and centrifuged at 4000✕g for 20 minutes at 4°C. The 
supernatant was removed and the pellet frozen at -20°C.  
Bacterial pellets were thawed and resuspended in 10ml Buffer B 
(8M urea, 10mM NaH2PO4, 10mM Tris-Cl, pH 8.0) and incubated with 
agitation for 60 minutes at RT before centrifuging at 14,000✕g for 30 
minutes at RT and retaining the supernatant (cleared lysate: CL). 1ml Ni-
NTA agarose was added to Ni-NTA Superflow columns (Quiagen) and 
washed with Buffer B prior to adding lysate supernatant and collecting 
the flow through (FT). The Ni-NTA column was then washed with 4ml 
Buffer C (8M urea, 100mM NaH2PO4, 10mM Tris-Cl, pH 6.3) three times 
and the fractions collected (W1-W3). The occludin peptides were eluted 
five times with 1ml Buffer E (8M urea, 100mM NaH2PO4, 10mM Tris-Cl, 
pH 4.5) (E1-E5).  
Protein quantification was determined using the 660nm protein 
assay kit (Pierce) and samples were concentrated using 1ml 0.5-1kDa 
float-a-lyzer dialysis device and SpectraGel Absorbant (Spectrum Labs). 
Concentrated samples were renatured by removal of the urea in 6 
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sequential dialysis steps with 50 mM Tris (pH 8) buffer containing 8, 6, 4, 
2, 1, 0.5M urea and no urea. All dialysis was performed in the presence of 
100 mM NaCl, 10% glycerol and 1 mM PMSF.  
 
 
2.9.3 Analysis of Occludin EC1, ECL2, ECL1+ECL2 and C-
terminus peptides 
 
 The purity of the recombinant occludin peptides was determined 
by SDS-PAGE and GelCode Blue staining (Thermo Scientific) or 
immunoblotting using antibodies specific for occludin C-terminus and 
ECL (Cell Signalling) (Figure 2.1). Protein quantification was determined 
using the 660nm protein assay kit (Pierce) or the Quant-IT protein assay 
kit (Molecular Probes).  
 
 
2.9.4 Transmigration and Infection Assay 
 
IEC-6 or m-ICcl2 cells were cultured in the apical compartment of 
PET cell culture transwell inserts (8 μm pore size, BD Biosciences) within 
a 24 well plate and barrier function assessed every 24 hours by TEER as 
described in section 2.8. At 7-13 days post-seeding TEER was measured 
prior to removal of the apical media and re-suspension of 5x106 pelleted 
RH-YFP T. gondii tachyzoites and addition to the apical PET compartment 
for 2 hours. 
3-5kDa FITC-conjugated dextran was added to the apical 
compartment of some PET inserts to measure barrier function during 
infection. TEER was then recorded and apical and basal media removed 
for analysis of permeability as described in section 2.8 and flow 
cytometry as described below. PET membranes were excised and 
analysed by immunocytochemistry and confocal microscopy as described 
in section 2.5. 
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To visualise attached and intracellular parasites, IEC-6 or m-ICcl2 
were cultured on 13mm glass coverslips (BDH) for four days prior to 
addition of 5x106 RH-YFP T. gondii tachyzoites for 2 hours before washing 
and removal of unattached parasites. Cells were fixed in 2% PFA for 20 
minutes and permeabilised in 0.2% Triton-X-100 for 10 minutes before 
H&E counterstaining, mounting as described in section 2.5 and viewing 
using an inverted Zeiss AxioVert 200M microscope. Images were 
analyzed using AxioVision image viewer.  
 Transmigrating parasites were identified from the basal 
compartment by centrifugation and analysis by flow cytometry using a 
Cytomics FC500 MPL (Beckman Coulter). Data was analysed post-
collection using FlowJo version 10 (TreeStar).  
 
 
2.10 Live Cell Imaging 
 
IEC-6 were plated onto 35 mm μ-dishes (Ibidi) coated with 
Matrigel® (Corning) and cultured for four days. Cells were labeled by 
staining with CellTracker™ Red CMPTX (Invitrogen) prior to apical 
addition of RH-YFP T. gondii tachyzoites immediately before imaging. 
Images were acquired using a LaVision BioTec TriM Scope II 2-photon 
microscope (Bielefeld) based on a Nikon Eclipse Ti optical inverted 
microscope with a Nikon 40x water immersion (Apo LWD λS NA 1.15) 
objective (Nikon UK Ltd) and a temperature control system (Life Imaging 
Services). Multi photon excitation was provided by a Coherent Chameleon 
Sapphire laser (Coherent Inc.) at 1060 nm to simultaneously excite 
CellTracker™ Red and RH-YFP T. gondii. Typical image volumes were 
100 × 100 × 27 μm and Z-stacks were separated by 1 μm. Time resolved 
data were acquired by continuous measuring of Z-stacks for up to 30 min. 
The frame rate was 51.2 s with these parameters. Images were analysed 
with the Fiji/ImageJ package. 
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Figure 2.1 Occludin peptide generation. Occludin peptides corresponding to 
amino acids 85-138 (full length ECL1), 191-241 (full length ECL2), 85-241 (full 
length ECL1-ECL2) and 261-521 (full length C-terminus) were generated as 
described in the Materials and Methods section. Peptide purity was assessed by 
SDS-PAGE and immunoblotting using commercial anti-occludin antibodies 
(Invitrogen). 
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2.11 SILAC Proteomic Analysis 
 
The SILAC Protein ID and Quantitation Media kit (Invitrogen) was used 
according to manufacturer’s instructions. IEC-6 cells were cultured on 
plastic 25cm2 flasks for six passages using SILAC DMEM containing either 
heavy [U-13C6]-L-lysine (MW = 152.1259) and [U-13C6 ,15N4]-L-Arginine 
(MW = 184.1241) or light [12C6]-L-lysine (MW = 146.1055) and [12C6, 
14N4]-L-Arginine (MW = 174.1117) prior to infection of light-labelled 
‘sample’ cells with 2.55x107 T. gondii (1:10 parasites:cells) and mock 
infection of heavy labelled ‘control’ cells with the same volume of media. 
To dissect the temporal response to infection, a time course of either two 
hours or twenty-four hours T. gondii infection was performed.  
Cells from each sample (heavy and light) were trypsinised then 
lysed using the m-PER kit (Thermo Scientific) to assess incorporation or 
mixed in a 1:1 ratio and lysed using the Mem-PER kit (Thermo Scientific) 
to fractionate the samples, as described below. Briefly, cells were washed 
in 1ml ice cold PBS then scraped into a 2ml Eppendorf prior to 
centrifugation at 300✕g for 5 minutes at 4°C. Pellets were resuspended 
in 0.5ml ice cold PBS and centrifuged at 300✕g for 5 minutes at 4°C. 
Pellets were next washed in 1.5ml cell Wash Solution (Thermo Scientific) 
supplemented with Halt protease and phosphatase inhibitor cocktail 
(Pierce) prior to centrifugation at 300✕g for 5 minutes at 4°C. The pellet 
was then resuspended in 0.75ml Cell Permeabilisation Solution (Thermo 
Scientific) supplemented with Halt protease and phosphatase inhibitor 
cocktail (Pierce) prior to centrifugation at 16,000✕g for 15 minutes at 
4°C and transfer of the supernatant to an Eppendorf (Cytoplasmic 
Fraction). The remaining pellet was resuspended in 0.5ml Solubilisation 
Solution (Thermo Scientific) supplemented with Halt protease and 
phosphatase inhibitor cocktail (Pierce) prior to centrifugation at 16,000
✕g for 15 minutes at 4°C and transfer of the supernatant to an Eppendorf 
(Membrane Fraction). 
Proteins were separated using NuPAGE Bis-Tris gels (Invitrogen) 
as described in section 2.7 and proteins stained using GelCode Blue 
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(Thermo Scientific). Gels were cut into 15 slices prior to being prepared 
for mass spectrometry. Briefly, gel slices were cut into 1mm cubes, 
transferred to 1.5ml Eppendorf tubes and washed for 15 minutes in 
200mM ammonium bicarbonate (ABC) in 50% (v/v) acetonitrile (1ml) to 
equilibrate the gel to pH8 and remove the stain, followed by 10 minute 
incubations in acetonitrile (Fisher) (1ml) to remove excess aqueous 
solution. Gel cubes were then incubated with 10mM dithiothreitol (DTT) 
in 50mM ABC (1ml) for 30 minutes at 60°C to reduce any cysteine thiol 
side chains before being alkylated with 100mM iodoacetamide in 50mM 
ABC in the dark for 30 minutes.  Gel cubes were then washed with two 15 
minute incubations in 200mM ABC in 50% (v/v) acetonitrile (1ml) 
followed by 10 minutes incubation in acetonitrile (1ml) to dehydrate and 
shrink the gel cubes prior to air drying. The proteins were digested with 
200-600ng Trypsin Gold (Promega) in 20-60μl of 10mM ABC. Further 
known volumes of ABC were added to ensure gel cubes were not dry 
before incubating at 37°C for 3 hours. Following digest the samples were 
acidified by incubating with 1% formic acid (same volume as 
trypsin+ABC) for 10 minutes. The extract peptides were removed and the 
remaining gel cubes washed with 50% acetonitrile (double the volume of 
trypsin+ABC+formic acid) to extract further peptides from the gel and 
combined with the digest samples. The pooled digest samples were then 
dried on the Medium Drying setting on a Speed Vac SC110 (Savant) fitted 
with a refrigerated Condensation Trap and a Vac V-500 (Buchi). The 
samples were then frozen at -80°C prior to analysis. Samples were 
dissolved in 0.5% formic acid and analysed using an Orbitrap Fusion 
Tribrid Mass Spectrometer (Thermo Scientific). 
The raw MS files were processed by Dr Francis Mulholland 
(Institute of Food Research) using MaxQuant [Cox and Mann, 2008] and 
proteins identified by searching against the Rattus norvegicus (Rat) 
UniProt database (downloaded 5.6.14). Search parameters: UniProt rat 
protein database species, rat; enzyme; trypsin; fixed modifications, 
carbamidomethylation and oxidation (M). Protein quantitation was 
performed using MaxQuant to generate heavy and light peptide ratios 
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(fold-change) and Perseus statistical analysis tool to generate 
significance-B (p-value <0.05) scores. The raw data was filtered according 
to >2-fold change (compared to non-infected control) and a Significance-
B p-value of <0.05. 
 
 
2.12 In Vitro Occludin Kinase Assay 
 
1ug recombinant occludin C-terminus peptide was incubated with 
either 200U purified CKII (New England Biolabs), 5μl IEC-6 lysates or 5μl 
IEC-6 lysates infected with T. gondii for 2 hours, prepared as described in 
section 2.7 in the presence of 1mM ATP (New England Biosciences) in 
kinase buffer (New England Biosciences) for 30 minutes at RT.  
 
 
2.12.1 Isoelectric Focussing 
 
Samples were de-salted by adding 480μl Rehydration Buffer (7M 
urea, 2M thiourea, 2% CHAPS) and concentrated using an Amicon Ultra 
0.5ml 3kDa Centrifugal Filter device (Merck Millipore) to 60μl prior to 
incubation in 140μl Rehydration Buffer supplemented with 0.5M DTT 
and 1% v/v pH 3-11NL IPG buffer (GE Healthcare) and addition to a re-
swelling tray. pH3-11NL IPG strips (GE Healthcare) were placed in the re-
swelling tray and covered with 2ml mineral oil and allowed to rehydrate 
overnight. Isoelectric focussing (IEF) of the occludin C-terminus was 
performed by transferring the IPG strips to ceramic strip holders, 
covering in mineral oil and placing on the Ettan IPGphor isoelectric 
focussing machine (GE Healthcare) with the following parameters: Step 
and Hold 500VHr, Gradient 500V-1000V (1 hour), Gradient 1000V-6000V 
(2 hours) and Step and Hold 6000V (40 minutes) (GE Healthcare). 
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2.12.2 2D Gel Electrophoresis 
 
After IEF the IPG strips were washed in deionized water to remove 
excess mineral oil and incubated in 5ml Strip Equilibration buffer for 15 
minutes (0.122M Tris-acetate, 0.5% w/v SDS, 6M urea, 3% w/v glycerol, 
0.01% bromophenol blue) supplemented with 52mM DTT to reduce any 
cysteine thiol side chains.  The IPG strips were then alkylated by 
incubation in 5ml Strip Equilibration buffer supplemented with 0.135M 
iodoacetamide in the dark for 15 minutes. The IPG strips were 
transferred to the top of 11cm pre-cast Criterion XT gels (BioRad) in a 
Criterion Cell (BioRad) and run using 1xMES buffer (BioRad) and run at 
200V constant for 35 minutes.  
 
 
2.12.3 Gel Staining 
 
Gels were first fixed overnight in 200ml Fixing Solution (50% 
methanol, 10% acetic acid) and subsequently stained with ProQ Diamond 
phosphoprotein stain (Molecular Probes). Gels were washed in 200ml 
deionized water for 10 minutes three times prior to staining with 120ml 
ProQ Diamond per gel for 90 minutes. Gels were then destained (20% 
acetonitrile, 50mM sodium acetate pH4) using 160ml solution for 30 
minutes  three times and washed with 200ml deionized water for 5 
minutes twice.  Gels were imaged at 50dpi using a Pharos FX+ Imaging 
System (BioRad) using excitation of 532nm and emission filter at 555nm. 
Gels were subsequently washed in deionized water for 5 minutes twice 
before staining for total protein using 120ml SYPRO Ruby (Molecular 
Probes) overnight prior to destaining (10% methanol, 6% acetic acid) 
with 200ml solution for 30 minutes and washing in 200ml deionized 
water twice. Gels were imaged at 50dpi using excitation 532nm and 
emission filter 555nm.  Images were analysed using Quantity One 
analysis software (BioRad) and protein spots matched using 
ProteomWeaver 2D Gel Analysis Software (Definiens). 
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2.12.4 Mass Spectrometry 
 
Samples were prepared for mass spectrometry analysis by Fran 
Mulholland (Institute of Food Research). Briefly, protein spots of interest 
were excised from the gel using an Investigator ProPick (Genomic 
Solutions), put into a 96-well microplate and subjected to in-gel digestion 
as described above substituting Glutamyl Endopeptidase (Roche 
Diagnostics) for Trypsin Gold. Samples were analysed using an Orbitrap 
Fusion Tribrid Mass Spectrometer (Thermo Scientific) and the raw MS 
files processed by Dr Francis Mulholland (Institute of Food Research). 
Files were converted to MASCOT Generic Format (mgf) format using MS 
Convert (http://proteowizard.sourceforge.net) and then searched using 
MASCOT (Matrix Science). Search parameters: MS1 5ppm; MS2 0.5Da; 
UniProt mouse protein database (downloaded 5.6.14); species, mouse; 
enzyme; glutamyl endopeptidase; fixed modifications, 
carbamidomethylation and oxidation (M).  
 
 
2.13 T. gondii-Occludin Binding Assay 
 
IEC-6 cells were plated onto 13 mm diameter glass coverslips 
(BDH) and cultured for 4 days prior to apical addition of either RH-YFP T. 
gondii tachyzoites (control) or RH-YFP T. gondii tachyzoites pre-
incubated with 2 μM recombinant occludin peptides for 15 min, for 2 h. 
To visualize intracellular parasites, IEC-6 cells were permeabilised and 
H&E counterstained before mounting and imaging of parasitophorous 
vacuoles using an inverted Zeiss AxioVert 200M microscope. Images were 
analyzed on AxioVision image viewer with 6–12 fields of view recorded 
for each slide. 
For peptide-parasite binding assays His-tagged occludin peptides 
or a His-tagged mCherry protein (20 μM in 6 M urea in buffer I (PBS with 
1 mM CaCl and 0.05% Tween-20)) were immobilised onto Schott 
Nexterion H slides (Jena) of a 16-well superstructure in a humidified 
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chamber for 2 h at 20 °C. Wells were washed in decreasing 
concentrations of urea (4–0 M) in buffer I then blocking solution for 1 h 
(25 mM ethanolamine in 100 mM sodium borate buffer). The wells were 
then washed in buffer I and incubated with YFP T. gondii tachyzoites (107 
per well) for 2 h at 20 °C. Slides were fixed with 3.7% formaldehyde (FA) 
prior to mounting and bound parasites were visualized by UV microscopy 
(Zeiss AxioVert 200M microscope and AxioVision image viewer). 
Parasites were counted using fluorescent pixel counts at 63× 
magnification (Adobe Photoshop CS6) with 6–12 fields of view recorded 
for each well. 
 
 
2.14 Bioinformatics 
 
To identify novel IEC-6 occludin kinases the bioinformatics 
ExPASy kinase-specific prediction software NetPhos (version 2.0) and 
NetPhosK (version 1.0) were used to predict occludin C-terminus 
phosphorylation sites by searching for homologous kinase target motifs 
within the occludin C-terminus aa sequence. NetPhos searches were 
performed using the default settings for parameter limitations. NetPhosK 
searches were performed using the default settings for parameter 
limitations set at a threshold of 0.5 and were without filtering. 
The murine occludin ECL1, ECL1+2, C-terminus and whole protein 
aa sequences were BLAST searched against the ME49, VEG and RH T. 
gondii genomes to search for potential binding proteins within the T. 
gondii genome databases at www.toxodb.org using an expectation value 
of 10, maximum descriptions 500 and low complexity filter. 
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2.15 Statistical Analysis 
 
All data was assessed for normal distribution using the 
Kolmogarov–Smirnoff test and for homogeneity of variance by the 
Bartlett's test. For parametric data, an independent t test, or a one-way 
ANOVA was carried out. For non-parametric data the Mann–Whitney U 
test and the Kruskal–Wallis test was used. Post-Hoc analyzes were 
carried out with Tukey's Multiple Comparison Test or Dunn's and 
Dunnett's Multiple Comparison tests. Data was analyzed using Prism 
GraphPad software (Versions 5 and 6). P values of less than 0.05 were 
considered significant. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ****P < 0.0001. 
Any data points that were two or more standard deviations away from 
the mean were considered outliers and disregarded from analysis. Error 
bars represent (±SEM) unless stated otherwise. 
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3 Model for Investigating Epithelial Tight Junction 
Barrier Function 
 
 
3.1 Introduction 
 
 
The SI represents the first point of contact between T. gondii and its 
host [Suzuki, 2013]. This chapter characterises IEC-6 as an in vitro model 
of SI epithelial cells suitable for studying T. gondii infection of the SI 
epithelium. The m-ICc12 cell line also utilised in this thesis has previously 
been fully characterised by Weight for T. gondii infection studies [Weight, 
2011]. Briefly, murine m-ICc12 SI cells, described by Bens et al were 
originally derived from the lower part of the intestinal microvilli from 20-
day-old L-type pyruvate kinase (L-PK)/Tag1 transgenic mice harbouring 
the SV40 virus [Bens et al, 1996] which halts replicative senescence to 
achieve immortalization via inactivation of senescence-6 (SEN-6), pRB 
and p53 genes [Lehman et al, 1993]. Within 13 days m-ICc12 develop a 
confluent monolayer of partially polarised cuboid cells, with an apical 
brush border and well-formed TJ. They retain a differentiated crypt-like 
phenotype and form a confluent domed monolayer [Bens et al, 1996]. To 
obtain this phenotype, m-ICc12 cell culture media requires 
supplementation with a variety of hormones, cofactors and growth 
factors [Weight, 2011].  
Although used successfully by Weight as an in vitro model of the SI 
to study T. gondii infection, immortalised cell lines such as m-ICc12 
originate from cancer cells so although widely used, these cancer-derived 
cell lines have limitations. The well-established human colon-derived 
Caco-2 cell line for example, has been used as a model of the SI for over 
thirty years, but can display altered proteomic profiles compared to the in 
vivo SI, leading to altered permeability, TEER and TJ protein expression 
[Hidalgo, 2001; Lenaerts et al, 2007]. Of note, considerable variation in 
Caco-2 barrier function also occurs between laboratories [Hayeshi et al, 
2008; Volpe et al, 2008]. Additionally, other common SI cell line models 
are often not of SI origin, for example the colonic carcinoma HT29 or T84 
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and canine kidney-derived MDCK. Ideally, in vitro models would be 
derived from the SI epithelium. 
Although primary and secondary cell lines provide the most 
functionally similar model to the SI due to being derived directly from 
native tissue, they are not easily sustainable for long-term culture. Non-
immortalised cell lines are therefore a preferable alternative to cancer-
derived or virus-immortalised cells. These cell lines offer functional 
models as they are derived from primary cells, originally taken from 
healthy tissue. Importantly, for this thesis the in vitro cell model needs to 
reflect the complex physiology of the SI, mimicking the physical and 
biological barrier of the epithelial monolayer. 
The non-immortalised IEC-6 cell line used in this thesis was 
originally derived from adult germ-free rat SI ileum [Quaroni et al, 1979]. 
Morphological and immunochemical studies by Quaroni et al confirmed 
IEC-6 derived from SI epithelial crypt cells and all four epithelial cell 
types could be identified [Quaroni et al, 1979]. They described a pre-
confluent homogenous population of epithelial-like cells growing as tight 
colonies of closely opposed cells and ultrastructural features were 
characteristic of intestinal crypt-villus cells, including large oval nuclei, a 
well-developed Golgi and ER network, numerous mitochondria, apical 
microvilli and well-defined junctional complexes with associated 
microfilaments at points of cell-cell contact [Quaroni et al, 1979]. Being 
non-transformed, IEC-6 offer advantages over immortalised cell lines for 
studying cellular differentiation and remain non-differentiated when 
cultured in the absence of mesenchymal factors [Wood et al, 2003].  
IEC-6 has been used over the last thirty years to study SI epithelial 
cells in vitro, including mucosal repair, barrier function, metabolism, 
proliferation, polarization and differentiation, as well as pathogen 
infection. For example, Guo et al used IEC-6 to examine the involvement 
of polyamines in epithelial AJ and TJ barrier function. The authors 
examined the effects of polyamine depletion on E-cadherin, β-catenin, α-
catenin, ZO-1, ZO-2 and JAM-A and found only AJ E-cadherin expression 
was altered [Guo et al, 2003]. Later, Cario et al investigated TLR2 
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signalling in TJ barrier regulation and found TLR2 stimulation preserved 
the TJ barrier in response to stress-induced damage via MyD88 [Cario et 
al, 2007]. Kimura et al used IEC-6 to examine the effect of bacterial 
endotoxin LPS on TJ barrier function and found apical or basolateral 
administration altered the effect on the TJ barrier; barrier function was 
not altered by apical LPS but was disrupted by basolateral LPS [Kimura et 
al, 1997]. These studies suggest IEC-6 is a suitable model for investigating 
the barrier function of the TJ. IEC-6 has also been utilised to investigate 
pathogen infection with Maciel et al examining epithelial barrier function 
following C. difficile toxin A challenge [Maciel et al, 2007].  
To date, few reports have used IEC-6 to investigate TJ protein 
expression and function or T. gondii infection. At the time of writing 
(September 2015), only eight publications have utilised IEC-6 to 
investigate occludin expression. Recently, Chen et al explored the 
regulation of occludin by αSNAP in acute pancreatitis and discovered 
downregulation of αSNAP leads to reduced occludin, enhanced apoptosis 
and ultimately increased TJ permeability [Chen et al, 2014]. Presently, 
IEC-6 has also only been described in three publications investigating T. 
gondii infection. Dimier and Bout found T. gondii tachyzoites actively 
invaded and replicated within IEC-6 but replication was inhibited by IFN-
γ [Dimier and Bout, 1993]. More recently IEC-6 was compared to a cat 
kidney cell line (CRFK) for bradyzoite infection susceptibility and 
cystogenesis [Muno et al, 2015]. These studies indicate IEC-6 is a suitable 
model for examining T. gondii infection. 
With the exception of these publications, limited information is 
available regarding IEC-6 growth characteristics on different substrates, 
which was addressed in this chapter. 
 
3.2 Results 
 
Characterisation of IEC-6 was undertaken to determine optimal 
culture conditions for development of an in vitro model of the SI for 
investigating TJ dynamics and T. gondii infection. A variety of substrates 
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including glass, plastic and permeable membranes were tested with or 
without an extracellular matrix (ECM) for development of polarised cell 
monolayers expressing TJ and AJ proteins. 
 
 
3.2.1 IEC-6 Culture on Plastic Substrates 
 
IEC-6 cultured on plastic substrates at a density of 5 x 104 formed 
a homogenous, confluent monolayer within four days. Within seven days 
post-confluence, cells organised into complex multicellular secondary 
structures, which increased in complexity by day fourteen and cells 
survived for at least twenty days.  
IEC-6 initially form linear aggregates or ‘ridges’ then accumulate 
into large multicellular aggregates and ultimately organise into complex 
multicellular structures (Figure 3.1A-E) confirming studies by Wood 
[Wood et al, 2003]. For comparison, m-ICc12 cells grown here on plastic 
gradually formed a complex of secondary dome-like structures as seen in 
Figure 3.1K-O and described by Bens et al, 2006 [Bens et al, 2006]. 
A non-coated plastic substrate was used for proteomic analysis by 
western blotting and mass spectrometry (Chapters 4 and 5). Typically 2 x 
106 cells were recovered from a 25cm2 plastic flask after seven days of 
culture. 
 
 
3.2.2 IEC-6 Culture Using an Extracellular Matrix 
 
An ECM was used here to mimic the stratum of the SI in vivo to 
provide structural support and promote cellular proliferation and 
differentiation in otherwise non-responsive cell lines [Adams and Watt, 
1993]. Naturally occurring components of the in vivo SI ECM such as 
collagen, laminin or fibronectin are used to create a thin ECM on culture-
ware [Rothen-Rutishauser et al, 2000] or a thicker artificial matrix such 
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as Matrigel® can be used as a physiological basement matrix [Kleinman 
and Martin, 2005; Wolpert et al, 1996].  
Carroll et al demonstrated a shift from a crypt-like phenotype to 
an enterocyte-like phenotype when IEC-6 were cultured on Matrigel® 
[Carroll et al, 1988]. The authors concluded that Matrigel® was required 
for IEC-6 to form a differentiated phenotype as the ECM enhanced 
proliferation and induced a multicellular structure within twelve hours as 
compared to growth of IEC-6 for four days on non-coated plastic [Carroll 
et al, 1988]. However, as depicted in Figure 3.1A-E, IEC-6 grown for at 
least seven days post confluence developed a complex morphology, 
suggesting a differentiated phenotype can be achieved without an ECM. 
Culturing IEC-6 on plastic coated with a thin collagen I and fibronectin 
ECM at <10μg/cm2 appeared to have no effect on cellular proliferation or 
differentiation. After seven days, IEC-6 cells cultured on an ECM 
demonstrated the same phenotype as those cultured on uncoated plastic 
(Figure 3.1F-J) and similarly survived for at least twenty days.  
These findings suggest IEC-6 retain the potential for 
differentiation in vitro and components of the IEC-6 cell culture media are 
capable of inducing cellular attachment, proliferation and differentiation. 
Therefore, an ECM was only used when a basal mucosa-like substrate was 
required for two-photon imaging of transmigrating T. gondii (Chapter 4). 
 
 
3.2.3 Cellular Differentiation of IEC-6 is Induced on Plastic 
 
To confirm IEC-6 differentiation on plastic alone, alkaline 
phosphatase (ALP) activity was assessed. ALP is a hydrolase expressed by 
brush border membranes of differentiated IECs [Quaroni and Hochman, 
1996; Wood et al, 2003] and its enzymatic activity is correlated with the 
degree of differentiation of IECs [Matsumoto et al, 1990]. Apical media 
from IEC-6 cells cultured on plastic 25cm2 flasks was examined for ALP-
mediated p-nitrophenol phosphate hydrolysis using a colorimetric assay 
(Figure 3.2). 
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Pre-confluence levels of ALP were low at day two, corresponding 
to high cellular growth and proliferation. As the monolayer became 
confluent, ALP activity increased reaching a 53-fold change within eight-
days of culture and attaining 78-fold change plateau within twelve-days 
of culture. This parallels the morphology seen in Figure 3.1 and previous 
studies on IEC-6 differentiation, which show an increase in ALP activity 
with culture [Ametani et al, 1996; Jeng et al, 1994; Wood et al, 2003]. It 
should be noted that these results reflect only one timecourse assay. 
 
 
3.2.4 IEC-6 Culture on Cell Culture Inserts 
 
Permeable cell culture inserts provide a well-characterised in vitro 
model of the SI epithelium as the inserts form apical (luminal) and basal 
(mucosal) compartments analogous to the in vivo SI lumen and mucosa 
[Cereijido et al, 1978 and Hidalgo et al, 1989] as depicted in Figure 3.3.  
TJ barrier function was measured by TEER and tracer flux through 
the monolayer and the membrane was excised for immunocytochemical 
analysis of TJ and AJ protein expression.  
Corning® Transwell® 24 well hanging polyethylene terephthalate 
(PET) tissue culture inserts with a pore size of 8μm were used for this 
study to allow transmigration of T. gondii, which are approximately 2μm 
by 6μm [Dubey et al, 1998]. The insert pores were easily visible by light 
microscopy (Figure 3.3 inset). IEC-6 cultured at a density of 5 x 105 per 
insert formed a confluent monolayer within six to twelve hours, 
suggesting increased proliferation compared to culture on plastic 
substrates. 
This enhanced growth on Transwell inserts has been previously 
described for other cell lines [Matter and Balda, 2003]. Within 24 hours 
IEC-6 obtained the complex multicellular morphology described in 3.2.2, 
further suggesting an increased rate of differentiation than with culture 
on plastic substrates.  
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Figure 3.2: ALP activity increases with IEC-6 cell culture. IEC-6 cells were 
cultured for 18 days in 25cm2 plastic flasks. ALP (U) was measured using a 
colorimetric assay on cell lysates at different times post-seeding. One unit (U) is 
defined as the amount of enzyme that hydrolyses 1μmol of p-NPP in a total 
reaction volume of 1ml in 1 minute at 37°C. Fold change in ALP activity is shown 
in relation to values obtained at the start of assessment (Day 2). Data 
representative of one timecourse assay.  
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A few cells were found on the underside of the inserts having migrated 
through the pores, however these only formed small clusters. Cells 
survived for up to twenty-one days before detaching from the membrane. 
The data presented here confirms IEC-6 cultured on PET inserts acquire a 
differentiated phenotype. 
 
 
3.2.5 IEC-6 Polarisation  
 
 The apparent IEC-6 differentiated phenotype on PET inserts was 
assessed by immunohistochemistry and confocal microscopy to visualise 
TJ and AJ protein localisation. IEC-6 were cultured at a density of 5 x 105 
per insert for seven days and as shown in Figure 3.4B (XY plane) and 
3.4B’ (YZ-plane), expression of N-acetylglucosamine and galactosyl (β-
1,3) N- acetylgalactosamine (surface carbohydrates) was restricted to the 
apical cell surface and 3.4C and 3.4C’ suggests a basal nucleus. Primary 
antibody and post-mounting staining specificity was confirmed (Methods 
section 2.5) using either species specific IgG or no primary antibody or 
stain. All controls were negative for non-specific secondary antibody or 
stain fluorescence (Figure 3.4F-H). 
IEC-6 monolayers cultured on PET inserts reached approximately 
16μm depth at seven days post-seeding days, 23μm within fourteen days 
and 30μm at twenty-one days post-seeding. Depth was greatest at points 
of multicellular formations and a confluent monolayer was present 
beneath the secondary cell layers. Compared to other intestinal cell lines 
such as T84, IEC-6 monolayers display a thin monolayer with flattened 
non-columnar cell morphology, suggesting only partial polarisation was 
achieved on PET inserts. Despite this, IEC-6 still provides an optimal 
model of the SI epithelium for investigation of T. gondii infection. 
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Figure 3.3: Cell culture insert system. Corning® Transwell® 24 well hanging 
PET tissue culture insert system schematic. PET insert positioned in an outer 
chamber in a 24 well plate with the cell monolayer cultured on the permeable 
membrane support, forming an apical and basal side of the monolayer. Inset: 
8μm PET insert pores are visible as distinct dark circles. T. gondii transmigration 
of the monolayer will be investigated using this model. Magnification 40×, scale 
bar = 20μm. 
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3.2.6 IEC-6 Tight Junction Protein Expression 
 
IEC-6 expression and localisation of TJ and AJ proteins was 
assessed by immunocytochemistry. Defined lateral membrane β-catenin, 
surface carbohydrates and basal nucleus and were observed (Figure 
3.4A-C and A’-C’) suggesting a partially polarised monolayer with defined 
apical and basal protein partitioning was acquired. ZO-1 expression 
demonstrated both membrane and cytoplasmic localisation, analogous 
with its dynamic mobility between the apical TJ, lateral membrane and 
cytoplasm [Shen, 2008] (Figure 3.4D). 
 
 
3.2.7 IEC-6 Occludin Expression 
 
Occludin imaging proved challenging in IEC-6 as defined 
membrane expression patterns were difficult to capture, similar to m-
ICc12 [Weight, 2011].  
The process of fixation appeared to affect occludin staining 
patterns; 2% paraformaldehyde (PFA) fixation gave higher levels of 
occludin staining in the nucleus whereas acetone fixation emphasised 
membrane occludin (Figure 3.5). Of note, only PFA retained T. gondii 
fluorescence so this method of fixation was used for infection studies. 
Confocal XZ-stack images in Figure 3.6 A’-C’ show cell depth increased 
between fourteen to twenty-one days and the multicellular layers are 
most visible at day twenty-one as irregular areas of staining (Figure 
3.6C). Occludin clearly localises to the apical membrane, visible as bright 
punctate fluorescence throughout the timecourse but most visible at day 
twenty-one (Figure 3.6C’). The basal nucleus and apical surface 
carbohydrates are also visible in figure 3.6C’, suggesting polarisation is 
achieved when IEC-6 are cultured longer than the seven-days described 
in Figure 3.4.  This data confirmed IEC-6 expressed apical membrane-
associated occludin alongside other TJ and AJ proteins.  
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Figure 3.5: Comparison between fixation with 2% paraformaldehyde and 
acetone.  Cells were cultured on PET inserts for 7 days and fixed with 2% PFA 
(A and A’) or acetone (B and B’) and stained for antibodies specific for occludin 
(green) and analysed by confocal microscopy. 2% PFA fixation displays higher 
background staining, which is also present in the nucleus, whereas acetone 
emphasises membrane-associated occludin. C) Negative control for occludin 
(rabbit IgG primary antibody). A-C) XY plane of view and A’-C’) XZ plane of view 
showing the apical punctate pattern of occludin expression. Magnification 40x. 
Scale bar 20μm. 
 
 
 
 
 
 
 
 
 
 
 
C 
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Due to low antibody-specificity IEC-6 did not provide the anticipated 
advantage over m-ICc12 for occludin localisation studies. Therefore, a cell-
free slide-based approach for studying T. gondii interactions with 
occludin is presented in chapter 6. 
Dalton et al and Weight both described a redistribution of occludin 
in response to T. gondii infection of the murine SI [Dalton et al, 2006; 
Weight, 2011]. Immunoblotting of occludin in both the insoluble and 
soluble fractions (Method section 2.7) from IEC-6 cultured on plastic 
25cm2 flasks revealed two occludin species, as described by Farshori and 
Kachar, 1999,  the lower molecular weight species (~60kDa) located at 
lateral membrane or cytoplasmic vesicular locations and the higher 
molecular weight bands (~65kDa) located primarily at the TJ [Farshori 
and Kachar, 1999; Wong et al, 1997]. 
Although IEC-6 occludin immunoblotting proved challenging, over 
the time-course of thirteen days, the higher molecular weight occludin 
species was associated with the membrane fraction and the lower 
molecular weight occludin species with the cytoplasmic fraction (Figure 
3.6E). 
 
 
3.2.8 The IEC-6 Epithelial Barrier 
 
As described earlier, the TJ forms a highly selective barrier 
between luminal contents and the underlying tissue of the intestine. 
Therefore, it was important to confirm a functional IEC-6 TJ barrier prior 
to T. gondii invasion studies. The barrier function of IEC-6 pore and leak 
pathways when cultured on PET inserts was assessed using TEER and 
permeability to FITC-dextran. 
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Figure 3.6: Occludin expression and localisation in IEC-6. A-C) IEC-6 were 
cultured on PET inserts for 7, 14 or 21 days, fixed with 2% PFA and stained for 
antibodies specific for occludin (green), surface carbohydrates (red) or Hoechst 
nuclear stain (blue) and analysed by confocal microscopy.  D) Negative control 
for occludin (green, rabbit IgG).  A-D represents XY images and A’-D’ represents 
XZ images. Magnification 40x. Scale bar 20μm. E) IEC-6 were cultured on plastic 
25cm2 flasks for thirteen days and analysed by immunoblotting for occludin. 
Protein expression was analysed in both membrane and cytoplasmic fractions 
(Method section 2.7).  
 
E 
7 Days       14 Days 
21 Days         Control 
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3.2.9 TEER and Permeability 
 
IEC-6 cells seeded at a density of 5 x 105 per PET insert were 
cultured for up to twenty-days and TEER recorded (Figure 3.7A). TEER 
quickly increased from 24Ω.cm2 to 130Ω.cm2 within twelve hours post 
seeding and then steadily increased to reach a peak of 270 Ω.cm2 at four 
to six days post-seeding. After six days TEER fluctuated and declined until 
day twenty when cells detached from the membrane. The minimal 
variation of TEER measurements between replicates suggested a stable 
pattern of IEC-6 TJ barrier formation so IEC-6 monolayers at four to six 
days post seeding presented optimal TJ barrier function. 
IEC-6 monolayer permeability was measured by the flux of 
fluorescent 3-5kDa FITC-Dextran from the apical to basal PET insert 
compartment. IEC-6 were cultured on PET inserts for seven days and 
1000μg/ml 3-5kDa FITC-Dextran added to the apical compartment as 
depicted in Figure 3.3. After two hours the level of FITC-dextran in the 
basal compartment was assessed. A blank insert was used as a control to 
measure the maximum level of diffusion through the membrane. In the 
control, a maximum of 19.7% tracer diffused to the basal compartment 
whereas with an intact IEC-6 monolayer, only 0.9% of the tracer diffused 
to the basal compartment (Figure 3.7B).  It should be noted that this 
experiment was only performed once. 
These results confirm PET inserts are suitable for monitoring 
barrier function in response to T. gondii infection. Partially polarised IEC-
6 monolayers cultured for between four and seven days present optimal 
barrier function according to TEER and permeability so will be used to 
study T. gondii infection and proteomics (Chapter 4 and 5).  
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3.3 Discussion 
 
The results presented here characterise IEC-6 culture on a range 
of substrates for investigating T. gondii infection. Early studies by 
Quaroni et al and Carroll et al suggested IEC-6 do not express antigens 
specific for a differentiated brush border without an ECM whereas more 
recent studies by Wood et al along with data presented here, suggest IEC-
6 do possess a differentiated phenotype in culture [Carroll et al, 1988; 
Quaroni et al, 1979; Wood et al, 2003]. Monolayer culture on permeable 
inserts are known to promote more extensive polarisation and 
differentiation [Matter and Balda, 2003] so although IEC-6 monolayers 
grown on PET inserts were relatively thin, the expression of surface 
carbohydrates and a basal nucleus also indicated partial polarisation 
within seven days of culture. Thus confirming IEC-6 grown on PET inserts 
are both differentiated and partially polarised, important for 
investigating the apical TJ barrier function in response to T. gondii 
infection. 
As described in chapter 1.6, regulation of the TJ barrier by 
formation of ion-selective pores and size-selective leak pathways 
requires a direct relationship between TJ structure and function. IEC-6 
culture on PET inserts allows functional TEER and FITC-dextran flux 
measurements as well as TJ structure assessment by the localisation of TJ 
proteins. However, TEER and permeability measurements should be 
analysed with caution as both are influenced by factors other than those 
specifically attributed to TJ function [Fanning et al, 1999; Yap et al, 1998].  
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Figure 3.7: Barrier function of IEC-6 cultured on PET inserts assessed by 
TEER and Permeability to FITC-dextran. A) Cells were cultured on PET 
inserts and TEER measurements taken for up to 20 days. Each time-point 
represents three experiments with three biological replicates. B) Cells were 
cultured on PET inserts for 7 days. 1000μg/ml FITC-dextran was added to the 
apical compartment and migration into the basal compartment was measured 
after 2 hours. Control represents the maximum FITC-dextran migration through 
a blank PET insert. Results represent one experiment. 
 
 
 
 
 
 
 
(No cells) 
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TEER measurements for instance account for both transcellular 
and paracellular resistance but as membrane resistance is generally 
much higher than intracellular resistance, changes in TEER represent a 
change in paracellular resistance [Reuss, 1991]. It should be noted that 
TEER is also extremely sensitive to factors such as culture media change 
or areas of low resistance such dead cells within the monolayer so cell 
monolayers should be allowed to equilibrate and morphological analysis 
of cultures should accompany these measurements [Fanning et al, 1999]. 
Although permeability to tracer molecules is less sensitive to defects in 
the cell monolayer, the contribution of transcellular migration should not 
be overlooked [Matter and Balda, 2003]. 
In vivo epithelia display a wide range of electrical resistances, for 
example typical TEER in the rabbit distal colon is 385 Ωcm2, compared to 
300,000 Ωcm2 in the rabbit urinary bladder. In vitro cell lines display a 
similar range of barrier resistances, Caco-2 TEER is 125-250 Ωcm2 
compared to MDCK 60-4000 Ωcm2 [Itallie and Anderson, 2009].  These 
differences are attributed to ‘tight’ or ‘leaky’ epithelia [Shen et al, 2011].  
In this study, the average TEER increase from 24.2Ω.cm2 to 
243.8Ω.cm2 confirms IEC-6 produce measurable barrier changes, 
important for investigating T. gondii effects on the TJ barrier. Published 
studies using IEC-6 produce a variety of TEER values; either low values of 
approximately 20Ω.cm2 [Bastian et al, 1999], mid-range of 91 Ω.cm2 
[Xinwai et al, 2014] or higher values of >400 Ω.cm2 [Xia et al, 2002], likely 
due to different culture conditions and insert systems [Matter and Balda, 
2003]. The second cell line used in this thesis, m-ICc12 reaches a maximum 
TEER of 120Ω.cm2 [Bens et al, 1996]. These IEC-6 and m-ICc12 TEER 
values, although widely accepted, are low compared to other intestinal 
cell lines such as T84, which consistently reach over 1000 Ω.cm2 [Tang 
and Goodenough, 2003], likely due to differences in their claudin 
expression [Furuse et al, 2001; Shen et al, 2011]. Within seven days of 
culture, IEC-6 monolayers were also impermeable to 3-5kDa FITC-
Dextran, suggesting a functional paracellular leak pathway.  
Although no single protein serves as an indicator of TJ structural 
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assembly [Anderson and Itallie, 1995; Stevenson et al, 1986], the 
localisation of specific TJ-associated components such as cytoplasmic 
plaque proteins or integral transmembrane proteins indicate a fully 
formed TJ [Balda and Matter, 2008; Le Shen et al, 2008]. Comparable with 
studies such as those by Le Shen et al, immunofluorescence localisation of 
the transmembrane protein occludin and cytoplasmic plaque protein ZO-
1 to a TJ membrane location with a typical apical punctate pattern were 
used here as markers of TJ complex formation, suggesting the TJ was fully 
formed within 7-days post-seeding used in this thesis [Le Shen et al, 
2008]. It is however well known that staining TJ proteins can be 
problematic, particularly with densely cultured transwell monolayers 
[Matter and Balda, 2003]. Unlike other cell lines such as MDCK where 
occludin forms a defined chicken wire-like pattern, IEC-6 occludin 
staining was less distinct and non-specific. It is known that the method of 
fixation can alter TJ protein staining but other fixation protocols trialled 
here such as ice-cold methanol fixation did not improve occludin staining 
[Matter and Balda, 2003]. The non-specific occludin staining pattern 
obtained with 2% PFA fixation may be due to cross-linking of proteins to 
the cytoskeleton. This cross-linking retains cellular stasis but reduces 
protein antigenicity, which results in increased background staining 
[Matter and Balda, 2003]. The presence of non-specific cytoplasmic and 
nuclear occludin staining prevents conclusive measurements of the 
redistribution of occludin in response to T. gondii infection. Therefore a 
novel proteomic strategy is used to assess the impact of T. gondii 
infection of TJ protein localisation (Chapter 4). 
 The plasticity of the TJ has previously been assessed using FRAP 
and FLIP [Shen et al, 2008; Liang and Weber, 2014; Turner et al, 2014; 
Weber, 2012]. Consistent with these studies, expression of ZO-1 seen 
here localised within both an apical membrane and cytoplasmic pool 
[Turner et al, 2014] whereas AJ β-catenin expression is restricted to a 
defined lateral membrane location [Yamada et al, 2005]. Occludin 
immunofluorescence could not confirm the distinct lateral membrane and 
TJ localisation previously described, possibly due to low specificity of the 
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antibody used in this study and insufficient optimisation of the method 
[Shen et al, 2008; Liang and Weber, 2014; Turner et al, 2014; Weber, 
2012]. Additional occludin antibodies have become available since these 
experiments were performed and these may yield enhanced occludin 
immunocytochemistry in future. Immunoblotting confirmed the presence 
of both high and low molecular weight occludin species in IEC-6, required 
for investigating occludin phosphorylation changes in response to T. 
gondii infection (chapter 5). 
 
 
3.4 Conclusions 
 
Using a PET insert system, an in vitro model of the small intestinal 
epithelium was established for T. gondii infection assays. 
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4 Toxoplasma gondii Invasion of IEC-6 and the 
Involvement of Tight Junction Proteins 
 
4.1 Introduction 
 
In this chapter T. gondii paracellular transmigration of the SI 
epithelium was examined and in vitro changes in the host cell proteome 
in response to infection were investigated, with a focus on TJ-associated 
proteins.  
To identify novel host cellular responses, it is first necessary to 
consider the mechanisms of host infection and dissemination by T. gondii.  
Prior to invasion, T. gondii organelle contents are secreted into the host 
cell, many of which could directly modulate the host cell proteome. For 
example, as described in chapter 1, ROP18, ROP5 and GRA15 have been 
identified as major contributors to parasite virulence [Hunter and Sibley, 
2012; Robben et al, 2004]. The next stage of infection involves 
transmigration of the SI epithelial barrier; the TJ paracellular pathway 
presents a potential route for rapid parasite dissemination to the hosts 
underlying tissues. However, the T. gondii paracellular route of infection 
has not yet been visualised. Following transmigration of the SI epithelial 
barrier, T. gondii exploit the motility of immune cells such as DCs in an 
intracellular Trojan Horse-like mechanism to spread throughout the body 
to secondary sites of infection, such as the brain, where bradyzoite cyst 
formation ultimately protects parasites from the immune system. An 
example of this was shown by recent studies using two-photon 
microscopy of mouse SI explants which indicated neutrophils and 
monocytes accumulated at foci of T.gondii infection [Coombes et al, 2013; 
Gregg et al, 2013]. These neutrophils contained viable parasites and were 
capable of transluminal migration across the intestinal epithelium, 
further facilitating parasite dissemination [Coombes et al, 2013]. During 
the course of infection, free tachyzoites were also identified in the gut 
lumen, likely from localised sites of replication in the SI epithelium, 
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suggesting a potential mechanism for re-entry and spread within the 
lumen [Gregg et al, 2013]. 
This evidence suggests T. gondii utilise a variety of strategies to 
disseminate throughout the host and may subvert a variety of host 
intracellular mechanisms. To investigate the involvement of host proteins 
during T. gondii infection, a number of experimental approaches have 
been used. For example, Barragan et al used co-immunoprecipitation to 
identify an interaction between host ICAM-1 and parasite MIC2, a 
microneme adhesion protein [Barragan et al, 2005]. Many groups have 
since utilised DNA microarrays to successfully investigate host cell 
transcriptome changes in response to infection with various T. gondii 
strains. For example, analysis of mouse brain infected with T. gondii 
found that genes involved in immune responses and cell activation were 
upregulated and those involved in neurological function were 
downregulated [Jia et al, 2013; Tanaka et al, 2013]. It is however the 
cellular protein complement that represents the biological function of 
genes and as a result, mass spectrometry (MS) based proteomics studies 
have increasingly been used to identify cellular proteins as well as their 
modification, quantification and localisation [Mann, 2006; Wastling et al, 
2009].  
 Since the application of proteomics to T. gondii, a number of groups 
have investigated the T. gondii proteome. This has been applied to the 
whole parasite proteome [Cohen et al, 2002; Krishna et al, 2015; Possenti 
et al, 2013; Xia et al, 2008; Zhou et al, 2013] as well as defined sub-sets 
such as excreted proteins [Zhou et al, 2005] or the rhoptry organelle 
proteome [Bradley et al, 2005]. These studies led to an improved 
understanding of the host-parasite relationship and revealed possible 
host-pathogen interactions such as novel parasite kinases, phosphatases 
and proteases that are likely to be involved in host cell invasion [Bradley 
et al, 2005].   
  Currently limited information is available regarding the specific 
role of the TJ proteome during T. gondii infection and the paracellular 
route of infection has not previously been visualised. Therefore, high-
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resolution multi-photon live imaging is used here to observe the 
paracellular route of parasite infection alongside a proteomics method to 
investigate host proteome changes in response to T. gondii infection of 
the SI epithelium, with a novel focus on the involvement of TJ proteins.  
 
 
4.2 Results 
 
Recombinant RH-strains of T.gondii tachyzoites expressing the 
YFP protein were used as they are highly fluorescent, necessary for 
visualisation of intracellular or transmigrating parasites [Gubbels et al, 
2003]. As T. gondii infection of IEC-6 has not been previously described, 
parasite infection kinetics were initially optimised. 
 
 
4.2.1 Toxoplasma gondii Transmigration of the IEC-6 
Monolayer 
 
To investigate the effects of parasite infection on IEC-6, the 
monolayer was assessed during in vitro transmigration using the PET 
insert system (Methods section 2.5 and 2.9.4). Immunofluorescence 
imaging of confluent IEC-6 cell monolayers cultured on PET inserts for 
four days and infected at a ratio of 5:1 parasites to cells for up to four 
hours confirmed T. gondii attached to the monolayer and clustered to 
cellular junctions, often with more than one parasite per cell (Figure 
4.1A). This attachment occurred in a non-homogenous manner with a few 
cells (26.5 ± 10.3%) being infected with two to six parasites whereas the 
majority of cells were non-infected, comparable with previously reported 
figures of 17-35% [Dimier and Bout, 1993; Kowalik et al, 2004].  
Parasites were seen to migrate from the apical to basal plane 
during infection, consistent with parasites using the paracellular route of 
invasion (Figure 4.1B-C) [Barragan et al, 2005]. IEC-6 were also cultured 
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on glass coverslips for four days and infected with T. gondii for two hours 
prior to fixation with 2% PFA and H&E staining in order to visualise 
formation of the parasitophorous vacuole, which was clearly visible as a 
white halo (figure 4.1D), indicating the onset of parasite replication after 
two hours infection.  
Using confocal imaging (Methods section 2.6) of confluent IEC-6 
cell monolayers cultured on PET inserts for four days and infected at a 
ratio of 5:1 parasites to cells for four hours, Z stack images composed of 
approximately 18 sections at 1μm intervals were taken at two, three and 
four hour time-points. To visualise parasite location within the plane of 
view by Z stack, cells monolayers were marked for the apical and basal 
membrane using rhodamine labelled surface carbohydrates and the 
surface of the PET membrane. Parasites were seen in the mid-basal plane 
of view (>9μm cell depth) within two hours and proportionally more 
parasites were mid-basally located after four hours, calculated by 
counting the number of parasites visible at >9μm cell depth for each time 
point (Figure 4.1E-G). Here, two hours infection was found to be optimal 
for capturing paracellular transmigration events as more parasites were 
associated with the apical plane close to the cellular junction, calculated 
by counting the number of parasites at <5μm cell depth, analogous with 
previous in vitro studies [Dalton et al, 2006; Weight, 2011]. 
 
 
4.2.2 The Tight Junction Barrier is Maintained During 
Toxoplasma gondii Infection 
 
The integrity of the IEC-6 monolayer during in vitro parasite 
infection was assessed to determine if the epithelial barrier remained 
intact during parasite transmigration using TEER measurements and 3-
5kDa FITC-dextran flux from the apical to basal PET insert compartment 
(Methods section 2.8). IEC-6 barrier function and membrane integrity 
were not affected by T. gondii as both TEER and paracellular permeability 
remained stable during the two-hour course of infection (Figure 4.2A-B). 
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Figure 4.1: Toxoplasma gondii infection of IEC-6 cells. A-F) Cells were 
cultured on PET inserts for four days, infected with T. gondii (green) for up to 
four hours, fixed with PFA and stained for lateral membrane β-catenin (blue) 
and cell surface carbohydrates (red). A) Magnified image illustrating parasite 
clustering to cellular junctions. B-C) Magnified images showing parasites within 
the paracellular space between cells. D) Cells were cultured on glass coverslips 
for four days, infected with T. gondii for two hours prior to fixation with 2% PFA 
and H&E staining. The parasitophorous vacuole is clearly visible as a white halo 
(white arrow). E) Cells were cultured on PET inserts for four days, infected with 
T. gondii (green) for up to four hours and fixed with PFA. Mid plane (9μm cell 
depth) merged XY image of T. gondii (green), β-catenin (blue) and cell surface 
carbohydrates (red), at two hours p.i, F) three hours p.i and G) four hour’s p.i. 
Magnification 40×.  
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Figure 4.2: IEC-6 barrier integrity is not affected by Toxoplasma gondii 
infection. IEC-6 were cultured on PET inserts for seven days prior to infection 
with T. gondii for two hours. A) No change in TEER due to parasite infection. 
TEER measurements from uninfected IEC-6 (control) were compared to infected 
IEC-6 (+Toxoplasma gondii) after two hours. Data represents two independent 
experiments with eighteen biological replicates. B) 1000μg/ml 3-5kDa FITC-
Dextran was added to the apical compartment of the PET insert and after two 
hours the level of FITC-dextran in the basal PET compartment was assessed. A 
blank insert (control) with no cells was used as a control to measure the 
maximum level of tracer diffusion through the membrane compared to no tracer 
diffusion when a confluent IEC-6 monolayer was infected (+Toxoplasma gondii). 
Data represents two independent experiments with four biological replicates.  
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4.2.3 Toxoplasma gondii Live Cell Imaging 
 
Parasite clustering to cellular junctions and localisation within the 
paracellular space suggest T. gondii transmigrate the IEC-6 monolayer via 
the paracellular pathway [Barragan et al, 2005]. As paracellular infection 
has not yet been visualised using live imaging, high-resolution multi-
photon imaging was used here to investigate the route of infection 
(Methods section 2.10). 
Confluent IEC-6 cell monolayers were cultured on Matrigel® 
matrix coated 35mm μ-dishes for four days, stained with CellTracker™ 
red and apically exposed to YFP-T. gondii. Matrigel® was used as a basal 
mucosa-like substrate to allow parasite dissemination away from the IEC-
6 monolayer. Live two-photon imaging confirmed extracellular parasites 
were actively motile, demonstrating circular gliding motility [Håkansson 
et al, 1999] and clustering to cellular junctions within five minutes of 
infection. The XY and equivalent XZ images in figure 4.3 represent the 
three layers of the epithelium presented in the accompanying video 
(Video 1) and corresponding figures: above the monolayer, the apical cell 
surface and the basal cell monolayer. 
 
 
4.2.4 Toxoplasma gondii Paracellular Route of Infection 
 
Live two-photon imaging confirmed T. gondii utilise the 
paracellular route of transmigration in IEC-6. Video 1 and the 
corresponding video stills (Figures 4.4 and 4.5) show a parasite initially 
located in close contact with the apical cellular junction, which is shown 
as a clear non-stained region between CellTracker red labelled host cells 
(Figure 4.4A and A’). The parasite re-orientates after 52 seconds (Figure 
4.4B and B’) and rapidly transmigrates through the paracellular space 
between host cells (Figure 4.4C and C’). The whole process taking less 
than 1 minute 42 seconds.  
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Figure 4.3: Live cell imaging of Toxoplasma gondii infection. A) IEC-6 
monolayers cultured on Matrigel® matrix coated 35mm μ-dishes for four days 
were stained with CellTracker™ red (red) and apically infected with T. gondii 
(green) immediately prior to two-photon live imaging. Three layers of the 
epithelial monolayer are clearly visible in both the XY (A-C) and YZ (D-F) plane 
of view. A and D) Parasites above the monolayer. B and E) The apical surface of 
the epithelium. Cellular junctions are visible as unstained regions between cells 
(red). C and F) Intracellular parasites within a PV in the basal region of the 
monolayer. Images are representative of those obtained from two experiments 
with replicates. Images were acquired using a LaVision BioTec TriM Scope II 
two-photon microscope (Bielefeld) based on a Nikon Eclipse Ti optical inverted 
microscope. Z-stacks were separated by 1 μm and the video frame rate was 
51.2 s. Images were analysed with the Fiji/ImageJ package. Magnification 40x. 
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Equivalent basal images (Figure 4.4D-F) show paracellular parasite 
egress through the IEC-6 monolayer, although the cellular junction is less 
visible. The process of egress was slower at 3 minutes 24 seconds. Due to 
limitations with the microscope field of view it was not possible to 
capture both transmigration and egress of the same parasite. The 
proposed route of paracellular transmigration is schematically 
represented in figure 4.5D-F. 
 
 
4.2.5 SILAC Proteomic Analysis 
 
The SILAC method metabolically incorporates a heavy (isotope-
labelled) or light (normal) form of an amino acid into all cellular proteins 
followed by MS analysis for identification and quantitation of proteins 
such as occludin [Amanchy et al, 2005; Chen et al, 2000, Ong et al, 2002]. 
The schematic in Figure 4.6 represents a flow chart of the 
Invitrogen™ SILAC protein identification method as described in 2.11. 
Briefly, two IEC-6 populations were grown on plastic 25cm2 flasks for six 
passages using SILAC DMEM containing either heavy [U-13C6]-L-lysine 
(MW = 152.1259) and [U-13C6 ,15N4]-L-Arginine (MW = 184.1241) or light 
[12C6]-L-lysine (MW = 146.1055) and [12C6, 14N4]-L-Arginine (MW = 
174.1117) prior to infection of light-labelled cells at a ratio of 1:10 cells:T. 
gondii. To dissect the temporal response to infection, a time course of 
either two hours or twenty-four hours T. gondii infection was performed. 
Cells from each sample (heavy and light) were mixed in a 1:1 ratio based 
on cell number prior to processing to reduce quantification errors due to 
unequal labelling [Harsha et al, 2008]. 
The samples were subsequently lysed and separated into 
membrane and cytoplasmic protein fractions. Two independent 
replications of the SILAC assay were undertaken with the second 
replicate modified to enhance protein identification and sensitivity.  
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Figure 4.4: Toxoplasma gondii utilise the paracellular pathway during 
transmigration and egress. IEC-6 monolayers cultured on Matrigel® matrix 
coated 35mm μ-dishes for four days were stained with CellTracker™ red (red) 
and apically infected with T. gondii (green) immediately prior to two-photon 
microscope live imaging. Sequential XY frames from Video 4.2 show a 
transmigrating parasite targeting the epithelial cellular junction (white arrows). 
Following initial localisation to the cellular junction A), the parasite re-
orientates B) and enters the paracellular junction C). A static intracellular 
parasite is clearly visible (White arrowheads). Corresponding YZ images show 
the parasite (marked *) localizes above the epithelial cellular junction A′), re-
orientates and moves between cells in the paracellular junction B′) and 
transmigrates through the epithelium C′). The paracellular junction region is 
visible as a non-stained space between cells (red). D-F) Basal images show 
parasite egress through the paracellular space (white arrow) between cells 
(red). The proposed route of paracellular transmigration involves G) Parasite 
localisation to the apical cellular junction, H) transmigration through the 
paracellular space and I) basal egress out of the paracellular space. Images 
representative of those obtained from two experiments with replicates. Images 
were acquired using a LaVision BioTec TriM Scope II two-photon microscope 
(Bielefeld) based on a Nikon Eclipse Ti optical inverted microscope. Z-stacks 
were separated by 1 μm and the video frame rate was 51.2 s. Images were 
analysed with the Fiji/ImageJ package. Magnification 40x. Scale bar = 5 μm. 
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Figure 4.5: Toxoplasma gondii paracellular infection mechanism. IEC-6 
monolayers cultured on Matrigel® matrix coated 35mm μ-dishes for four days 
were stained with CellTracker™ red (red) and apically infected with T. gondii 
(green) immediately prior to two-photon microscope live imaging. A-C) 3D 
representation of frames from Video 4.2 show a transmigrating parasite (white 
arrow) targeting the epithelial cellular junction. Following initial localisation to 
the cellular junction A), the parasite re-orientates B) and enters the paracellular 
junction C). D-F) Schematic representation of the proposed paracellular route of 
infection. A) A parasite targets the epithelial cellular junction and adheres to the 
cell. B) The parasite enters the paracellular space. C) The parasite transmigrates 
the epithelium and disseminates away from the SI. Images are representative of 
those obtained from two experiments with replicates. Images were acquired 
using a LaVision BioTec TriM Scope II two-photon microscope (Bielefeld) based 
on a Nikon Eclipse Ti optical inverted microscope. Z-stacks were separated by 
1 μm. Images were analysed with the Fiji/ImageJ package.  
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Therefore the two assays were not directly comparable and only the data 
from the second, more sensitive replicate are presented here as ~2000 
more proteins were identified per sample. 
As the heavy or light peptides are isotopically distinct, 
incorporation leads to a known mass shift [Mann, 2006]. The relative 
intensity of the light and heavy peptides is easily distinguished by MS and 
allows the differential quantification of proteins in the samples. Heavy 
and light L-lysine peak pairs are separated by 6.0204 Da and heavy light 
L-Arginine peak pairs by 10.0124 Da. As Arginine containing peptides 
ionize more readily than Lysine containing peptides, double labelling 
results in increased sensitivity and sequence coverage [Ong et al, 2003]. 
The raw MS files were processed using MaxQuant [Cox and Mann, 
2008] and proteins identified by searching against the Rattus norvegicus 
(Rat) UniProt database (downloaded 5.6.14). Protein quantitation was 
performed using MaxQuant to generate heavy and light peptide ratios 
(fold-change) and Perseus statistical analysis to generate significance-B 
(p-value) scores. Raw data files are included in Appendix B. The raw data 
was filtered according to >2-fold change (compared to non-infected 
control) and a p-value of <0.05. Due to the large number of host proteins 
modulated during the time course, only data related to proteins with 
functional information are discussed. 
In total, we identified 3489 host membrane proteins and 3396 
cytoplasmic proteins at two hours p.i and 3464 membrane proteins and 
3172 cytoplasmic proteins at twenty-four hours p.i. At two hours p.i a 
total of 50 membrane proteins exhibited a significant 2-fold or greater 
increase in their abundance and 14 exhibited a decrease. 
Similarly, 57 cytoplasmic proteins exhibited a significant 2-fold or 
greater increase in their abundance and 11 exhibited a decrease. After 
twenty-four hours of infection, a total of 78 membrane proteins exhibited 
a significant 2-fold or greater increase in their abundance and 67 
exhibited a decrease. Similarly, 121 cytoplasmic proteins exhibited a 
significant 2-fold or greater increase in their abundance and 35 exhibited 
a decrease.  
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Figure 4.6: Schematic representation of SILAC workflow.  Two IEC-6 
samples were cultured for six passages in SILAC DMEM containing either 
0.1mg/ml heavy L-lysine and L-Arginine or light L-lysine and L-arginine. After 
100% incorporation, light labelled cells were infected with T. gondii for two 
hours. Cells were mixed in a 1:1 ratio and lysed with Thermo Scientific™ Mem-
PER mammalian protein extraction reagent. Triplicate samples were separated 
by SDS-PAGE and stained with coomassie before gel bands were excised. After 
in-gel digestion and alkylation peptides were analysed using a Thermo 
Scientific™ Orbitrap Fusion™ Tribrid™ mass spectrometer.  
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IEC-6 + ‘heavy’ Lys and Arg 
(Control) 
Mix cells 1:1  
In-gel trypsin digestion  
and alkylation 
Excise gel bands (1-30, left)  
Analyse tryptic peptides by 
MS 
Expand both populations for six doublings 
Lyse cells, separate into membrane (1-15) and cytoplasmic (16-30) fractions 
and analyse by SDS-PAGE (below, left) 
‘Control’ population 
mock infected with 
DMEM 
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  Functional annotation of the identified proteins was carried out 
using the protein annotation through evolutionary relationship 
(PANTHER) Gene Ontology (GO) classification system 
(http://www.pantherdb.org Version 10) [Mi et al, 2013]. After two hours 
of infection the majority of proteins demonstrating a decrease in 
abundance were structural molecules (14.3%), or involved in protein-
protein binding (26.5%) or catalytic activity (36.7%) (Figure 4.7A). 
Similarly, after twenty-four hours of infection the majority were involved 
in catalytic activity (35.7%), protein-protein binding (28.6%) or were 
structural molecules (10.7%) (Figure 4.7B). After two hours of infection 
the majority of proteins demonstrating an increase in abundance were 
involved in catalytic activity (36.3%), protein-protein binding (22.0%) or 
were structural molecules (19.8%). (Figure 4.8A) and after twenty-four 
hours of infection the majority of proteins demonstrating an increase in 
abundance were involved in catalytic activity (48.6.3%) or protein-
protein binding (25.7%) (Figure 4.8B). In addition, analysis of the 
differentially expressed proteins using the PANTHER overrepresentation 
test (version 10 release 2015-04-30) revealed a significant (p<0.05) 
enrichment of proteins involved in biological processes such as 
regulation of apoptotic signalling pathway at two hours p.i and numerous 
processes such as metabolic pathways, negative regulation of apoptotic 
signalling, response to nutrient levels, response to hormones and the 
stress response at twenty-four hours p.i. (Appendix C), processes which 
are discussed in relation to T. gondii paracellular transmigration in 
chapter 7. 
 
 
4.2.6 Role of the Epithelial Tight Junction During Infection 
 
The TJ complex is composed of adaptor or scaffold proteins as well 
as regulatory proteins such as kinases and phosphatases which all form 
protein-protein interactions with their substrates.  
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Figure 4.7: Functional categorisation of the SILAC IEC-6 proteins 
decreasing in abundance during T. gondii infection. Numbers correspond to 
the percentage of identified proteins in each category compared to the total 
number of proteins. GO annotation was provided by http://www.pantherdb.org 
(version 10). A) Quantification of the predicted function of IEC-6 proteins that 
decreased in abundance after two hours T. gondii infection. B) Quantification of 
the predicted function of IEC-6 proteins that decreased in abundance after 
twenty-four hours T. gondii infection. A list of all identified proteins is provided 
in Appendix B. 
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Figure 4.8: Functional categorisation of the SILAC IEC-6 proteins 
increasing in abundance during T. gondii infection. Numbers correspond to 
the percentage of identified proteins in each category compared to the total 
number of proteins. GO annotation was provided by http://www.pantherdb.org 
(version 10). A) Quantification of the predicted function of IEC-6 proteins that 
increased in abundance after two hours T. gondii infection. B) Quantification of 
the predicted function of IEC-6 proteins that increased in abundance after 
twenty-four hours T. gondii infection. A list of all identified proteins is provided 
in Appendix B. 
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A comprehensive list of known TJ proteins was constructed by 
integrating current functional annotations, protein-protein interactions 
and known signalling pathways [Aijaz et al, 2006; Anderson and Van 
Itallie, 2009; Balda and Matter 2008 and 2009; Chiba et al, 2008; Dorfel 
and Huber, 2012; Furuse and Tsukita, 2006; Gonzalez-Mariscal et al, 
2008; Kohler and Zahraoui, 2005; Liu et al, 2003; Matter et al, 2005; 
Matter and Balda, 2003 and 2014; McNeil et al, 2006; Morimoto et al, 
2005; Müller et al, 2005; Salama et al, 2006; Schneeberger and Lynch, 
2004; Suzuki et al, 2006; Tang, 2006; Turksen and Troy, 2004; Ye et al, 
2006; Zahraoui, 2005] (Appendix D).  
Comparison between the SILAC dataset and known TJ protein list 
by Dr Tamás Korcsmáros (Institute of Food Research) using scripts 
written in Python identified nine IEC-6 TJ-associated proteins 
significantly modulated by T. gondii. The rat Uniprot IDs were inferred 
human orthologs with the InParanoid webservice, summarised in Table 
4.1; at two hours p.i Bcar1, Ybox3 and Mras increased in abundance (red 
box) and at twenty-four hours p.i Cstf and Ybx3 TJ-associated proteins 
increased in abundance (red box) and Akt1, Arhgef11, Cldn15 and Prkcι. 
decreased in abundance (green box). These proteins will be discussed in 
detail in chapter 7. 
 
 
4.3 Discussion 
 
In this chapter T. gondii IEC-6 infection kinetics were established 
and parasites were confirmed to utilise the paracellular route of infection 
as well as extensively modulating the host cell proteome upon infection. 
During T. gondii infection the IEC-6 barrier function was 
maintained, suggesting tachyzoites do not disrupt the integrity or 
function of the TJ barrier.  
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The non-homogenous tachyzoite binding to the IEC-6 monolayer 
described here has been frequently observed in previous studies [Dvorak 
and Crane, 1981; Mineo and Kasper, 1994] and confluent monolayers are 
typically less infected than non-confluent monolayers as parasites 
preferentially attach to cells in mid-S phase of the host cell-cycle 
[Grimwood et al, 1996]. This may explain the low percentage of infected 
cells in this study as the majority of cells in a confluent culture are in G0 
or resting phase rather than mid-S phase [Black and Boothroyd, 2000].   
After oral infection, T. gondii attachment and transmigration of the 
SI epithelium are crucial for dissemination within the host to reach 
secondary sites of infection such as the brain, eyes or developing foetus. 
Barragan and Sibley suggest establishment of this early wave of rapidly 
migrating parasites may be particularly important to assure 
dissemination prior to the onset of an immune response [Barragan and 
Sibley, 2002].  
As seen by two-photon live cell imaging (Figure 4.3-4.4 and Video 4.1), T. 
gondii paracellular transmigration is a complex multi-stage process 
involving gliding motility and targeting to cellular junctions prior to 
initial attachment. Video 4.1 highlights the rapid re-orientation of the 
parasite and entry into the paracellular space. The parasite then appears 
to transmigrate through the monolayer, leaving the paracellular space 
empty (figure 4.4A-C). This process is rapid, with the transmigration 
stage taking less than the speed of one video frame (<52 seconds), 
comparable with 15-40 seconds in previous studies [Carruthers and 
Boothroyd, 2007; Egarter et al, 2014; Werk, 1985]. The equivalent basal 
images (Figure 4.4D) show parasite egress from the monolayer, although 
the cellular junction is less visible. 
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Although the observations here describe only the paracellular 
pathway, we cannot rule out the possibility that parasites may also cross 
the IEC-6 monolayer in vitro or SI in vivo by the transcellular route 
[Barragan et al, 2005]. However, this is unlikely as T. gondii rarely exit a 
host cell from the basal side when apically infected [Morisaki et al, 1995; 
Tardieux and Menard, 2008]. Parasite transmigration of the SI via the 
paracellular pathway is also preferable to transcellular invasion in the 
early stages of infection as the replication and cytolytic stage ultimately 
destroys the host cell, which leads to tissue injury and induction of an 
inflammatory response which could limit early parasite dissemination 
from the SI to secondary immunoprivileged sites of infection [Black and 
Boothroyd, 2000].   
The requirement for host cell invasion prior to T. gondii 
replication highlights the intimate relationship that has evolved between 
the parasite and host cell that leads to modification of host cell functions 
and changes in host protein abundance. Previous studies have described 
how T. gondii reorganises the host organelles and cytoskeleton, induces 
an anti-apoptotic state and highjacks immune cell migration [Laliberte 
and Carruthers, 2008]. Others have focused on identifying global host cell 
transcriptome or proteome changes in response to T. gondii infection of 
macrophage or HFF cells in vitro and brain tissue in vivo [Blader et al, 
2001; Nelson et al, 2008; Sahu et al, 2014; Saeij et al, 2007; Xia et al, 2008; 
Zhou et al, 2011 and 2013]. However, as the initial site of T. gondii 
infection in vivo is the SI, we developed a quantitative SILAC proteomics 
method to examine IEC-6 host cell proteome modulation in response to T. 
gondii infection. Functional classification of the IEC-6 proteome of 
infected and non-infected cells identified changes in the abundance of 
catalytic, binding and structural proteins as well as statistically significant 
enrichment of differentially regulated proteins involved in cell 
metabolism, glycolysis, organelle organisation, cellular transport, cell 
cycle, transcription, cell structure and the cellular stress response; all 
analogous with previous studies [Nelson et al, 2008; Zhou et al, 2011]. 
Host cells have also evolved lines of defence against parasite invasion and 
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replication; at both two and twenty-four hours of infection we confirmed 
increased abundance of host cell proteins involved in negative regulation 
of apoptotic signalling pathways [Nelson et al, 2008].  
The finding that host ICAM-1 significantly increased in abundance 
with a fold change of 4.16 (Appendix B P202) during infection was 
particularly interesting as this has previously been shown by a number of 
groups in a variety of biological barriers encountered by T. gondii 
[Barragan et al, 2005; Furtado et al, 2012; Klok et al, 1999; Nagineni et al, 
2000; Pfaff et al, 2005; Sumagin and Parkos, 2014; Yang et al, 2005]. 
Barragan et al first confirmed a mechanism of paracellular transmigration 
mediated by interactions between host ICAM-1 and parasite adhesin 
MIC2 [Barragan et al, 2005]. The authors found that only the parasite 
surface form of MIC2, not the secreted form, bound to host ICAM-1 as the 
mature secreted form of MIC2 lacks the integrin I/A-domain. Thereby 
suggesting that the host-parasite interaction is similar to that of β2 
integrins and that T. gondii may utilise a similar mechanism of 
paracellular transmigration to leuckocyte vascular extravasation or 
transepithelial migration [Barragan et al, 2005; Sumagin and Parkos, 
2015].  
Taken with the live imaging evidence for the paracellular route of 
infection described above, this finding led to our novel hypothesis that T. 
gondii may interact with and modulate apical TJ-associated proteins 
during paracellular transmigration of the SI epithelium. A mechanism 
that has been exploited by viruses and bacterial pathogens, although how 
this contributes to disease development and progression is poorly 
understood [Zihni et al, 2014].  
Accordingly, identifying the components of the TJ protein complex 
modulated in response to T. gondii will be an important step towards 
understanding the molecular mechanisms of paracellular parasite 
infection and will aid the development of therapeutic strategies against T. 
gondii. The SILAC proteomics data set was examined for modulation of 
TJ-associated proteins in response to T. gondii infection. Although, it 
should be noted that we are only just beginning to understand the 
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function of the TJ in molecular terms, as the architecture of the TJ 
remains incomplete and further important constituents may remain to be 
defined.  
After two hours of T. gondii infection three host proteins 
associated with the TJ were modulated; Bcar1, Ybox3 and Mras compared 
to six after twenty-four hours of infection including Cstf2, Ybx3, Akt1, 
Arhgef11, Cldn15 and Prkcι. These proteins relate to early parasite 
infection strategies such as attachment, TJ disruption and paracellular 
transmigration as well as the initiation of intracellular PV formation. As 
not all cells in the monolayer are infected at this stage, a large proportion 
of host cells remain unchanged and this may account for the low number 
of proteins that appear to be modulated at this time point.  
Breast cancer antioestrogen resistance 1 (Bcar1 also known as 
p130CAS), is an adaptor protein that belongs to the CAS family of scaffold 
proteins that are associated with the formation of multi-protein signalling 
complexes that play a role in cell motility, cell adhesion, cytoskeleton 
remodelling, invasion, survival and proliferation [Defilippi et al, 2006; 
Leal et al, 2015]. As Bcar1 relays signals downstream of integrins via c-
SRC, FAK and PI3 kinases, it is tempting to speculate that the 
upregulation of Bcar1 may be due to parasite attachment to host surface 
integrins [Furtado et al, 1992]. Although here there was no change 
observed in its abundance during infection, PI3K is known to associate 
with occludin and JAM-A to mediate the recruitment of PTEN to the TJ 
and activate Akt, though changes in kinase activity were not measured in 
this study [Matter et al, 2005].  
Mras is a Ras-related protein whose downstream effector afadin 
(AF6) binds to ZO-1 at the TJ to maintain cell-cell contacts [Kuriyama et 
al, 1996; Quilliam et al, 1999]. However, competitive binding of Mras to 
ZO-1 may disrupt the TJ barrier, a possible consequence of its increased 
abundance at the host cell membrane [Yamamoto et al, 1997]. As ZO-1 
also directly interacts with occludin, it is possible that increased Mras 
binding to ZO-1 modulates the localisation of occludin at the TJ [Furuse et 
al, 1994].  
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The proteins modulated at twenty-four hours p.i correlate with a 
later stage of infection where PV formation extensively remodels the host 
cell proteome and alters subcellular protein compartmentalisation. 
However, as T. gondii does not infect all cells to which parasites attach, 
some cells will be affected by T. gondii secreted factors. For example, 
parasites secrete ROP and MIC proteins into neighbouring cells to 
prepare them for invasion; the host cell cycle for instance has been shown 
to be targeted as T. gondii preferentially infect cells in the S-phase [Blader 
and Saeij, 2009; Grimwood et al, 1996; Koshy et al, 2012; Lavine and 
Arrizabalaga, 2009; Molestina et al, 2008]. 
The upregulation of Ybox binding protein 3 (Ybox3, also known as 
ZONAB) at both two and twenty-four hours p.i is therefore interesting as 
it has been linked to cell cycle progression. As ZO-1 sequesters and 
inhibits ZONAB in the cytoplasm, the increased ZONAB abundance in the 
host cell cytoplasm at two hours p.i may lead to ZONAB accumulation in 
the nucleus and interaction with the G1/S phase regulator CDK4, which 
leads to increased expression of genes that promote cell cycle 
progression to S-phase [Balda et al, 2003; Matter et al, 2005]. The 
increased ZONAB abundance in the membrane at twenty-four hours p.i 
suggests junctional localisation of the transcription factor and 
inactivation of the pathway.  
Likewise, the Rho guanine nucleotide exchange factor (GEF) 11 
(ARHGEF11, also known as PDZ-RhoGEF) has been linked to cell cycle 
progression. ARHGEF11 mediates RhoA-activated actomyosin at the TJ 
and binds to ZO-1 [Itoh et al, 2012]. Downstream RhoA signalling 
regulates paracellular permeability via GEF-H1 as well as promoting S-
phase progression via ZONAB [Zihni et al, 2014].  
Decreased abundance of ARHGEF11 has been shown to disrupt TJ 
assembly and establishment of the TJ barrier with Rho signalling 
pathways playing a central role.  For example, phosphorylation of the Rho 
target MLC is significantly downregulated in ARHGEF11-depleted cells, 
although ARHGEF11 depletion does not affect occludin expression [Itoh, 
2013; Samarin et at, 2007]. The decrease in abundance of ARHGEF11 at 
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the host membrane may therefore promote cell cycle progression to the 
preferential S-phase as well as disrupt the TJ barrier in a Rho dependant 
mechanism, which is potentially important for parasite paracellular 
transmigration.  
 Further evidence for parasite modification of the host cell cycle is 
provided by the 26-fold increase in abundance of cleavage stimulation 
factor 2 (Cstf2 also known as Cstf-64), a member of the cstf complex that 
plays a role in polyadenylation of mRNA [Takagaki et al, 1992]. Cstf2 has 
been shown to be significantly upregulated during the G0 to S-phase 
transition [Martincic et al, 1998]. As Cstf2 binds to the molecular scaffold 
protein symplekin, which associates with ZO-1 at the TJ and ZONAB in the 
nucleus [Chang et al, 2012; Xing et al, 2004], the significantly increased 
abundance of Cstf2 in the host cell cytoplasm may promote association 
with ZONAB in the nucleus and instigate progression of the host cell cycle 
to S-phase. 
RAC-α serine threonine protein kinase (Akt, also known as protein 
kinase B, PKB) has been shown to play a role in TJ regulation in the 
intestine by forming a complex with ZO-2 and JAM-A [Monteiro et al, 
2013]. This complex formation at the TJ may explain the decreased 
abundance of Akt in the host cytoplasm. It has been confirmed that the 
PI3K/Akt pathway is a major target for T. gondii-dependant inhibition of 
apoptosis via Akt phosphorylation of Bad [Datta et al, 1997; Danial, 2008; 
Quan et al, 2013], a mechanism required to promote host cell survival 
[Duronio, 2008; Kim and Denkers, 2006; Scheid and Woodgett, 2001]. 
The PI3K/Akt pathway has also been implicated in Claudin-2 expression 
via inhibition of GSK-3β and nuclear translocation of β-catenin, 
demonstrating the complexity of this signalling pathway [Amasheh et al, 
2010; Wang et al, 2011].  
The decrease in abundance of claudin-15 (cldn15) is particularly 
interesting as it directly relates to TJ barrier function. In the SI 
epithelium, expression of claudins varies between the crypt and villus 
and is associated with TJ permeability [Amasheh et al, 2002; Wada et al, 
2013]. For example a decrease in claudin-15 at the TJ is known to 
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increase permeability and can initiate IBD [Darsigny et al, 2009]. 
Interestingly, Clostridium perfringens enterotoxin binding to claudin-3 
and -4 leads to their dissociation and subsequent TJ degradation [Sonoda 
et al, 1999]. It is possible that T. gondii similarly disrupts claudin-15 at 
the TJ during paracellular transmigration either by directly binding to 
claudin-15 or indirectly via parasite binding to other TJ proteins such as 
occludin, although the interaction between claudins and occludin is not 
well understood. Of note, claudins have been shown to interact with cell 
surface receptors such as integrins [Ding et al, 2012; Stone, 2011; Furtado 
et al, 1992], reiterating the possible mechanism of T. gondii induced TJ 
disruption via binding to host integrins prior to infection.  
The decrease in atypical protein kinase C ι (Prkci) abundance at 
the host cell membrane is noteworthy as aPKC is directly associated with 
the phosphorylation status of the transmembrane TJ proteins occludin 
and claudins [Andreeva et al, 2001; Aono et al, 2008; Raleigh et al, 2011; 
Rao, 2009; Sjo and Magnusson, 2010; Suzuki et al, 2009]. 
Hyperphosphorylated occludin is located at the TJ and plays a role in TJ 
assembly [Sakakibara et al, 1997] and similarly, claudin phosphorylation 
has been linked to TJ assembly and function. For example, PKCθ 
phosphorylation of claudin-1 and -4 is required for TJ insertion [Banan, 
2005]. In contrast, PP2A phosphatase dephosphorylation decreases 
claudin-1 and ZO-1 localisation at the TJ and reduces barrier function 
[Nunbhakdi-Craig et al, 2002]. As T. gondii secrete PP2 phosphatase as 
well as a number of ROP-derived kinases into the host cell prior to 
infection [Bradley et al, 2005; Dubremetz, 2007; Gilbert et al, 2007; Jan et 
al, 2009; Laliberte and Carruthers, 2008], claudin dephosphorylation 
could contribute to TJ disruption during parasite infection. It is tempting 
to speculate that either T. gondii infection modulates host kinase 
interactions with occludin or parasite-derived kinases and phosphatases 
directly target occludin in order to disrupt the TJ and enhance T. gondii 
transmigration of the paracellular pathway.  
As the signalling pathways associated with these modulated host 
proteins demonstrate complex cross talk, network analysis is currently in 
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progress to fully understand the interactions between the modulated host 
proteins and the effect of their abundance changes on downstream 
signalling pathways. It should be noted that modelling of the TJ signalling 
complex is challenging as a wealth of information must be integrated into 
the mathematical model; TJ-associated protein-protein interactions may 
be weak or transient and TJ assembly and disassembly is highly dynamic 
and occurs over a short time. Clearly there is still much to be learnt in 
order to understand the complex interplay between TJ-associated 
proteins and downstream signalling pathways and how these are 
modulated during T. gondii infection. Elucidating how the dysregulation 
of junctional signalling mechanisms contributes to disease development 
will be key for diseases associated with a loss of TJ barrier function such 
as IBD. 
 One drawback of the SILAC method is that only quantifies changes 
in protein abundance and not changes in protein function, for example 
enzyme activity levels. Therefore future validation should include 
functional studies, such as analysis of changes in PI3K activity, potentially 
utilising an in vitro kinase assay as described in chapter five. In addition, 
SILAC does not discriminate between host-cell proteins modulated by 
direct parasite infection or parasite secreted factors. In future therefore, 
filtered conditioned media from parasite cultures or infected cells could 
be used as additional controls to identify host proteins modulated by 
secreted factors. As infected and non-infected cells were analysed 
simultaneously by SILAC, a technique that could be used to isolate 
infected cells and distinguish between host proteome modulation by 
intracellular parasites or transmigrating parasites would be single-cell 
laser dissection [Fink et al, 2006; Xu and Caprioli, 2002]. This would 
increase resolution and permit targeted proteomic analysis of SI 
epithelial cells in vitro or in vivo at specific stages of infection.  
In order to validate the differentially expressed TJ proteins, 
immunohistochemistry could be used to ensure protein expression 
corresponds with the SILAC results presented here. Another attractive 
future experiment would be to confirm our in vitro findings in vivo, using 
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the SILAC rodent model [Krüger et al, 2008; McClatchy et al, 2007; Wu et 
al, 2004]. To verify the physiological relevance of the identified TJ 
proteins modulated during T.gondii infection, site directed mutagenesis 
of cell lines or gene KO mice [Furuse, 2009] could be utilised in 
combination with confocal or two-photon live microscopy to assess 
changes in parasite paracellular transmigration. Encouraging preliminary 
experiments also suggest co-immunoprecipitation of host cell lysates 
with T. gondii and MS analysis could also be used in future to identify T. 
gondii proteins interacting with the host TJ [Weight, unpublished]. 
 
 
4.4 Conclusions 
 
This chapter has provided evidence for T. gondii tachyzoite 
transmigration of the SI epithelium via the paracellular route at an early 
stage of infection, an effective mechanism for rapid traversal of the 
epithelium. To our knowledge, this novel finding is the first live-imaging 
observation of T. gondii utilising the paracellular route of transmigration. 
We also examined modulation of the IEC-6 proteome in response to 
infection and highlighted the important role of the TJ-associated proteins. 
Although it was not possible to identify occludin in differentially infected 
SILAC labelled IEC-6 cell cultures, many of the modulated proteins show 
cross talk with occludin downstream signalling pathways and further 
analysis of these interactions is in progress. We predict that secretion of 
parasite-derived kinases into the host cell during infection alters the 
occludin phosphorylation status, disrupting the TJ barrier and increasing 
parasite paracellular transmigration. These changes in phosphorylation 
status during infection will be investigated using an in vitro kinase assay 
in Chapter five.  
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5 Changes in Occludin Phosphorylation in Response 
to Toxoplasma gondii Infection 
 
5.1 Introduction 
 
The previous chapter confirmed parasites utilise the paracellular 
route of infection and described changes in the host TJ proteome in 
response to T. gondii infection. As a number of parasite derived kinases 
and phosphatases are secreted into the host cytoplasm during infection, it 
could be predicted that the cytoplasmic occludin C-terminus 
phosphorylation status is modulated during infection and will be 
investigated in this chapter. 
Pathogens such as enteropathogenic E. coli (EPEC) [Simonovic et 
al, 2000; Zhang et al, 2010], C. difficile [Nusrat et al, 2001], C. perfringens 
[Fujita et al, 2000; Sonoda et al, 1999] and S. typhimurium [Jepson et al, 
1995] as well as the Der p 1 allergen [Wan et al, 2000] and reovirus 
[Barton et al, 2001] have been shown to disrupt the TJ protein complex 
and dissociate occludin from intestinal epithelial TJs in order to 
transmigrate the epithelium. This has been linked to a shift from 
hyperphosphorylated TJ-associated occludin to non-phosphorylated 
intracellular compartment-associated occludin [Rao, 2009; Simonovic et 
al, 2000; Weight, 2011]. Transient occludin phosphorylation or 
dephosphorylation by T. gondii could therefore present a mechanism for 
occludin localisation to and from the TJ, enabling parasite paracellular 
infection of the SI epithelium. 
Occludin phosphorylation was first described in 1997 due to the 
range of occludin bands resolved by SDS-PAGE [Furuse et al, 1993; Saitou 
et al, 1997]. The molecular weight of these bands in MDCK I cells is 
between 62kDa-82kDa depending on the phosphorylation status of 
serine (S), threonine (T) and tyrosine (Y) residues in the occludin C-
terminus [Sakakibara et al, 1997]. Occludin phosphorylation also appears 
to play a central role in TJ regulation; Sakakibara et al demonstrated that 
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occludin phosphorylation is directly involved in TJ assembly and that 
highly phosphorylated occludin is predominantly located at the TJ 
[Sakakibara et al, 1997]. Similarly, Wong, Farshori and Kachar also 
confirmed phosphorylation regulates occludin localisation to and from 
the TJ at steady state [Farshori and Kachar, 1999; Wong, 1997]. 
Consequently, non-phosphorylated occludin species are located 
intracellularly in the vesicular compartment, serine-threonine 
phosphorylated species at the lateral membrane and the functionally 
active multiple-serine hyper-phosphorylated species exclusively at the TJ 
[Andreeva et al, 2001; Sakakibara et al, 1997; Tsukamoto and Nigam 
1999; Wong, 1997]. This occludin trafficking pattern to and from the TJ 
mirrors the FRAP studies, described in chapter 1, in which occludin is 
first delivered to the lateral cell membrane then traffics within the 
membrane to the TJ [Shen et al, 2008].   
Dorfel and Huber have extensively reviewed occludin 
phosphorylation in epithelial cells and the authors conclude several 
known kinases such as c-Src, ROCK, cPKC, PKCη PKCζ, CKII and VEGF 
dynamically and reversibly phosphorylate occludin to modulate TJ 
structure and permeability. Table 5.1 summarises the current known 
effects on TJ function associated with phosphorylation of occludin C-
terminus aa residues. Human aa residues are stated with corresponding 
murine residues in brackets and the experimental models relate to hypo- 
(red) or hyper- (green) phosphorylated cellular occludin [Dorfel and 
Huber, 2012]. Phosphatases such as PP1, PP2A, and DEP-1, which have 
been associated with TJ integrity, also reverse the action of kinases to 
play an important role in coordinating occludin phosphorylation but they 
have been much less studied [McCole, 2013; Seth et al, 2007].  
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Deregulated TJ protein phosphorylation has also been associated with 
inflammatory intestinal diseases such as IBD or cancer so it is therefore 
an important regulatory mechanism of TJ barrier function [Dorfel and 
Huber, 2009].   
At the time of writing it is not clear whether the phosphorylation 
of occludin by various kinases is mutually exclusive or if they could act in 
combination and it is also probable that other  kinases target the occludin 
C-terminus aa residues and this will be investigated as part of this 
chapter. 
 
 
5.2 Results 
 
5.2.1 Prediction of Novel Occludin Kinases 
 
To identify novel IEC-6 occludin kinases the bioinformatics 
ExPASy kinase-specific prediction software NetPhos and NetPhosK were 
used to predict occludin C-terminus phosphorylation sites by searching 
for homologous kinase target motifs within the occludin C-terminus aa 
sequence [Blom et al, 2004]. 50 potential occludin C-terminus serine, 
threonine and tyrosine phosphorylation sites were identified, 26 of which 
conformed to consensus kinase sequence motifs (Figure 5.1). The search 
threshold was set to 0.05 to reduce the number of false-positives. 
Comparison with the SILAC dataset presented in chapter four (Appendix 
B), confirmed the IEC-6 cell line expressed 15 kinases that could 
potentially phosphorylate the occludin C-terminus in an in vitro kinase 
assay: CKI, CKII, ROCK, EGFR, Src, Yes, Lyn, INSR, Cdk5, GSK, FAK, PKCδ, 
PKCι and MAPK as well as phosphatase PP1. Searching for novel occludin 
C-terminus phosphorylation sites targeted by these IEC-6 kinases 
identified three CKII, two PKC, one EGFR/INSR and one RSK C-terminus 
phosphorylation site. The locations of these novel phosphorylation sites 
are depicted in Figure 5. 
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Figure 5.1: Occludin kinase bioinformatics. A) Full-length murine occludin 
sequence. B) Murine occludin C-terminus aa phosphorylation sites and kinases 
predicted using ExPASy kinase prediction software NetPhos and NetPhosK by 
searching the occludin C-terminus sequence for known kinase target motifs 
[Blom et al, 1999 and 2004] at a threshold of 0.05. Predicted occludin C-
terminus aa phosphorylation sites are highlighted in BOLD: tyrosine (Y), 
threonine (T) and serine (S). Novel CKII phosphorylation sites are indicated in 
yellow, PKC in pink, EGF in green and RSK in orange and Occludin aa c-terminus 
residues that have been experimentally confirmed are highlighted in blue and 
the kinase is indicated. C) The occludin phosphorylation hotspot aa residues 
[Dorfel and Huber, 2012] are highlighted in red and the experimentally 
confirmed kinase is indicated  [Andreeva et al, 2006; Basuroy et al, 2003; 
Cordenonsi et al, 1999; Du et al, 2010; Elias et al, 2009; Jain et al, 2011; Kale et 
al, 2003; Murakami et al, 2009; Raleigh et al, 2011; Smales et al, 2003; 
Sundstrom et al, 2009; Suzuki et al, 2009; Yamamoto et al, 2008]. 
 
 
 
 
 
 
 
 A          B                           C 
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5.2.2 In Vitro Occludin Kinase Assay 
 
Since O’Farrell and Klose demonstrated that proteins could be 
separated based on their isoelectric point and molecular weight, two-
dimensional gel electrophoresis (2D-GE) has been used as a method of 
separating complex protein samples [O’Farrell, 1975; Klose, 1975]. 
Furthermore, labelling using fluorescent dyes such as ProQ Diamond 
[Steinberg et al, 2003] and Phos-tag [Kinoshita et al, 2004] has been used 
to quantitate protein phosphorylation. Using these properties a novel in 
vitro kinase assay was developed here to assess changes in occludin 
phosphorylation status. 
The in vitro kinase assay reflects a simplified cellular system 
where recombinant occludin C-terminus peptides were incubated in the 
presence of active purified kinase and the phosphorylation status 
assessed by 2D-GE and MS. As 2D-GE separates post-translationally 
modified proteins, the spots on a 2D gel reflect differences in the extent of 
occludin phosphorylation. 
 To confirm the in vitro kinase assay could detect changes in 
occludin phosphorylation, the ubiquitously expressed serine/threonine 
kinase CKII was initially used as the source of kinase [Dorfel et al, 2009 
and 2013]. Recombinant occludin C-terminus peptides incubated with 
purified CKII in the presence of ATP were compared with no kinase 
controls. The peptides were separated horizontally by their net charge 
using pH4-11 1D isoelectric focusing (IEF) strips prior to vertical 
separation based on their molecular weight in conjunction with SDS-
PAGE. 
In the presence of CKII, a series of phosphorylated occludin 
species were detected using the ProQ Diamond phosphoprotein stain 
[Schulenberg et al, 2003] (Figure 5.2D) compared to the control (Figure 
5.2B). SYPRO Ruby total protein staining confirmed high abundance of 
non-phosphorylated occludin and low abundance of highly 
phosphorylated occludin (Figure 5.2A and C) [Steinberg et al, 2003].  
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Figure 5.2: In vitro occludin kinase assay. Recombinant occludin C-terminus 
peptides were incubated with purified CKII in the presence of ATP and 
compared with no kinase controls. A) Control samples stained using SYPRO 
Ruby for total protein, image intensity 52%. B) Control sample stained using 
ProQ Diamond for phosphoproteins, image intensity 69%. C) CKII sample 
stained using SYPRO Ruby for total protein, image intensity 52%. D) CKII sample 
stained using ProQ Diamond for phosphoproteins, image intensity 69%. E) 
Overlay image of ProQ Diamond control in orange and CKII in blue. A-E) 2D-GE 
images were aligned using conserved protein spots, depicted as a vertical red 
line.  
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For comparison, both sets of images were taken at an intensity of 
52% and 69% respectively. The blue spot mobility shift towards the left 
of the gel in the overlay image (Figure 5.2E) confirmed an increase in 
phosphorylation in the presence of CKII, whereas the orange spot 
mobility shift towards the right of the gel confirmed the presence of non-
phosphorylated total protein in the control. 
 
 
5.2.3 Occludin Phosphorylation Analysis by Mass 
Spectrometry 
 
The ExPASy Peptide Cutter software [Gasteiger et al, 2005] was 
used to predict potential occludin C-terminus protease cleavage sites. 
Peptide cleavage of the occludin C-terminus phosphorylation hotspot 
region, and protein sequence coverage for trypsin, asp-N endopeptidase 
and glutamyl endopeptidase were compared by MS. Glutamyl 
endopeptidase gave the greatest occludin sequence coverage at 53% and 
optimal 12aa peptide length within the hotspot region.  
To verify the predicted novel CKII occludin C-terminus 
phosphorylation sites: S334 T392 and S470, the seven phosphorylated 
peptide spots in Figure 5.1B were picked from gels and analysed by MS 
(Method section 2.12). Although each spot identified several of the 
phosphorylated residues, seven unique occludin C-terminus aa residues 
phosphorylated by CKII (Table 5.2) were identified; confirming the 
presence of the previously experimentally validated T399 
phosphorylation site and although the predicted CKII sites were not 
detected, six novel occludin C-terminus aa residues were found to be 
phosphorylated by CKII. Further experimental validation will be required 
to confirm the biological significance of these findings. 
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5.2.4 IEC-6 occludin phosphorylation footprint modulation by 
Toxoplasma gondii 
 
To investigate the IEC-6 occludin phosphorylation footprint, the in 
vitro kinase assay was modified to include IEC-6 lysates as the source of 
native cellular kinases. IEC-6 monolayers cultured in 25cm2 plastic flasks 
for seven days were either non-infected or infected with T. gondii for two 
hours, lysed and incubated with recombinant fragments of occludin C-
terminus and compared with no kinase controls as above. 
Subsequent 2D-GE identified a series of phosphorylated occludin 
species in the presence of infected (Figure 5.3F) and uninfected IEC-6 
lysates (Figure 5.3D) compared to no kinase controls (Figure 5.3B) using 
the ProQ Diamond phosphoprotein stain [Schulenberg et al, 2003]. 
SYPRO Ruby total protein staining [Steinberg et al, 2003] confirmed a 
high abundance of non-phosphorylated occludin in the control (Figure 
5.3A) and low abundance of highly phosphorylated occludin due to 
incubation with non-infected IEC-6 and infected IEC-6 (Figure 5.3C and 
E). The occludin C-terminus protein spot mobility shift towards the left of 
the ProQ Diamond stained gels (Figure 5.3D and F) demonstrated high 
abundance of phosphorylated occludin C-terminus species in the 
presence of non-infected and infected IEC-6 lysates, whereas the spot 
mobility towards the right of the gel (Figure 5.3B) confirmed the 
presence of non-phosphorylated occludin species in the control.  
It should be noted that the apparent abundance of phosphorylated 
occludin C-terminus in the control is due to the high intensity of the 
image (80%) and does not reflect the actual low abundance of 
phosphorylated occludin C-terminus. Due to these inconsistencies it was 
not possible to quantify any differences between the non-infected and 
infected samples and it was only possible to perform this experiment 
once in the time available.  
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Figure 5.3: Toxoplasma gondii modulation of IEC-6 in vitro occludin kinase 
assay. IEC-6 monolayers cultured in 25cm2 plastic flasks for seven days were 
uninfected or infected with T. gondii for two hours. IEC-6 were subsequently 
lysed and incubated with recombinant fragments of occludin C-terminus 
peptides in the presence of ATP and compared with no lysate controls. A) 
Control samples stained using SYPRO Ruby for total protein, image intensity 
52%. B) Control sample stained using ProQ Diamond for phosphoproteins, 
image intensity 80%. C) Non-infected IEC-6 lysate sample stained using SYPRO 
Ruby for total protein, image intensity 55%. D) Non-infected IEC-6 lysate sample 
stained using ProQ Diamond for phosphoproteins, image intensity 55%. E) 
Infected IEC-6 lysate sample stained using SYPRO Ruby for total protein, image 
intensity 55%. F) Infected IEC-6 lysate sample stained using ProQ Diamond for 
phosphoproteins, image intensity 58%. A-E) 2D-GE images were aligned using 
conserved protein spots at the far left and right of the images (red lines). Protein 
spots analysed by MS are crossed by a vertical red line. 
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5.2.5 Toxoplasma gondii Derived Kinases Targeting Occludin 
 
Potential T. gondii proteins targeting the occludin C-terminus were 
identified using a bioinformatics approach; the rat occludin C-terminus 
sequence was searched against the T. gondii genome using NCBI-BLAST 
provided at www.toxodb.org (release number 24 14th April 2015) [Gajria 
et al, 2008]. The database was used to search for occludin homology with 
the T. gondii ME49, GT1 and VEG strain genomes as the RH strain genome 
was incomplete at the time of writing. 53 parasite-derived proteins were 
identified as potentially interacting with the occludin C-terminus 
(Appendix E) and functional classification of C-terminus interacting 
parasite proteins using GO annotation revealed involvement in 
phosphorylation and dephosphorylation (5.6%) but the majority of 
proteins were unclassified (83%). Two parasite-derived kinases were 
predicted to interact with the occludin C-terminus: wee kinase and 
calmodulin kinase (CAM) TgCDPK1, a calmodulin-like domain protein 
kinase (CDPK) family member, as well as one tyrosine/serine/threonine 
phosphatase (Appendix E). 
 
 
5.3 Discussion 
 
The occludin in vitro kinase assay identified six novel CKII 
occludin C-terminus phosphorylation sites and preliminary results 
confirm the in vitro kinase assay is able to detect occludin C-terminus 
phosphorylation by infected and non-infected IEC-6 lysates, although 
differences between the occludin phosphorylation footprint remain to be 
identified.  
The balance between host kinases and phosphatases is known to 
regulate occludin phosphorylation at a range of C-terminus sites, directly 
affecting its function at the TJ [Cummins, 2011; Dorfel and Huber, 2011 
and 2012].  
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Many of these known occludin phosphorylation sites are located 
within a highly conserved 11aa sequence representing a Serine-
Threonine kinase hotspot within the proximal occludin C-terminus, close 
to the hydrophobic coiled-coil occludin ELL (OCEL) domain [Buschmann 
et al, 2013; Dorfel and Huber, 2012]. The six hotspot aa residues are 
targeted by six different kinases including c-Src, nPKCη and CKII and the 
location of this hotspot near a cysteine residue previously associated with 
occludin self-association suggests targeted phosphorylation in this region 
could play a role in occludin dimer formation between neighbouring cells 
[Nusrat el al, 2000], essential for TJ barrier regulation as well as ZO-1 
recruitment and association with claudins [Bellmann et al, 2013; Blasig et 
al, 2006; Li et al, 2005; McCaffrey et al, 2008; Nusrat et al, 2000; Schulzke 
and Gunzel, 2012; Walter et al, 2009]. It is currently unknown if the 
occludin C-terminus aa residues are phosphorylated sequentially or 
randomly and whether the phosphorylation of some aa residues is 
functionally more important than others [Sakakibara et al, 1997].   
Several groups have examined the effect of occludin 
phosphorylation on TJ molecular structure and barrier function by 
various kinases, many of which are expressed in IEC-6. CKII for example 
has been widely studied and is confirmed to phosphorylate at least three 
occludin C-terminus aa residues in mouse, Xenopus laevis and human 
[Cordenonsi et al, 1999; Dorfel et al, 2009; Smales et al, 2003]. 
Furthermore, studies by Raleigh et al provided some functional insight; 
CKII mediated phosphorylation of occludin S408 modulates interactions 
between ZO-1, Claudins-1 and -2 and implicates S408 phosphorylation 
and dephosphorylation as a molecular switch that regulates paracellular 
TJ structure and function [Raleigh et al, 2011]. Using phosphomimetic 
mutations, Dorfel and Huber found triple CKII phosphorylation increased 
TEER, enhanced TJ disassembly and association with ZO-1 but not ZO-2. 
In contrast mono-phosphorylated S408 displayed reduced binding to ZO-
1 [Dorfel and Huber, 2013]. With the recent mapping of the ZO-1 binding 
site to occludin C-terminus aa residues 468-475 [Tash et al, 2012], the 
authors proposed that CKII phosphorylation modulates the ZO-1 and -2 
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binding site as a mechanism of TJ assembly and function [Dorfel et al, 
2013]. Interestingly, in vitro binding assays suggested S408 
dephosphorylation also promotes occludin trafficking to the TJ and 
increased association with ZO-1, claudin-1 and -2 [Raleigh et al, 2011]. 
With the knowledge that the ZO proteins also act as NACos, differential 
binding of ZO-1 or -2 to occludin in response to CKII phosphorylation 
could also modulate TJ gene expression [Dorfel and Huber, 2013]. Other 
occludin kinases have been less studied; tyrosine kinases have been 
associated with TJ destabilisation and disruption, possibly by preventing 
interactions with ZO-1 [Kale et al, 2003]. Furthermore, CKI has been 
shown to phosphorylate occludin but the aa residues targeted and 
physiological effects are currently unknown [Dorfel and Huber, 2012].  
Cellular kinases and phosphatases may not require direct 
interaction with occludin to elicit an effect on TJ barrier function. For 
instance, phosphorylation of occludin Y397 by Src-associated kinases 
activates another tyrosine kinase, focal adhesion kinase (FAK) to induce 
TJ barrier disruption via the actin cytoskeleton, and it is not currently 
known if FAK can directly phosphorylate occludin or if a secondary 
mechanism is involved  [Siu et al, 2009]. Likewise, PP1 has been 
suggested to interact and phosphorylate occludin serine residues but its 
primary dephosphorylation target may be an additional TJ protein [Seth 
et al, 2007]. 
Clearly, the dynamic phosphorylation and dephosphorylation of 
occludin plays a vital role in TJ structure and function, although the aa 
residues targeted by cellular kinases and phosphatases as well as their 
specific effect on occludin function are still unknown. Many more kinases 
and phosphatases targeting occludin are likely still to be discovered. 
Consequently, an in vitro kinase assay was developed to further 
investigate occludin phosphorylation. CKII was confirmed to 
phosphorylate the occludin C-terminus and ten novel targeted aa 
residues were identified. Additional validation will be required using 
phospho-specific antibodies, mutation of phosphorylated residues, kinase 
inhibitors or siRNA knockdown as well as functional evaluation in vitro or 
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in vivo, to uncover the physiological significance of this finding. An 
attractive future study would be to identify whether occludin function at 
the TJ is differentially regulated by different kinases and phosphatases 
and the effect on occludin mobility within the TJ. It should however not 
be overlooked that these kinases and phosphatases may also target other 
components of the TJ such as ZO-1, -2 and -3, claudins and JAM in order to 
regulate the TJ barrier function. 
Recent analysis of the T. gondii genome identified 108 predicted 
active kinases [Peixoto et al, 2010], 38 of which are located in the parasite 
rhoptry and potentially secreted directly into the host cell cytoplasm 
during infection, although few of their host substrates have been 
identified [Bradley et al, 2005; Dubremetz, 2007; Yamamoto et al, 2009]. 
Other secreted parasite proteins include MIC-associated adhesins 
involved in host attachment. ROP-associated proteases, phosphatases, 
actin binding Toxofilin and the small GTPase Rab11 involved in invasion 
and formation of the PV, as well as RON-associated proteins involved in 
MJ formation [Bradley and Sibley, 2007; Kim, 2004; Poupel et al, 2000].  
Here, two parasite-derived kinases are predicted to interact 
directly with the occludin C-terminus, wee kinase and CDPK1 as well as 
one dual specificity phosphatase. Clearly, the parasite phosphatase could 
play a role in occludin dephosphorylation and dissociation from the TJ 
seen during infection [Weight and Jones et al, 2015]. Interestingly, CDPKs 
have been linked to parasite host cell attachment and egress, although the 
mechanism is not fully understood [Kieschnick et al, 2001; Lim et al, 
2012]. Calmodulin-dependant kinases have previously been shown to 
interact with TJ JAM [Martinez-Estrada et al, 2001]. As JAM also 
associates with occludin, cingulin and ZO-1 [Martìn-Padura et al, 1998], 
and CDPK binding to JAM is attenuated by TJ dissociation [Martinez-
Estrada et al, 2001], this suggests a possible role for T. gondii CDPK1 
(TgCDPK1) in host TJ structure reorganisation. Further evidence is 
provided by TgCDPK1 sensitivity to KT5926, an inhibitor of MLCK 
[Kieschnick et al, 2001]. MLCK plays a key role in host TJ permeability by 
regulating actin reorganisation and localisation of ZO-1 and occludin to 
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the TJ [Cunningham and Turner, 2012; Shen et al, 2006]. TgCDPK1 
phosphorylation of host occludin may therefore promote occludin 
recruitment to the TJ via interactions with JAM, ZO-1 and the actin 
cytoskeleton and facilitate parasite paracellular infection via parasite 
binding to occludin at the TJ. The SILAC dataset described in chapter four 
also identified a decrease in host PKCι during infection, suggesting 
parasites may additionally modulate host kinase, protease or 
phosphatase expression to facilitate infection. A decrease in PKCι has 
been associated with increased TEER and depletion of pore-forming 
claudin-2 from the TJ, suggesting a key role for PKCι in TJ protein 
recruitment and paracellular permeability [Lu et al, 2015]. As claudin-2 
interacts with occludin at the TJ, its loss may reduce occludin 
mobilisation at the TJ. Both of these mechanisms, secretion of parasite 
derived kinases and phosphatases or modulation of host kinase and 
phosphatase expression, potentially play an important role in occludin 
phosphorylation and dephosphorylation during T. gondii infection. 
The evidence for occludin redistribution from the apical TJ to an 
intracellular location during T. gondii infection alongside the link 
between occludin phosphorylation and cellular localisation [Farshori and 
Kachar, 1999; Weight and Jones et al, 2015; Wong, 1997] led to the 
hypothesis that the occludin phosphorylation status is modulated during 
T. gondii paracellular infection. 
To investigate the effect of T. gondii infection on occludin 
phosphorylation, infected and uninfected IEC-6 lysates were substituted 
as the source of kinase in the in vitro assay. This revealed IEC-6 cellular 
kinases were active under the experimental conditions and able to 
phosphorylate the recombinant occludin C-terminus peptide in vitro. 
Although the preliminary results suggest a possible increase in 
phosphorylated occludin species in response to infection (Figure 5.2D 
and F), it was not possible within the time frame to quantify the 
modification of occludin phosphorylation or identify the targeted C-
terminus aa residues.  
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The preliminary in vitro kinase assay results provide a starting 
point for future studies; whole parasites, parasite lysates and conditioned 
media (secreted kinases) should be included in future in vitro kinase 
assays to determine the direct effect of parasites in comparison to 
infected cells.  In addition, purified host-derived or parasite-derived 
kinases could be utilised in the occludin in vitro kinase assay to determine 
the significance of phosphorylation of particular C-terminus aa residues. 
Comparison of occludin phosphorylation at different stages of parasite 
infection, such as 2 hours or 24 hours p.i may also give an insight into the 
role of occludin in both early paracellular infection and later intracellular 
PV formation.  
As low occludin sequence coverage and low protein abundance are 
a major limitation of the current MS-based phosphoproteomics 
technique, in future affinity based enrichment of phosphopeptides by 
immobilised metal affinity chromatography (IMAC), titanium dioxide 
chromatography or phospho-antibody co-immunoprecipitation could be 
coupled with targeted MS to overcome these proteomics challenges 
[Delom and Chevet, 2006; Hjerrild and Gammeltoft, 2006; Rigbolt and 
Blagoev, 2012].  
 
5.4 Conclusions 
 
This chapter confirmed the occludin in vitro kinase assay was suitable for 
quantifying recombinant occludin C-terminus phosphorylation. Using 
purified CKII six novel CKII occludin C-terminus phosphorylation sites 
were identified. Preliminary results also confirmed host IEC-6 kinases are 
active and able to phosphorylate the occludin C-terminus peptide in vitro, 
although it was not possible to quantify modulation of occludin 
phosphorylation in response to IEC-6 T. gondii infection. Although a key 
role for occludin phosphorylation during T. gondii infection was 
proposed, further studies are required to fully understand the molecular 
mechanisms and consequence of occludin phosphorylation during 
paracellular infection. 
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6 Toxoplasma gondii Interactions with Occludin  
 
6.1 Introduction 
 
The previous chapters described T. gondii paracellular 
transmigration and modulation of TJ proteins during T. gondii infection, 
including occludin phosphorylation. It is possible that T.gondii interacts 
directly with the extracellular domains of occludin during parasite 
paracellular transmigration of the SI epithelium. Therefore, in this 
chapter this hypothesis is tested to determine whether T. gondii interacts 
with occludin extracellular loop (ECL) domains.  
Occludin is not exclusively required for TJ formation but it is a 
functional component, possibly dependent on the adhesive capabilities of 
its ECL domains [Furuse et al, 1996; Tsukita et al, 2001; Van Itallie and 
Anderson, 1997]. Due to their position within the paracellular space, the 
ECLs of occludin are thought to functionally regulate paracellular 
permeability by forming homophilic interactions with adjacent cells to 
create a barrier to macromolecules but not charged ions, potentially 
regulating the TJ leak pathway [Al-Sadi et al, 2011; Balda et al, 2000; 
Hartsock and Nelson, 2008]. However, despite many studies, the role of 
occludin in paracellular permeability and the functional relevance of its 
ECL domains still remains unclear.  
Medina et al and Bellmann in separate studies confirmed occludin 
ECL2 forms homologous interactions on adjacent cells and is required for 
occludin localisation at the TJ [Bellmann et al, 2014; Medina et al, 2000]. 
Occludin ECL2 is also known to interact with claudins and JAM-A and 
disruption of these interactions inhibits reformation of TJ’s [Furuse et al, 
1998; Nusrat et al, 2005]. Interestingly, the addition of synthetic ECL1 
peptides to epithelial cells results in increased TEER and occludin 
localisation to the TJ [Lacaz-Vieira 1999; Van Itallie et al, 1997]. Similarly, 
Tavelin et al established ECL1 significantly increased TJ permeability and 
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specifically identified ECL1 peptide residues 90-103 as responsible for 
this barrier disruption [Tavelin et al, 2003]. In contrast, Wong and 
Gumbiner found ECL2 peptides reversibly disrupted the TJ barrier and 
reduced occludin localisation at the TJ whilst not affecting other TJ 
proteins. The authors also reported that ECL1 was inactive [Wong and 
Gumbiner, 1997].  
These marked differences between ECL1 and ECL2 on the TJ may 
be explained by differences in the cell lines and occludin peptide 
sequences used, given that ECL1 is only ~53% conserved between 
chickens and humans [Tavelin et al, 2003]. Differences in peptide 
concentration and administration, solubility and correct folding of the 
peptides, experimental time course and maturity of the cell monolayers in 
the above studies may have also played a role. The variance between 
studies also raises the possibility that occludin ECL1 and ECL2 may 
differentially regulate the TJ barrier by either directly mediating 
paracellular permeability or acting as a regulator of other TJ proteins 
such as claudins.  
The specific interaction between T. gondii and occludin has to date 
only been described by Weight using recombinant occludin peptides 
[Weight, 2011]. This interaction, particularly between parasites and the 
ECL of occludin, will be further investigated in this chapter. 
 
 
6.2 Results 
 
The murine SI epithelial cell line, m-ICc12 was used in this chapter to 
confirm and quantify previous findings by Weight [Weight, 2011].  
Functional recombinant occludin C-terminus, ECL1+ECL2, ECL1 and 
ECL2 peptides were produced (Figure 2.1) and to our knowledge this is 
the first report of functional recombinant ECL1 being expressed in a 
prokaryotic system as previous studies with ECL1 have utilized synthetic 
peptides [Lacaz-Vieira 1999; Tavelin et al, 2003; Van Itallie et al, 1997; 
Wong and Gumbiner, 1997].  
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As both ECL1 and ECL2 are highly hydrophobic and form insoluble 
polymers in solution, soluble stocks of the recombinant occludin peptides 
were produced immediately prior to each assay to prevent peptide 
aggregation. 
 
 
6.2.1 Toxoplasma gondii Interactions with Occludin Alter 
Parasite Attachment and Infection 
 
Confluent m-ICc12 monolayers grown on glass coverslips for four 
days were apically infected for two hours with either T. gondii alone 
(control) or T. gondii pre-incubated with 2μM recombinant occludin 
peptides for 15 minutes prior to co-culture. Of note, yields of ECL1 
peptides were poor compared to ECL1+2, ECL2 and the C-terminus, 
therefore ECL1 could not be included in this cell-based assay. 
To distinguish between T. gondii attachment and invasion of the 
m-ICc12 monolayer, haematoxylin and eosin (H&E) staining of cells post-
infection highlighted the PV (Figure 6.1A inset), indicative of intracellular 
infection. Although the ‘domed’ morphology of confluent m-ICc12 
monolayers caused difficulties in parasite visualisation, in control 
samples the total number of attached parasites was 36.0% (±13.9%) 
higher than the number of invading parasites, which indicates that 
although attachment is necessary for successful invasion, not all attached 
parasites invade host cells (Figure 6.1A).  
Significant changes in T. gondii attachment and invasion were 
observed in response to parasite interactions with occludin ECL1+ECL2 
in comparison with ECL2 or C-terminus peptides. In agreement with the 
results presented in chapter three, parasite infection of host cells was 
non-homogeneous with many parasites being associated with a few cells 
and the majority of cells having no parasite interactions (Figure 6.1B). 
Figure 6.1C and D show T. gondii pre-incubation with ECL1+ECL2 both 
significantly increased the number of invading parasites (p ≤ 0.0001) and 
significantly decreased the number of attached parasites (p ≤ 0.0001). In 
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contrast, pre-incubation with ECL2 had no effect on parasite attachment 
or invasion (p ≥0.05) but interestingly, a significant decrease in 
attachment was observed by pre-incubation with occludin C-terminus (p 
≤ 0.001) (Figure 6.1C and D). 
Confluent m-ICc12 monolayers grown on PET inserts for four days 
were apically infected for two hours with either T. gondii pre-incubated 
with recombinant occludin ECL2 peptide or T. gondii administered 
simultaneously with the occludin ECL2 peptide and the results compared 
to addition of T. gondii alone (control). In agreement with results shown 
in chapter four, administration of T. gondii alone did not affect the barrier 
integrity of m-ICc12 assessed by TEER. In contrast, addition of ECL2 
simultaneously with parasites significantly increased TEER (p ≤ 0.005), 
which was attenuated by pre-incubation with parasites (Figure 6.2A). M-
ICc12 monolayer permeability to FITC-dextran also decreased with the 
addition of occludin peptides, which was again attenuated by pre-
incubation with parasites, although this did not reach statistical 
significance (Figure 6.2B). 
Although these results suggest T. gondii interact with the occludin 
ECL1+ECL2, ECL2 and C-terminus peptides in vitro, addition of the 
recombinant occludin ECL2 peptide appears to significantly alter the 
barrier function of the m-ICc12 monolayer. This raises the question of 
whether the observed changes to T. gondii attachment and invasion were 
due to alteration of the TJ barrier function via interactions between 
recombinant occludin peptides and native cellular occludin rather than 
solely due to parasite interactions with occludin. 
 
 
6.2.2 Toxoplasma gondii Bind to the Extracellular Loops of 
Occludin 
 
A cell-free chamber-slide assay was developed to assess parasite 
binding to occludin in a cell-free system.  
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Figure 6.1: Toxoplasma gondii inhibition of attachment and invasion in 
response to recombinant murine occludin peptides. Confluent m-ICc12 cell 
monolayers grown on glass coverslips for four days were apically infected with 
A) 5x106 Toxoplasma gondii for 2 hours (control) or B) 5x106 Toxoplasma gondii 
pre-incubated with 2.0μM recombinant ECL1+ECL2 for 15 minutes prior to 
infection for 2 hours. Intracellular invaded parasites were identified by the 
white halo of the parasitophorous vacuole (Inset and white arrow). Percentage 
change in attachment C) and invasion D) when parasites are pre-incubated with 
recombinant fragments of occludin compared to cells treated with parasites 
only (control). Data representative of three independent experiments with 3-4 
biological replicates. ***P=≤0.001 ****P=≤0.0001.  
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Figure 6.2: Toxoplasma gondii invasion and transmigration of m-ICc12 in 
response to recombinant fragments of murine occludin. Confluent m-ICc12 
cell monolayers grown on PET inserts for thirteen days were apically infected 
with 5x106 Toxoplasma gondii for 2 hours (control) or 5x106 Toxoplasma gondii 
pre-incubated with 2.0μM recombinant ECL1+ECL2 for 15 minutes prior to 
infection for 2 hours. TEER was measured pre- and post-infection and cellular 
permeability to 1000μg/ml FITC-dextran measured post-infection. A) 
Percentage change in TEER and B) permeability when parasites are pre-
incubated with recombinant fragments of occludin compared to cells treated 
with parasites only (control). Data representative of one independent 
experiment with 3-4 biological replicates. **P=≤0.01.  
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His-tagged occludin peptide immobilisation was assessed by 
fluorescence microscopy using a Penta.HIS alexa fluor 488 conjugated 
antibody (Qiagen). The signal intensity in the green channel was at least 
500 fluorescence units in the sample wells, compared to zero in the 
control wells and although peptide immobilisation was sparse at 30μM 
protein concentration per well (Figure 6.3A), limited peptide quantities 
were available, especially for ECL1. Some variation in peptide 
immobilisation was observed between the ECL1+2 and ECL1 peptides 
compared to the ECL2 or C-terminus peptides, likely due to differences in 
HIS-tag availability to the fluorescent antibody (Figure 6.3A and B). 
Importantly, these differences did not correspond with levels of T. gondii 
binding. 
Significant differences in T. gondii binding were reproducibly 
observed in slide wells containing immobilised occludin ECL1+ECL2 and 
ECL1 peptides in comparison with ECL2, C-terminus or control peptides 
(Figure 6.4A and B). Parasites were seen to significantly bind and 
aggregate in wells containing ECL1+ECL2 or ECL1 (p ≤ 0.01) compared to 
low density parasite binding and minor aggregation in wells containing C-
terminus (p ≥ 0.05) or ECL2 (p ≥ 0.05) and low parasite binding in control 
wells containing either no peptides or m-Cherry (p ≥ 0.05). 
 
 
6.2.3 Potential Toxoplasma gondii Derived Occludin Binding 
Partners  
 
A bioinformatics approach was used to identify putative T. gondii 
occludin binding partners. The rat occludin sequence was BLASTED 
against the T. gondii genome using NCBI-BLAST (www.toxodb.org release 
number 24 14th April 2015) [Gajria et al, 2008]. The database was used 
to search for occludin homology with the T. gondii ME49, GT1 and VEG 
strain genomes. The RH strain genome was incomplete at the time of 
writing (September 2015).  
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Figure 6.3: Detection of recombinant occludin peptide immobilisation on 
Schott Nexterion Slide H. A) 30μM HIS-tagged occludin peptides ECL1+ECL2, 
ECL1, ECL2 and C-terminus, as well as HIS-tagged mCherry protein (control) 
and buffer alone (blank) were immobilised onto individual wells of Scott 
Nexterion H Slides (Jena, Germany). Peptides were detected using a Penta-HIS 
alexa fluor 488 conjugated antibody (Qiagen), visualised by fluorescence 
microscopy and quantified by fluorescent alexa fluor 488 pixel area. B) 
representative immunofluoresnce image of occludin ECL2 peptide 
immobilisation. C) Representative immunofluoresnce image of buffer alone 
(blank). Data representative of one independent experiment with biological 
replicates. Scale bar 20µm. 
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Figure 6.4: T. gondii binding to recombinant fragments of murine 
occludin. His-tagged occludin peptides ECL1, ECL2, ECL1+ECL2 and C-terminus, 
His-tagged mCherry protein and buffer alone (control) were immobilised onto 
individual wells of Scott Nexterion H Slides (Jena, Germany). 1x107 Toxoplasma 
gondii were added per well for 2 hours. Bound parasites were visualised by 
fluorescence microscopy A) and quantified by fluorescent YFP pixel area B). 
Scale bar = 20μm. Data representative of six independent experiments with 
biological replicates. **P=≤0.01  
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129 parasite-derived proteins were predicted to interact with 
occludin ECL1 compared to only 16 with occludin ECL2 (Appendix E). 
Functional classification of these ECL1 proteins using GO annotation 
revealed involvement in protein folding (2.3%), protein transport (3.9%) 
as well as phosphorylation and dephosphorylation (3.1%). The majority 
of proteins were unclassified (79.1%) (Figure 6.5). 48 parasite-derived 
proteins were identified as interacting with the full-length occludin 
(Appendix E), suggesting parasite specificity for interactions with 
occludin domains. 
It was not within the scope of this project to undertake further in-
depth bioinformatics investigation of these findings, although they do 
present an interesting area for future research. 
 
 
6.3  Discussion 
 
In this chapter, evidence suggests T. gondii specifically bind to the 
occludin ECLs. Many pathogens have developed mechanisms for targeting 
TJ-associated proteins to infect the SI epithelium and specific interactions 
with occludin ECL domains during infection have been described, 
although the mechanism is unknown. This interaction is of particular 
interest as the ECLs of occludin are integral to maintaining the epithelial 
TJ barrier [Nusrat et al, 2005]. For example Entamoeba histolica 
expresses an occludin-like protein that can alter epithelial barrier 
function by displacing host occludin-occludin interactions via its ECL 
domains [Goplen et al, 2013].  
Here evidence is provided for in vitro T. gondii tachyzoite binding 
to occludin ECL1. Pre-incubation of T. gondii with the ECL1+ECL2 and to a 
lesser extent the C-terminus peptide, significantly reduced attachment to 
the epithelial cells in comparison with ECL2, suggesting T. gondii 
tachyzoites physically interact with the ECL1+2 and C-terminus peptide, 
which blocks cellular parasite attachment. This peptide intercalation into 
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the TJ or interaction with endogenous occludin would interfere with 
normal TJ function and potentially affect T. gondii transmigration. 
Additionally, the specific interaction between T. gondii and the ECLs 
means appropriate control peptides are difficult to achieve; here the 
occludin C-terminus peptide was used alongside an unrelated m-cherry 
peptide. Furthermore, the purification or detection tags added to the 
peptide fragments may affect their in vitro function due to their molecular 
size. In this study the small polyhistidine-tag (6xHIS-tag) was utilised to 
mitigate this effect. 
Addition of the ECL2 peptide to m-ICc12 significantly disrupted the 
TJ barrier, as described in previous studies using synthetic peptides 
corresponding to occludin ECL2. Wong and Gumbiner found ECL2 at 
<5μM significantly disrupted TJ function of Xenopus kidney cell line A6 
and decreased the amount of occludin at the TJ without affecting other TJ 
proteins. Nusrat et al later confirmed ECL2 associated with T84 occludin 
and impeded functional TJ assembly [Nusrat et al, 2005; Wong and 
Gumbiner, 1997].  
The results of the solid phase in vitro chamber slide-based 
occludin peptide binding assay suggest T. gondii interacts directly with 
ECL1. The lack of charged residues in ECL1 as well as a high proportion of 
tyrosine and glycine residues led to speculation that this domain was 
involved in sealing the paracellular space [Ando-Akatsuka et al, 1996].  
To predict parasite-derived occludin-binding proteins occludin 
ECL sequences were BLAST searched against the T. gondii genome and 
the protein functions classified using GO annotation. Following 
attachment to cellular junctions, parasites secrete a range of effector 
proteins from specialised organelles. Based on this it was hypothesised 
that these act upon the TJ proteins during infection. The BLAST search of 
potential ECL1 binding partners identified ROP25, GRA6, a putative MIC 
protein and a SAG1-related sequence (SRS) protein.  
 
 
 
 158 
 
 
 
 
 
 
 
 
 
 
Figure 6.5: Functional categorisation of the T. gondii-derived proteins 
predicted to interact with occludin domains. The numbers correspond to the 
percentage of identified proteins in each category compared to the total number 
of proteins. The occludin ECL1 domain was first searched for T. gondii 
homologues using NCBI-BLAST search and GO annotation was provided by 
www.toxodb.org (version 7.3). Proteins without a GO classification were 
designated unclassified. A list of all identified proteins is provided in Appendix 
E.  
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MIC2 for example, has been shown to bind host ICAM1, a known receptor 
for T. gondii paracellular transmigration [Barragan et al, 2005]. The 
predicted interaction between a putative T. gondii MIC protein and ECL1 
suggests binding to ECL1 could contribute to T. gondii paracellular 
transmigration.  
During the initial stages of infection, microneme proteins are 
secreted from the apical microneme organelle onto the parasite surface to 
facilitate adhesion and invasion [Carruthers and Tomley, 2008]. The next 
stage of parasite infection involves rhoptry protein secretion into the host 
cell where they traffic to the host nucleus, remain in the cytoplasm to 
facilitate PV formation, or relocate to the PV membrane [Hunter and 
Sibley, 2012]. ROPs including ROP25 identified here, are 
serine/threonine kinases, proteases or phosphatases that potentially play 
a role in the regulation of occludin via phosphorylation, a mechanism 
described in chapter five in which the phosphorylation status of occludin 
is altered in response to parasite infection.  
During the later stages of infection, dense granule proteins are 
secreted into the PV where they can contribute to controlling the host 
immune responses [Shastri et al, 2014]. GRA6 for example has been 
shown to recruit monocytes and neutrophils to sites of infection to 
promote parasite dissemination [Ma et al, 2014] and an interaction with 
occludin ECL1 could play a role in this mechanism. 
The potential interaction between ECL1 and SRS29C (formerly 
SRS2) is particularly noteworthy as the SRS protein superfamily of T. 
gondii surface proteins are known to facilitate host cell attachment and 
invasion as well as evasion and modulation of the host immune response 
[Templeton, 2007]. The SRS proteins typically contain one or two 
domains with multiple cysteine residues that create disulphide bonds and 
a GPI anchor that promotes attachment to the host cell surface [Manger 
1998]. SAG1 for example interacts with host cell proteoglycans through 
the formation of a deep, positively charged docking site [Mineo et al, 
1993]. However, the roles of the superfamily members remains poorly 
understood. Targeted gene deletion studies recently identified SRS29C as 
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a negative regulator of virulence; high expression was linked to reduced 
host inflammatory response, a mechanism that presumably promotes 
parasite proliferation and dissemination before the host immune 
response can limit tachyzoite infection [Wasmuth et al, 2012]. Taken 
together this evidence suggests SRS29C could facilitate initial host cell 
attachment and paracellular transmigration via interactions with 
occludin ECL1, promoting parasite dissemination at an early stage of 
infection. 
This homology-based analysis is somewhat limited as it does not 
give an indication of whether the predicted interactions are functionally 
relevant and does not account for structural interactions. These methods 
are also known to be prone to high false-positive rates [Lin et al, 2004; 
Wuchty, 2011]. However, as the T. gondii genome currently contains 
many uncharacterised proteins with unknown structures, highlighted by 
numerous unclassified proteins in the GO results, our preliminary 
analysis of potential parasite-occludin interactions was based on 
sequence similarity alone. Further in-depth bioinformatics analysis and 
integration with the SILAC data presented in chapter four would help 
identify biologically relevant candidate host-parasite interactions and 
potentially the molecular mechanisms by which T. gondii interact with 
the host cell. In addition, co-immunoprecipitation of recombinant 
occludin peptides with T. gondii lysates, combined with sensitive MS, 
would identify the molecular T. gondii proteins that interact with 
occludin. 
 
 
6.4 Conclusions 
 
This chapter has provided evidence for T. gondii tachyzoite 
binding to the ECLs of occludin. Taken together with the findings in 
chapter three for T. gondii transmigration through the paracellular 
pathway, a model of parasite infection is proposed whereby paracellular 
T. gondii binding to ECL1 via parasite surface proteins disrupts occludin 
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homodimer formation between neighbouring cells, consequently 
disrupting the TJ barrier and permitting parasite transmigration and 
dissemination to secondary sites of infection. To our knowledge, this 
novel finding is the first description of a role for occludin ECL1 during T. 
gondii infection and the above model describes a potential mechanism for 
parasite paracellular transmigration of the SI epithelium. 
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7 Discussion 
 
 
In this thesis infection of the SI epithelium was modelled in vitro using 
the IEC-6 and m-ICc12 cell lines (chapter four and six). The results reveal 
T. gondii paracellular infection of the SI epithelium and illustrate the 
importance of interactions between parasites and the TJ, specifically the 
TJ protein occluding (chapter six). Modulation of the occludin C-terminus 
domain phosphorylation status is important for occludin localisation to 
the TJ and subsequent parasite binding to the occludin ECLs represents a 
mechanism of paracellular transmigration of the TJ barrier (chapter five 
and six).  
 
 
7.1 Infection of IEC-6 Cells by Toxoplasma gondii 
 
T. gondii is an obligate intracellular parasite that requires host cell 
invasion for replication and survival by evading host detection and 
defence mechanisms as well as to access host metabolites. As oral 
infection is the primary cause of toxoplasmosis, the first point of contact 
between T. gondii and host is the intestinal epithelium, permitting rapid 
parasite dissemination away from the GI tract to immunoprivileged sites 
and establishment of chronic infection. As T. gondii infection triggers 
inflammatory pathology resembling that of chronic IBD [Pizarro et al, 
2003], elucidating the mechanisms of pathogenic TJ disruption and the 
complex interplay between TJ signalling pathways will further 
understanding of the mechanisms of pathogen infection as well as give an 
insight into the initiation and progression of diseases such as CD and UC. 
As such, T. gondii utilised in this thesis can be viewed as an experimental 
model for studying mechanisms of TJ disruption that leads to intestinal 
inflammatory disease with the aim of identifying new therapeutic targets 
to treat these diseases [Egan et al, 2012]. 
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7.2 Modulation of Tight Junction-Associated Proteins During 
Toxoplasma gondii Infection 
 
T. gondii have evolved novel mechanisms for promoting infection, 
including intracellular PV formation to provide an environment in which 
to avoid clearance by host autophagy or phagocytosis as well as 
specialised apical secretory organelles termed micronemes and rhoptries 
that sequentially release proteins into the host cell [Sharma and Chitnis, 
2013]. Micronemes firstly discharge MICs to the parasite surface where 
they form adhesive complexes that bind to host cell receptors [Soldati et 
al, 2001] and secondly rhoptry contents are secreted directly into the 
host cell cytoplasm where they manipulate a range of host cell processes 
such as metabolism, cell cycle and apoptosis as well as reorganising the 
host cell cytoskeleton and organelles [Laliberte and Carruthers, 2008; 
Nelson et al, 2008; Zhou et al, 2011]. 
The in vitro two-photon imaging presented in chapter four reveals 
the complex multi-stage processes involved in parasite paracellular 
transmigration, to our knowledge visualised for the first time in this 
thesis. Parasites exhibit gliding motility and target cellular junctions 
before attachment, reorientation, entry into the paracellular space, 
transmigration through the epithelium and egress from the paracellular 
space. During all stages of infection T. gondii maintains an intimate 
relationship with the host cell, therefore identifying the mechanisms 
involved will be important in further understanding the interactions 
between parasites and host cells. 
The apical TJ that occludes the paracellular space between cells of 
the SI epithelium functions as both a barrier and fence, separating the 
inner organs and tissues from the outside environment as well 
maintaining cell polarity [Anderson and Van Itallie, 2009; Cereijido et al, 
2008]. The continuous cycle of TJ assembly and disassembly of the TJ-
complex controls the paracellular permeability; regulated by dynamic 
interactions between the integral transmembrane proteins occludin, JAM-
A and claudin(s) with the cytoplasmic plaque of peripheral adaptor, 
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scaffold and signalling proteins that link the junctional membrane to the 
actomyosin cytoskeleton [Balda and Matter, 2008; Shen et al, 2011]. 
Furthermore, bidirectional signalling to and from the cell interior 
regulates cellular differentiation, proliferation, migration and survival 
[Balda and Matter, 2009] but the complex interplay between TJ molecular 
structure and function is only beginning to be understood.  
The results presented in chapter four indicate T. gondii intimately 
interacts with the host cellular junction prior to re-orientation, (Video 1); 
potentially secreting organelle contents into the paracellular space or 
host cell cytoplasm. With the knowledge that even host cells that are not 
infected contain physiologically relevant amounts of T. gondii effector 
proteins [Koshy et al, 2012], this finding may reflect parasite modification 
of the host TJ by secreted effector proteins as a mechanism of preparing 
the host cell for transmigration.  
To ensure their intracellular replication and survival T. gondii have 
evolved strategies to modulate host cell structure and function such as 
subversion of the host actin cytoskeleton and cell cycle progression. It has 
to date been difficult to dissect the complex interactions between 
parasites and the host as both organisms share similar components such 
as the cytoskeleton. However, recent studies such as the SILAC 
technology described in this thesis have provided new insights into the 
potential mechanisms of host cell subversion.  
Parasite modulation of host TJ-associated Bcar1, Ybox3 and Mras 
proteins at two hours p.i and Cstf2, Ybx3, Akt1, Arhgef11, Cldn15 and 
Prkcι proteins at twenty-four hours p.i implies extensive remodelling of 
the host TJ proteome occurs during infection and a number of 
downstream signalling pathways were hypothesised to be affected, 
emphasising the complexity of apical TJ protein-protein interactions and 
the necessity for understanding the mechanisms of TJ regulation.  
Figure 7.1 illustrates the striking connection between these 
modulated TJ-associated proteins (highlighted in cyan) and ZO-1, ZO-2, 
JAM-A and β1-integrin; inferring T. gondii disrupts associations between 
surface receptors and the integral transmembrane TJ proteins occludin 
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and claudin(s) as well as their interactions with TJ-associated adaptor 
and scaffolding proteins and ultimately their connections to the actin 
cytoskeleton and the host cell cycle.  
 
 
7.2.1 T. gondii Modulation of the Host Actin Cytoskeleton 
 
Recent studies have described the importance of host actin in 
entry of T. gondii into host cells [Gonzalez et al, 2009]. The parasite MJ for 
instance has been shown to be associated with formation of a host ring-
shaped F-actin structure, proposed to be necessary for parasite anchoring 
and propulsion into the host cell, although it is not known how the host 
cortical actin barrier is breached to enable formation of the PV [Delorme-
Walker et al, 2012]. Parasite nutrient acquisition via recruitment of host 
mitochondria and ER to the PV, which enables parasite access to host 
metabolites, has also been linked to the host actin cytoskeleton [Gonzalez 
et al, 2009] in a process involving invagination of the PV membrane and 
delivery of lysosomes by host microtubules, although the exact 
mechanism of nutrient entry is unclear [Coppens et al, 2006; Sibley et al, 
1995]. Remodelling of the host actin cytoskeleton may also be involved in 
T. gondii division and egress [Chandramohanadas et al, 2009; Hu et al, 
2006]. Interestingly, T. gondii toxofilin a secreted ROP effector protein, 
has been shown to sequester host actin monomers and cap actin filament 
ends [Bradley et al, 2005; Delorme-Walker et al, 2012; Poupel et al, 
2000], a potential mechanism of host actin cytoskeleton remodelling 
[Frenal and Soldati-Favre, 2009]. 
The mechanism of parasite induced host actin cytoskeleton 
remodelling is not currently known, therefore the proposed T. gondii 
disruption of the host TJ-complex described in this thesis may initiate 
host actin cytoskeleton remodelling via disruption of interactions 
between the integral TJ proteins and TJ-associated adaptor and 
scaffolding proteins.  
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Parasite-mediated changes to Arhgef11, Akt, Mras and Csft2 
abundance could be predicted to affect the direct or indirect binding to 
the ZO proteins or JAM-A to physically disrupt interactions with occludin 
and claudin(s) [Monteiro et al, 2013] that in turn promotes dissociation 
of downstream signalling components such as PTEN, AF6 and PI3K from 
the TJ-complex that alter host actin cytoskeleton dynamics [Matter et al, 
2005]. AF6 for example is recruited to the forming PV where it activates 
PI3K and recruits PIP2 and PIP3 and knockdown of ARF6 has been shown 
to reduce parasite internalisation [Da Silva et al, 2009]. It could therefore 
be hypothesised that T. gondii dissociation of Akt from the TJ-complex via 
disruption of the integral TJ-proteins is a parasite mechanism of inducing 
AF6 induced PI3K activation and subsequent PIP2 and PIP3 recruitment 
(Figure 7.1).  
Combining the modulated TJ-associated proteins and the reduction 
of pore-forming claudin-15 during infection described in this thesis with 
the dynamic model of occludin, ZO-1 and claudin mobility within the TJ 
described by Shen et al, gives a potential insight into the association 
between the TJ-associated proteins during T. gondii paracellular 
transmigration (Figure 7.2). The mobility of ZO-1, occludin and claudin-1 
within the TJ is distinct; occludin is highly mobile between an apical TJ 
and lateral membrane location whereas claudin(s) either remain static 
within the TJ or exchange between the apical TJ and lateral membrane. 
ZO-1 however is highly mobile between the apical TJ, lateral membrane 
and cytoplasmic pool, allowing rapid signal dissemination between the TJ 
and cell interior [Van Itallie and Anderson, 2013; Shen, 2008]. 
Additionally, ZO-1 has been shown to interact with both occludin and 
claudin(s), anchoring them to the TJ complex [Bal et al, 2012; Itoh et al, 
1999], recently confirmed by proximity-based proteomic studies which 
identified the ZO-1 N-terminus as interacting with the integral 
transmembrane proteins whereas the C-terminus as interacting with the 
actin cytoskeleton [Fredriksso et al, 2015; Van-Itallie et al, 2013].  
This implies alterations in ZO-1 mobility between the TJ, lateral 
membrane and cytoplasm may be the mechanism that links the integral 
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transmembrane proteins to the actin cytoskeleton [Van Itallie et al, 2013]. 
The predicted association between these TJ proteins and ZO-1 mobility at 
steady state prior to parasite infection is shown in Figure 7.2A; 
transmembrane occludin and claudin dimers on neighbouring cells form 
the semi-permeable paracellular TJ barrier, stabilised by ZO-1 
localisation to the complex. The peripheral plaque of scaffolding and 
adaptor proteins links the integral TJ proteins to the actin cytoskeleton 
and nuclear signalling pathways, maintaining the paracellular barrier 
[Matter and Balda, 2009; Turner, 2009]. Figure 7.2B depicts the predicted 
mechanism of modulation of the TJ barrier during T. gondii infection; the 
association between ZO-1 and the occludin and claudin(s) dimers on 
neighbouring cells is disrupted either by parasite secreted factors or 
physical interactions between parasites and the integral TJ proteins such 
as occludin described in this thesis. This leads to loss of ZO-1 mediated 
occludin stabilisation at the TJ and transient occludin re-localisation to 
the lateral membrane and intracellular cytoplasmic location [Weight, 
2011].  
This proposed mechanism is supported by evidence from a 
number of pathogens that also disrupt occludin, claudin(s) and ZO-1 at 
the TJ to overcome the epithelial barrier and infect host cells. EPEC for 
example has been shown to disrupt TJs by dissociating occludin, ZO-1 and 
the barrier-forming claudins from the TJ-complex [Muza-Moons et al, 
2004; Philpott et al, 1996; Simonovic et al, 2000; Spitz et al, 1995], 
promoting claudin and occludin re-localisation to the cytoplasm and ZO-1 
re-localisation to sites of bacterial pedestal formation [Hanajima-Ozawa 
et al, 2007; Peralta-Ramirez et al, 2008]. Vibrio cholera derived ZOT also 
dissociates ZO-1 from the TJ complex possibly by PKC alterations of actin 
filaments [Fasano et al, 1995; Pierro et al, 2001; Schmidt et al, 2007;] and 
Helicobacter pylori CagA induces dissociation of ZO-1 from the TJ [Amieva 
et al, 2003]. Salmonella also causes a decrease in ZO-1 and 
phosphorylated occludin [Kohler et al, 2007]. Although it is understood 
that disruption of the TJ complex by extracellular stimuli leads to MLCK 
regulated contraction of actin filaments and opening of the TJ during 
 169 
pathogen paracellular infection, the complete mechanism of TJ disruption 
has to date remained elusive.  [Shen et al, 2006]. 
The TJ permeability barrier is likely maintained during T. gondii 
transmigration by the fixed pool of claudin dimers that can be recruited 
to the TJ complex independently of TJ-associated scaffolding proteins 
[Shen, 2008; Van Itallie and Anderson, 2014]. This is supported by the 
evidence that Salmonella infection is associated with an increase in 
barrier-forming claudin-1 at the TJ [Kohler et al, 2007]. Therefore, the 
loss of pore-forming claudin-15 [Suzuki et al, 2014] from the TJ complex 
during infection, identified by SILAC in chapter four, indicates the pore-
forming claudins may be displaced by barrier-forming claudins; a 
potential host cell response to maintain the integrity of the TJ barrier. 
Furthermore, the decrease in host PKCι at twenty-four hours correlates 
with claudin-15 displacement as it has been associated with depletion of 
pore-forming claudin-2 from the TJ complex [Lu et al, 2015]. C. 
perfringens enterotoxin (CPE) is an example of this mechanism as it 
displaces claudin-4 and claudin-19 from TJ strands creating permeable 
ion pores [Saitoh et al, 2015; Sonoda et al, 1999]. As claudin-19 crystal 
structure is comparable to claudin-15, parasite binding may induce 
similar conformational changes to disrupt claudin polymers, disassemble 
TJ strands and increase TJ permeability [Saitoh et al, 2015].  
 
 
7.2.2 T. gondii Modulation of the Host Cell Cycle 
 
The altered abundance of host cell Cstf2, Ybox3 and Arhgef11 also 
indicates parasite manipulation of the TJ to alter progression of the host 
cell cycle, which is required for parasite intracellular infection and 
replication as T. gondii preferentially infect cells in the S-phase [Blader 
and Saeij, 2009; Dvorak and Crane, 1981; Grimwood et al, 1996; Koshy et 
al, 2012; Lavine and Arrizabalaga, 2009]. 
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Media from T. gondii infected cells has been shown to induce non-
infected cells to enter S-phase, suggesting T. gondii secreted factors 
stimulate host cell modulation [Lavine and Arrizabalaga, 2009]. Using 
HFF cells T. gondii infection has been shown to induce host cell cycle 
progression from the G0 to S-phase and remain arrested at S-phase until 
intracellular invasion induces arrest at G2 phase to enable parasite 
proliferation [Brunet et al, 2008; Molestina et al, 2008].  
RhoA mediated GEF-H1 regulation of cell cycle progression has 
been linked to occludin localisation to the TJ, illustrated in figure 7.1 
(highlighted in brown). GEF-H1 recruitment to the TJ via binding to 
Cingulin or JACOP, which also bind to occludin at the TJ, results in GEF-H1 
inhibition. Whereas if it is not sequestered at the TJ, GEF-H1 promotes 
RhoA-mediated actin cytoskeleton reorganisation which leads to cell 
cycle progression from G1 to S-phase via activation of Ras or RalA and 
ultimately ZONAB in the nucleus [Balda et al, 2003; Matter et al, 2005; 
Terry et al, 2010]. 
Interestingly, occludin expression and TJ strand formation has been 
directly linked to actin cytoskeleton dynamics and the cell cycle [Kojima 
et al, 1998; Runkle et al, 2011]. Parasite-mediated dissociation of 
occludin from the TJ may therefore represent a mechanism of TJ-complex 
disruption and promotion of the GEF-H1, RhoA, ZONAB signalling 
pathway that mediates actin cytoskeleton remodelling and cell cycle 
progression to S-phase.  
This novel link between occludin and parasite-mediated cell cycle 
progression; that occludin expression, localisation to the TJ and the 
number of TJ strands are directly associated with host cell cycle 
progression to S-phase, may describe a novel potential mechanism of 
parasite infection, intracellular replication and survival. Significantly, it 
may also explain the intracellular cytoplasmic re-localisation of occludin 
during parasite infection [Weight, 2011]. This hypothesis was formed 
from the previous finding that TJ strands were disrupted and occludin 
lost from cell borders during cell cycle progression to S-phase [Kojima et 
al, 1998]. As occludin is known to localise with centrosomes in MDCK 
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cells [Runkle et al, 2011], occludin re-distribution from the apical TJ to 
centrosomes may be the missing link that explains why T. gondii 
promotes TJ disruption during infection. Furthermore, phosphorylation 
of occludin at S490 near the coiled-coil domain appears to be a switch 
that promotes occludin endocytosis to an intracellular location prior to 
association with centrosomes [Runkle et al, 2011]. This finding also 
provides a potential explanation for the observed loss of TJ occludin in 
disorders associated with hyperproliferation such as diabetic retinopathy 
or epithelial cancers [Antonetti et al, 1998; Birkenfeld et al, 2008; Harhaj 
et al, 2006; Kimura et al, 1997; Lemieux et al, 2009; Osanai et al, 2006; 
Soler et al, 1999; Tobioka et al, 2002] and also the abnormal postnatal 
growth retardation and hyperplasia of the gastric epithelium in occludin 
knockout mice [Schulzke et al, 2005]. 
 
 
7.2.3 T. gondii Modulation of Occludin Phosphorylation 
 
The requirement for static claudin paracellular pores in 
maintaining the TJ permeability barrier, particularly in response to 
occludin loss, may explain the apparent discrepancies in occludin 
function described in previous studies and explain why occludin alone 
cannot form functional TJ strands [Saitou et al, 1998] and how the TJ 
barrier is maintained during T. gondii infection even though occludin is 
re-distributed to an apparantly intracellular vesicular location [Dalton, 
2006; Weight, 2011]. Although TJ barrier regulation and remodelling by 
the continuous cycle of TJ-associated occludin endocytosis, 
internalisation, recycling and degradation is not a novel finding [Fletcher 
et al, 2014; Ivanov et al, 2004; Shen et al, 2008; Marchiando et al, 2010; 
Turner et al, 2014], it demonstrates the plasticity of occludin within the 
TJ complex, regulated by the phosphorylation status of the occludin C-
terminus [Rao, 2009; Simonovic et al, 2000]. The location of the occludin 
C-terminus phosphorylation hotspot near a cysteine residue associated 
with occludin dimer formation [Buschmann et al, 2013; Dorfel and Huber, 
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2012], implies occludin C-terminus phosphorylation may regulate 
occludin dimer formation and subsequent association with claudin(s) and 
ZO-1; a process confirmed by triple CKII phosphorylation of occludin C-
terminus enhancing binding to ZO-1 and discovery of occludin S408 as a 
molecular switch controlling paracellular TJ permeability [Dorfel and 
Huber, 2013; Raleigh et al, 2011].  
Linking the preliminary occludin C-terminus phosphorylation 
status changes described in chapter five with the proposed roles of the TJ 
proteins occludin, claudin(s) and ZO-1 during T. gondii paracellular 
infection indicates transient occludin phosphorylation and 
dephosphorylation during T. gondii infection disrupts occludin 
interactions with claudin(s) and ZO-1.  
For example CKII mediated phosphorylation of S408 has been 
shown to enhance occludin dimer formation and reduce occludin 
association with ZO-1. Claudin-2 is then able to form dimers on 
neighbouring cells that create paracellular ion pores, promoting 
paracellular ion flux through the paracellular pathway and enhancing 
highly mobile occludin within the TJ. Conversely, occludin S408 
dephosphorylation enhances occludin association with ZO-1 via the U5-
GuK domain. ZO-1 in turn binds claudin-2 via the PDZ domain. Claudin-2 
mobility is therefore increased which disrupts the function of the 
paracellular pore pathway. ZO-1 therefore acts as a scaffold to maintain 
the complex when occludin S408 is phosphorylated  (Figure 7.3) [Raleigh 
et al, 2011; Turner et al, 2014].  
The parasite kinase TgCDPK1, predicted to interact with the 
occludin C-terminus in chapter five, may be the regulatory kinase that 
alters the TJ complex structure during infection. As CDPK has been 
associated with JAM and cingulin as well as localisation of ZO-1 and 
occludin to the TJ via actin cytoskeleton reorganisation [Martinez-Estrada 
et al, 2001; Martin-Padura et al, 1998], it is possible that TgCDPK1 
phosphorylation of occludin promotes occludin recruitment to the apical 
TJ complex, stabilised by interactions with JAM, cingulin, ZO-1, RhoA, 
Arhgef11 and the actin cytoskeleton. 
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7.2.4 T. gondii Binding to Occludin 
 
The increased recruitment of occludin to the apical TJ during T. 
gondii infection alludes to a further role for occludin as a receptor during 
parasite paracellular transmigration [Dalton et al, 2006; Weight, 2011].  
As occludin is a major transmembrane protein of the TJ with two 
extracellular domains, of which ECL1 forms homodimers with 
neighbouring cells, it is possible that T. gondii interacts directly with 
these domains during parasite paracellular transmigration of SI 
epithelium. Subsequently in chapter six, occludin ECL1 was identified as a 
potential host receptor, possibly interacting with a putative parasite 
secreted MIC effector protein that could be predicted to promote 
paracellular transmigration as the microneme proteins accumulate on the 
parasite surface during the initial stages of infection [Carruthers, 2006].  
Clostridium perfringens has been shown to bind to the ECL2 of 
claudins -3 and -4 in order to disrupt the TJ complex [Fujita et al, 2000; 
Takahashi et al, 2005]. Therefore T. gondii binding to occludin ECL1 could 
be predicted to disrupt occludin dimer interactions on neighbouring cells, 
transiently opening the epithelial TJ during paracellular transmigration, a 
proposal substantiated by the observation that occludin ECL1 confers 
cell-cell adhesion and addition of occludin ECL1 peptides to cell 
monolayers impairs TJ function [Lacaz-Vieira 1999; Tavelin et al, 2003]. 
Parasite surface molecules and complementary host cell ligands 
largely mediate initial contact with the host cell; parasite surface SAG1 
and laminin for example have been implicated in attachment to host cells 
via the β1 integrin receptor [Furtado et al 1992; Mineo et al, 1993]. 
Although SAG1 is important for host cell attachment, it is not 
absolutely required as SAG1 mutants are still capable of invasion 
[Grimwood and Smith, 1996].  Differential SAG expression in T. gondii 
type I, II and II has also been linked to parasite virulence. Expression of 
SAG3 for instance has been linked to acute virulence [Tomavo, 1996] and 
although SAG1 appears to be expressed in both the virulent RH (Type I) 
and avirulent ME49 (Type II) strains [Lekutis et al, 2001], SRS2 antigen 
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abundance is low in type I but highly abundant in type II and III strains 
[Manger et al, 1998]. Although the functional significance of this 
correlation is currently unknown, it suggests T. gondii expression of 
surface antigens may account for the multitude of parasite-host 
interactions, many of which demonstrate crossover functions or 
redundancy, that facilitate infection of the broad parasite host range.  
The fact that T. gondii possesses the ability to attach and invade 
almost any nucleated cell alongside the expression of occludin in a broad 
range of cell types [Feldman et al, 2005] indicates the novel interaction 
between T. gondii and occludin ECL1 described in this thesis may be a 
conserved mechanism for parasite paracellular transmigration of host 
epithelial cell monolayers including the SI epithelium, blood-brain barrier 
and placenta and could potentially be linked to parasite virulence. 
Further analysis of T. gondii binding to ECL1 will be required to reveal if 
drugs targeting this interaction could be a therapeutic strategy to block 
the early stages of infection and prevent toxoplasmosis. 
In summary, the data presented in this thesis provides an insight 
into the fundamental signalling mechanisms between parasite and host 
and the complex regulation of the TJ permeability barrier both at steady 
state and in response to T. gondii infection. T. gondii infection of IEC-6 
appears to modulate two main signalling pathways to enable parasite 
infection, intracellular replication and survival: Firstly, subversion of the 
host actin cytoskeleton and secondly, modulation of the host cell cycle. 
The proteins involved in these signalling pathways often exhibit multiple 
roles and demonstrate extensive cross-talk with the integral 
transmembrane proteins and the cytoplasmic plaque of scaffolding, 
adaptor and signalling proteins as well as components of adherens 
junctions [Gonzalez-Mariscal, 2003; Matter and Balda, 2003]. Therefore, 
further in depth pathway reconstruction maps and network analysis of 
the proteins involved in signalling pathways downstream of the integral 
TJ proteins will be required to fully understand how T. gondii modulation 
of the TJ-complex connects TJ architecture to TJ barrier function and the 
paracellular permeability of the pore and leak pathways, as well to 
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elucidate how the interaction between T.gondii and occludin promotes 
host actin cytoskeleton remodelling and host cell cycle progression to S-
phase.  
As effective treatments against toxoplasmosis have not yet been 
developed, the involvement of occludin in the host cell cycle offers a novel 
approach for disease prevention; by identifying the T. gondii protein 
interacting with occludin ECL1, blocking of this complementary parasite 
receptor could potentially prevent toxoplasmosis. Furthermore, the 
knowledge that infection by pathogens such as Helicobacter pylori, 
Salmonella Typhi and Citrobacter rodentium have all been associated with 
development of GI carcinomas, though the molecular mechanisms 
responsible are yet to be determined [Lax and Thomas, 2002] led to the 
hypothesis that promotion of cell hyperproliferation, by T. gondii 
modulation of the host cell cycle, could potentially increase the rate of 
malignant transformation and contribute to the early stages of 
carcinogenesis. 
 
 
7.3 Proposed mechanism of Toxoplasma gondii paracellular 
infection of IEC-6 cells 
 
Based on the results presented in this thesis, the following model 
of T. gondii paracellular infection of the SI epithelium is proposed (Figure 
7.4). The SI epithelial cell monolayer is represented by columnar cells 
with apical microvilli and basal nucleus. Occludin and claudin form 
dimers on neighbouring cells. Occludin phosphorylation status is 
represented by the number of phosphorylated C-terminus residues (P). 
The dynamic behaviour of TJ-associated proteins is represented by 
mobility between three cellular compartments; cytoplasmic vesicular 
pool, lateral membrane pool and apical TJ pool. ZO-1 migrates between all 
three pools whereas claudins and occludin only migrate between the 
lateral and TJ membrane location. Claudin(s) also maintain a fixed TJ pool 
(chapter 1) [Shen, 2008].  
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Figure 7.4A: Parasites adhere to the apical host membrane. T. gondii gliding 
motility brings parasites into close proximity with SI epithelial cells followed by 
cellular contact mediated by interactions between parasite surface antigens, 
such as SRS or MIC proteins, and apical host membrane proteins such as β-
Integrin or ICAM-1 (purple). The TJ complex is stable at steady state: occludin is 
mobile within the apical TJ, claudin(s) are mobile between the apical TJ and 
lateral membrane pools and ZO-1 is mobile between all three cellular pools. 
Claudin(s) form dimers on neighbouring cells to create paracellular ion pores 
and also retain a fixed, non-mobile TJ pool. 
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Figure 7.4B: Secretion of parasite effector proteins. Parasite attachment, 
reorientation and sequential secretion of effector proteins (purple circles) into 
the host cell subverts a variety of host mechanisms such as actin cytoskeleton 
rearrangement well as redistributing host cell proteins such as ICAM-1 and PKC 
from the apical surface to a lateral membrane location.  
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Figure 7.4C: Occludin hyperphosphorylation and TJ complex disruption. 
Direct secretion of parasite ROP kinases (purple ellipse) into the host cytoplasm 
causes hyperphosphorylation of the occludin C-terminus, enhancing mobility 
within the apical TJ, promoting occludin dimer formation and reducing occludin 
association with ZO-1, which remains mobile between the apical TJ, lateral 
membrane and cytoplasm. Claudin mobility between the apical TJ and lateral 
membrane is not altered. 
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Figure 7.4D: Parasite binding to occludin ECL1. Parasite binding to occludin 
ECL1, acting as a parasite attachment receptor, via parasite surface molecules 
with homology to ECL1 leads to paracellular transmigration.  
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Figure 7.4E: Occludin dimer disruption. Parasite binding to ECL1 disrupts 
occludin dimers and enhances occludin association with ZO-1 via the GuK 
domain, which in turn binds claudin(s) via the PDZ domain, increasing 
claudin(s) mobility between the apical TJ and lateral membrane and disrupting 
the function of the paracellular pore pathway, whilst retaining a fixed, non-
mobile apical TJ pool that maintains the TJ barrier. As parasites transmigrate 
through the paracellular pathway occludin ECLs are dissociated and accumulate 
on the parasite surface [Weight, 2011], leading to TJ occludin degradation and 
recycling to an intracellular cytoplasmic vesicular compartment by endocytosis 
[Weight, 2011]. Occludin is then redistributed to the host nucleus where it 
promotes cell cycle progression to S-phase. Interactions between lateral host 
membrane proteins such as ICAM-1 and T. gondii surface molecules such as 
MIC2 facilitates transmigration through the paracellular space.  
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Figure 7.4F: Parasite dissemination or basolateral re-invasion. 
Transmigration and egress out of the paracellular space leads to parasite 
invasion of SI epithelial-associated immune cells (purple circle) in a Trojan 
horse mechanism or basolateral re-invasion of neighbouring cells that requires 
gliding motility and MJ formation at the host-parasite interface followed by 
active invasion, intracellular PV formation (purple oval), GRA release and 
extensive modulation of host cell structure and function such as recruitment of 
host organelles. Interactions between occludin on the parasite surface and 
basolateral membrane expressed occludin may assist MJ formation and 
recruitment of occludin to the PV [Weight, 2011].  
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Figure 7.3G: Establishment of the lytic cycle. Intracellular replication within 
the PV (purple oval) modulates host structure and function to enable parasite 
nutrient acquisition.  Parasite replication ultimately leads to host cell lysis, 
tissue destruction and parasite dissemination into the lumen and underlying 
mucosa eliciting a potent host immune response (purple circles) and clearing of 
the acute tachyzoite stage of infection accompanied by transformation of 
bradyzoites into tissue cysts and chronic infection. 
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7.4 Future directions 
 
 
7.4.1 Validate in vivo T. gondii paracellular transmigration and 
binding to occludin 
 
The T. gondii infection studies in this thesis were performed in 
vitro using the IEC-6 cell line and although cultured IEC-6 display 
morphological characteristics of SI epithelial absorptive enterocytes and 
develop a measurable paracellular barrier, it remains unclear if in vitro 
infection is relevant to infection in vivo as certain aspects of the model 
may not emulate the complexity of the SI epithelial TJ barrier in tissues 
parasites normally infect.  
Therefore, the next stage of this research will be to investigate 
interactions between T. gondii and the TJ-complex in vivo and examine T. 
gondii manipulation of the host immune response during parasite 
paracellular infection and ultimately integrate the findings into the 
paracellular transmigration mechanism described in this thesis. 
Animal models are useful to study the complexity of parasite-host 
interactions; as mice are natural hosts for T. gondii, physiologically 
relevant murine models such as ex vivo SI epithelial explants or the in vivo 
intestinal loop model could be utilised in conjunction with two-photon 
microscopy to directly visualise real-time interactions between T. gondii 
and the SI epithelium [Caserta et al, 2011; Millet et al, 2014; Sumagin et 
al, 2014]. For example, two-photon excited SI epithelial autofluorescence 
or SI epithelial staining with CellTracker™ red, combined with fluorescent 
YFP-parasites would provide in vitro confirmation of the paracellular 
route of infection presented chapter four of this thesis [Klinger et al, 
2011; Orzekowsky-Schroeder et al, 2011]. Similar to studies by Coombes 
and Gregg, mice expressing fluorescent reporter genes such as CD11c-
YFP (DCs), MHCII-GFP (IECs) and LysM-gGFP (neutrophils and 
monocytes) could also be utilised to simultaneously visualise real-time 
interactions between fluorescently tagged parasites and specific immune 
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cell populations, cytokines or cell signalling events [Beuneu et al, 2010; 
Chtanova et al, 2014; Coombes et al, 2013; Faust et al, 2000; Garrod et al, 
2012; Gregg et al, 2013; Lindquist et al, 2004].  
Additionally, mice expressing fluorescent occludin or ZO-1 fusion 
proteins within the SI epithelium could be utilised to confirm parasite 
binding to occludin in vivo, although it should be noted that current 
models utilise YFP and GFP reporter genes which would be incompatible 
with YFP-T.gondii [Marchiando et al, 2010]. Generation of parasite RH 
strains expressing fluorescent reporters such as mCherry or Tomato 
would therefore be beneficial [Gregg et al, 2013]. Accompanying these 
studies with fluorescently labelled claudin(s) would provide in vitro 
confirmation of predicted interactions between T. gondii and 
differentially located claudins described in this thesis.  
 
 
7.4.2 Identify which T. gondii proteins interact with occludin 
ECL1 to enable paracellular transmigration 
 
Although the identity of occludin ECL1-T. gondii binding partners 
was not established here, preliminary data from co-immunoprecipitation 
and MS analysis by Weight identified T. gondii-derived proteins including 
SAG1, SAG2, MIC4 and a number of ROP and GRA proteins as potentially 
interacting with occludin [Weight, unpublished]. These results are 
interesting as parasite surface proteins SAG1 and SAG2 could potentially 
bind directly to ECL1 and MIC4 could transiently associate with ECL1 to 
promote attachment and paracellular transmigration [Carruthers, 2006]. 
Combining these preliminary results with the bioinformatics searches 
presented in chapter six of this thesis suggests MIC proteins and SAG-1 
related sequences potentially interact with occludin ECL1, a finding also 
described recently by Lorenzi et al who found that MIC proteins are 
highly conserved between T. gondii strains and that MICs play a role as 
host receptors. This provides a starting point for further investigation as 
the parasite-derived occludin binding proteins have not yet been 
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identified. As the occludin ECL1 peptide was successfully produced as 
part of this thesis, it could be employed as bait in yeast two-hybrid 
screening of T. gondii library or used in HIS-tag pull down experiments 
with T. gondii lysates to identify novel binding partners and verify the 
bioinformatics findings. Searching the results for potential parasite 
transmembrane proteins or those expressing signalling peptides, may 
enable discrimination between T. gondii surface molecules and secreted 
effectors interacting with ECL1 [Hakimi and Bougdour, 2015]. Putative 
parasite-ECL1 interactions should be verified by investigating the effect 
of mutation or deletion of ECL1 aa residues or parasite-derived proteins 
on attachment, transmigration and invasion of IEC-6 by utilising both the 
cell-based infection model and cell-free binding model described in 
chapter six of this thesis. Combining the site-directed mutations with 
crystallography could also potentially uncover the structural basis of 
ECL1-parasite interactions. For example, the Clostridium perfringens 
enterotoxin-host complex has been crystallised and ECL2 residues 194-
319 identified as the binding site [Van Itallie et al, 2008]. Similarly 
identifying T.gondii-occludin ECL1 binding sites may therefore provide 
important structural information for potential therapeutic intervention.  
 
 
7.5 Overall conclusions 
 
In summary the results presented in this thesis confirm T. gondii 
utilises the paracellular route of infection in an in vitro model of the SI 
epithelium. Intercellular TJs were shown to be integral to the regulated 
maintenance of TJ barrier function alongside the dynamic plasticity of the 
TJ-associated proteins. Consequently occludin was proposed to play a key 
role in parasite paracellular transmigration, replication and survival 
through T. gondii modulation of the occludin C-terminus domain 
phosphorylation status, direct parasite binding to the occludin ECLs, 
occludin dissociation from the TJ and occludin redistribution to the 
cytoplasm that leads to progression of the host cell cycle to S-phase. 
 188 
Potential parasite candidate proteins were revealed for each stage of 
paracellular transmigration, demonstrating the complex interactions 
between parasites and the SI epithelial TJ as well revealing extensive 
parasite modulation of downstream signalling pathways. Therefore, 
occludin has been shown to play an important role both in regulation of 
the TJ paracellular barrier and as a receptor for T. gondii infection, 
intracellular replication and survival. 
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Appendix A 
 
Recombinant Occludin Peptide Generation 
 
DNA regions coding for extracellular loop (ECL) 1 (residues 85 to 
138) (184bp) ECL2 (residues 191 to 241) (167bp), ECL1+ECL2 (residues 
85 to 241) (485bp) and C-terminus (residues 261 to 521) (800bp) 
murine occludin fragments were PCR amplified from pBABE-FLAG + Occ 
plasmid DNA (Britta Engelhardt, University of Bern, Switzerland) 
[Bamforth et al, 1999] and cloned into the NdeI and BamHI sites of the 
expression vector pET15b (Novagen). 
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Plasmid map of pBABE-FLAG-tagged occludin (Britta Engelhardt, University of 
Bern, Switzerland) 
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Example of plasmid map of pET15b expression vector containing HIS-tagged 
ECL1+ECL2 (Novagen) 
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Appendix B 
 
SILAC Dataset 
 
The raw SILAC MS files were processed using MaxQuant [Cox and 
Mann, 2008] and proteins identified by searching against the Rattus 
norvegicus (Rat) UniProt database (downloaded 5.6.14). Protein 
quantitation was performed using MaxQuant to generate heavy and light 
peptide ratios (fold-change) and Perseus statistical analysis to generate 
significance-B (p-value) scores. The raw data was filtered according to 
>2-fold change (compared to uninfected control) and a p-value of <0.05.  
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Appendix C 
 
Functional Annotation of differentially expressed proteins during 
T. gondii infection of IEC-6 
 
 
Functional annotation of SILAC proteins modulated during T. gondii 
infection using the protein annotation through evolutionary relationship 
(PANTHER) Gene Ontology (GO) classification system 
(http://www.pantherdb.org Version 10) [Mi et al, 2013]. Results filtered 
by significant (p<0.05) enrichment of proteins. 
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Time p.i 
(hours) 
GO biological process 
Fold 
change 
P-value 
2 
negative regulation of apoptotic signalling 
pathway 
 > 5 3.36E-03 
2 
regulation of intrinsic apoptotic signalling 
pathway 
 > 5 8.56E-03 
24 isocitrate metabolic process  > 5 7.54E-03 
24 2-oxoglutarate metabolic process  > 5 5.70E-04 
24 tricarboxylic acid cycle  > 5 1.44E-05 
24 citrate metabolic process  > 5 4.16E-05 
24 tricarboxylic acid metabolic process  > 5 6.01E-06 
24 aerobic respiration  > 5 1.00E-04 
24 fatty acid beta-oxidation  > 5 8.16E-03 
24 dicarboxylic acid metabolic process  > 5 4.84E-07 
24 protein homotetramerization  > 5 1.03E-03 
24 fatty acid catabolic process  > 5 6.89E-03 
24 cellular respiration  > 5 3.80E-05 
24 monocarboxylic acid catabolic process  > 5 2.83E-02 
24 pyridine nucleotide metabolic process  > 5 1.20E-02 
24 nicotinamide nucleotide metabolic process  > 5 1.20E-02 
24 oxidoreduction coenzyme metabolic process  > 5 4.17E-03 
24 
energy derivation by oxidation of organic 
compounds 
 > 5 6.61E-06 
24 
generation of precursor metabolites and 
energy 
 > 5 1.71E-08 
24 
pyridine-containing compound metabolic 
process 
 > 5 2.21E-02 
24 protein tetramerization  > 5 1.12E-02 
24 coenzyme metabolic process  > 5 3.37E-05 
24 
negative regulation of apoptotic signalling 
pathway 
 > 5 1.46E-03 
24 organic acid catabolic process  > 5 3.21E-02 
24 carboxylic acid catabolic process  > 5 3.21E-02 
24 cofactor metabolic process  > 5 8.61E-05 
24 monocarboxylic acid metabolic process  > 5 2.11E-08 
24 lipid catabolic process  > 5 1.69E-02 
24 carboxylic acid metabolic process  > 5 2.57E-14 
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Time p.i 
(hours) 
GO biological process 
Fold 
change 
P-value 
24 oxoacid metabolic process  > 5 1.74E-15 
24 organic acid metabolic process 4.92 4.89E-15 
24 oxidation-reduction process 4.66 1.58E-14 
24 fatty acid metabolic process 4.53 1.32E-02 
24 ncRNA metabolic process 4.41 3.90E-03 
24 response to hypoxia 4.39 1.86E-03 
24 response to decreased oxygen levels 4.32 2.38E-03 
24 response to oxygen levels 4.19 1.76E-03 
24 single-organism catabolic process 3.71 1.60E-05 
24 small molecule metabolic process 3.6 5.87E-14 
24 response to nutrient levels 3.55 9.39E-04 
24 response to extracellular stimulus 3.39 2.15E-03 
24 RNA processing 3.3 1.82E-02 
24 protein complex subunit organization 2.92 1.17E-05 
24 
organonitrogen compound metabolic 
process 
2.82 1.96E-04 
24 protein complex assembly 2.8 5.82E-03 
24 protein complex biogenesis 2.8 5.82E-03 
24 single-organism biosynthetic process 2.71 1.13E-02 
24 negative regulation of cell death 2.63 3.09E-02 
24 macromolecular complex assembly 2.51 1.10E-02 
24 response to hormone 2.47 4.63E-02 
24 single-organism metabolic process 2.37 5.28E-13 
24 cellular component biogenesis 2.34 8.22E-05 
24 catabolic process 2.3 2.46E-02 
24 organic substance transport 2.2 3.53E-02 
24 
macromolecular complex subunit 
organization 
2.19 3.66E-03 
24 response to external stimulus 2.18 7.57E-03 
24 response to stress 2.1 2.21E-05 
24 nitrogen compound metabolic process 1.96 2.15E-05 
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Appendix D 
 
 
Tight Junction Proteome 
 
 
 
Comprehensive list of known TJ proteins constructed by 
integrating current functional annotations, protein-protein interactions 
and known signalling pathways [Aijaz et al, 2006; Anderson and Van 
Itallie, 2009; Balda and Matter 2008 and 2009; Chiba et al, 2008; Dorfel 
and Huber, 2012; Furuse and Tsukits, 2006; Gonzalez-Mariscal et al, 
2008; Kohler and Zahraoui, 2005;  Lui et al, 2003; Matter et al, 2005; 
Matter and Balda, 2003 and 2014; McNeil et al, 2006; Morimoto et al, 
2005; Muller et al, 2005; Salama et al, 2006; Schneeberger and Lynch, 
2004; Suzuki et al, 2006; Tang, 2006; Turksen and Troy, 2004; Ye et al, 
2006; Zahraoui, 2005].  
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Appendix E 
 
 
BLAST search results and GO annotation 
 
 
Potential T. gondii interactions with occludin ECLs were identified 
by BLAST searching for homology between the rat occludin domain 
sequences and the T. gondii genome using NCBI-BLAST provided at 
www.toxodb.org (release number 24 14th April 2015) [Gajria et al, 
2008]. The database was used to search for occludin homology first with 
T. gondii ME49 stain, followed by GT1 and lastly the VEG strain genomes. 
Protein function classification by GO annotation was provided by 
www.toxodb.org (release number 24 14th April 2015) [Gajria et al, 
2008].  
T. gondii proteins with homology to occludin domains are 
annotated in the table below. Gene IDs are only given for a single strain, 
searched in the order above, if homology was found for more than one 
strain. The annotated proteins discussed in chapters five and six are 
highlighted in red. TMD: number of transmembrane domains. 
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Occludin 
homology 
domain 
Gene ID Protein annotation 
MW 
(Da) 
Length 
(aa) 
TMD 
ECL1+ECL2 TGME49_119850 hypothetical protein, conserved 56662 538 0 
ECL1+ECL2 TGME49_081590 hypothetical protein 13874 116 2 
ECL1+ECL2 TGME49_116550 hypothetical protein 12988 113 2 
ECL1+ECL2 TGME49_036540 RRM domain-containing protein 53440 513 0 
ECL1+ECL2 TGME49_119890 hypothetical protein 25535 236 0 
ECL1+ECL2 TGME49_025830 hypothetical protein 104168 989 0 
ECL1+ECL2 TGME49_064610 heterogeneous nuclear ribonucleoprotein A3, putative 44975 430 0 
ECL1+ECL2 TGME49_062620 Gbp1p protein, putative 31761 293 0 
ECL1+ECL2 TGME49_036650 DEAD/DEAH box helicase, putative 59969 550 0 
ECL1+ECL2 TGME49_012850 hypothetical protein 43503 414 0 
ECL1+ECL2 TGME49_035930 KH domain-containing protein 64265 570 0 
ECL1+ECL2 TGME49_064150 hypothetical protein 31441 307 0 
ECL1+ECL2 TGME49_072010 nucleolar protein family A, putative 20932 210 0 
ECL1+ECL2 TGME49_069690 hypothetical protein 94305 865 1 
ECL1+ECL2 TGME49_013850 hypothetical protein 15644 147 1 
ECL1+ECL2 TGME49_070170 hypothetical protein 21290 223 0 
ECL1+ECL2 TGME49_091930 nucleolar phosphoprotein nucleolin, putative 73118 705 0 
ECL1+ECL2 TGME49_025320 hypothetical protein, conserved 54459 504 0 
ECL1+ECL2 TGME49_040560 microsomal glutathione S-transferase 3, putative 22204 205 3 
ECL1+ECL2 TGME49_111430 fibrillarin, putative 31989 304 0 
ECL1+ECL2 TGME49_066800 integral membrane protein, putative 32533 302 4 
ECL1+ECL2 TGME49_004480 DnaJ domain-containing protein 66709 606 0 
ECL1+ECL2 TGME49_032660 58 kDa phosphoprotein, putative 45143 425 0 
ECL1+ECL2 TGME49_026250 ATP-dependent RNA helicase, putative 78594 734 0 
ECL1+ECL2 TGME49_027340 hypothetical protein 15173 136 2 
ECL1+ECL2 TGME49_090870 patched family domain-containing protein, conserved 130574 1178 12 
ECL1+ECL2 TGME49_020390 hypothetical protein 27530 258 4 
ECL1+ECL2 TGME49_109200 zinc finger (CCCH type) protein, putative 101662 1051 0 
ECL1 TGME49_119850 hypothetical protein, conserved 56662 538 0 
ECL1 TGME49_036540 RRM domain-containing protein 53440 513 0 
ECL1 TGME49_119890 hypothetical protein 25535 236 0 
ECL1 TGME49_081590 hypothetical protein 13874 116 2 
ECL1 TGME49_116550 hypothetical protein 12988 113 2 
ECL1 TGME49_025830 hypothetical protein 104168 989 0 
ECL1 TGME49_064610 heterogeneous nuclear ribonucleoprotein A3, putative 44975 430 0 
ECL1 TGME49_036650 DEAD/DEAH box helicase, putative 59969 550 0 
ECL1 TGME49_062620 Gbp1p protein, putative 31761 293 0 
ECL1 TGME49_012850 hypothetical protein 43503 414 0 
ECL1 TGME49_035930 KH domain-containing protein 64265 570 0 
ECL1 TGME49_072010 nucleolar protein family A, putative 20932 210 0 
ECL1 TGME49_069690 hypothetical protein 94305 865 1 
ECL1 TGME49_013850 hypothetical protein 15644 147 1 
ECL1 TGME49_091930 nucleolar phosphoprotein nucleolin, putative 73118 705 0 
ECL1 TGME49_111430 fibrillarin, putative 31989 304 0 
ECL1 TGME49_004480 DnaJ domain-containing protein 66709 606 0 
ECL1 TGME49_032660 58 kDa phosphoprotein, putative 45143 425 0 
ECL1 TGME49_070170 hypothetical protein 21290 223 0 
ECL1 TGME49_026250 ATP-dependent RNA helicase, putative 78594 734 0 
ECL1 TGME49_064150 hypothetical protein 31441 307 0 
ECL1 TGME49_030940 hypothetical protein 28883 284 0 
ECL1 TGGT1_065230 conserved hypothetical protein 27259 247 0 
ECL1 TGME49_105520 40S ribosomal protein S2, putative 29336 269 0 
ECL1 TGME49_069650 hypothetical protein 51441 492 0 
ECL1 TGME49_065430 hypothetical protein 10883 101 0 
ECL1 TGME49_014150 mitochondrial import inner membrane translocase subunit, putative 19551 188 1 
ECL1 TGME49_120600 glycine-rich protein 2, putative 23061 209 0 
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ECL1 TGME49_061680 hypothetical protein 155128 1464 0 
ECL1 TGME49_089540 hypothetical protein, conserved 100518 937 0 
ECL1 TGME49_112220 mitochondrial import inner membrane translocase subunit TIM17, putative 22613 213 0 
ECL1 TGME49_078680 hypothetical protein 22776 215 0 
ECL1 TGME49_064640 bromodomain domain-containing protein 140477 1354 0 
ECL1 TGME49_038510 hypothetical protein, conserved 116256 1082 0 
ECL1 TGVEG_047760 conserved hypothetical protein 63095 588 0 
ECL1 TGME49_059640 nucleoporin, putative 302390 2894 0 
ECL1 TGME49_062610 hypothetical protein 68234 637 7 
ECL1 TGME49_094290 der1-like family domain-containing protein, conserved 32059 293 5 
ECL1 TGME49_057360 hypothetical protein 155183 1457 0 
ECL1 TGME49_121520 P23 co-chaperone, putative 24784 226 1 
ECL1 TGME49_017540 splicing factor, putative 38105 351 0 
ECL1 TGME49_075440 granule antigen protein GRA6 23309 224 2 
ECL1 TGME49_003210 hypothetical protein 34602 334 0 
ECL1 TGME49_113270 hypothetical protein 151891 1546 0 
ECL1 TGME49_121500 CELF family protein, putative 50939 475 0 
ECL1 TGME49_086730 signal recognition particle 19 kDa protein, putative 24016 222 0 
ECL1 TGME49_082020 hypothetical protein 41558 394 1 
ECL1 TGME49_058390 DnaJ protein, putative 44654 397 0 
ECL1 TGME49_045710 MORN repeat protein, putative 31259 273 0 
ECL1 TGME49_013030 hypothetical protein 35156 323 0 
ECL1 TGME49_106380 U1 small nuclear ribonucleoprotein, putative 22084 215 0 
ECL1 TGME49_003780 hypothetical protein 145088 1475 0 
ECL1 TGME49_017880 KH domain-containing protein 41468 412 0 
ECL1 TGME49_045500 dipeptidyl peptidase IV domain-containing protein 173470 1584 0 
ECL1 TGME49_037520 hypothetical protein 114772 1147 0 
ECL1 TGME49_032170 hypothetical protein 80969 745 1 
ECL1 TGGT1_046955 hypothetical protein 41377 404 0 
ECL1 TGME49_053080 replication protein A2, putative 28748 278 0 
ECL1 TGME49_118160 major sperm protein domain-containing protein 25976 239 1 
ECL1 TGME49_109200 zinc finger (CCCH type) protein, putative 101662 1051 0 
ECL1 TGME49_097430 hypothetical protein, conserved 25337 248 0 
ECL1 TGME49_016080 hypothetical protein, conserved 79433 709 0 
ECL1 TGME49_014750 hypothetical protein 119986 1108 0 
ECL1 TGME49_056030 hypothetical protein 29223 256 0 
ECL1 TGME49_027870 hypothetical protein 11224 103 0 
ECL1 TGME49_100200 histone H2A 15920 155 0 
ECL1 TGME49_111400 hypothetical protein, conserved 158711 1520 0 
ECL1 TGME49_073630 DnaJ domain-containing protein 16113 141 0 
ECL1 TGGT1_087090 hypothetical protein 34811 332 0 
ECL1 TGME49_045660 hypothetical protein, conserved 69146 667 0 
ECL1 TGME49_073760 heat shock protein 70, putative 72881 674 0 
ECL1 TGME49_110560 hypothetical protein 208093 1898 14 
ECL1 TGME49_057350 eukaryotic translation intiation factor, putative 89777 820 0 
ECL1 TGME49_000280 WD-repeat protein, putative 90213 834 0 
ECL1 TGME49_047550 heat shock protein 60 60915 575 0 
ECL1 TGME49_040560 microsomal glutathione S-transferase 3, putative 22204 205 3 
ECL1 TGME49_106560 hypothetical protein 67326 698 0 
ECL1 TGME49_034920 hypothetical protein 119455 1112 0 
ECL1 TGME49_077980 dynein light chain, putative 11494 103 0 
ECL1 TGME49_105790 hypothetical protein 206111 1918 0 
ECL1 TGME49_105780 exoribonuclease, putative 138631 1239 0 
ECL1 TGME49_036120 hypothetical protein, conserved 32073 298 1 
ECL1 TGGT1_065550 conserved hypothetical protein 114940 1057 0 
ECL1 TGME49_095620 zinc finger (CCCH type) protein, putative 128507 1237 0 
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ECL1 TGME49_093640 hypothetical protein 22001 190 0 
ECL1 TGME49_091330 hypothetical protein 25513 228 0 
ECL1 TGME49_068570 zinc finger (CCCH type) protein, putative 44240 422 0 
ECL1 TGME49_000370 protein farnesyltranstransferase beta subunit, putative 69876 638 0 
ECL1 TGME49_033480 SRS29C (= SRS2, P35)  39120 372 0 
ECL1 TGVEG_081500 conserved hypothetical protein 39605 377 0 
ECL1 TGME49_120050 ribosomal protein L5, putative 35342 310 0 
ECL1 TGGT1_060630 conserved hypothetical protein 93141 927 0 
ECL1 TGME49_057720 phospholipid-transporting P-type ATPase, putative 247041 2225 9 
ECL1 TGME49_120010 hypothetical protein 98244 964 0 
ECL1 TGVEG_001300 hypothetical protein 11868 101 2 
ECL1 TGGT1_089980 UVb-resistance protein uvr8, putative 62124 578 0 
ECL1 TGME49_091140 CCR4-Not complex component, Not1 domain-containing protein, conserved 265871 2562 0 
ECL1 TGME49_003030 hypothetical protein 37346 342 7 
ECL1 TGME49_047420 hypothetical protein 37365 347 3 
ECL1 TGME49_009450 TLD domain-containing protein 85277 817 0 
ECL1 TGVEG_035400 plant ubiquilin, putative 118954 1158 0 
ECL1 TGME49_039130 Tyrosine kinase-like (TKL) protein 180152 1658 0 
ECL1 TGME49_119590 hypothetical protein 236539 2180 0 
ECL1 TGGT1_053690 DEAD/DEAH box helicase, putative 61270 564 0 
ECL1 TGME49_014530 DnaJ domain-containing protein 77968 714 0 
ECL1 TGME49_094990 hypothetical protein 20012 209 0 
ECL1 TGME49_098600 leucine zipper-like transcriptional regulator 91036 855 0 
ECL1 TGME49_020860 DEAD/DEAH box helicase, putative 65159 602 0 
ECL1 TGME49_002780 Rhoptry kinase family protein ROP25 120370 1122 2 
ECL1 TGME49_020080 hypothetical protein 28124 271 1 
ECL1 TGME49_106660 RNA pseudouridine synthase domain containing protein 676333 6535 0 
ECL1 TGVEG_066630 hypothetical protein 13419 117 0 
ECL1 TGME49_055910 hypothetical protein, conserved 24955 231 0 
ECL1 TGGT1_013970 conserved hypothetical protein 46590 447 0 
ECL1 TGGT1_112930 conserved hypothetical protein 68675 723 0 
ECL1 TGME49_060520 hypothetical protein 48430 472 0 
ECL1 TGME49_021550 CMGC kinase, MAPK family, MEK kinase-related (incomplete catalytic triad) 65458 599 0 
ECL1 TGME49_007430 ATP-dependent RNA helicase DDX family protein, putative 82793 768 0 
ECL1 TGME49_040340 hypothetical protein 134545 1276 0 
ECL1 TGME49_065250 alpha-1 type II collagen, putative 160181 1564 0 
ECL1 TGME49_026620 hypothetical protein 171138 1636 0 
ECL1 TGME49_043310 hypothetical protein 132520 1266 0 
ECL1 TGME49_083880 RNA binding motif-containing protein 87772 802 0 
ECL1 TGME49_005680 transmembrane domain-containing protein 79066 805 6 
ECL1 TGME49_115520 microneme protein, putative 36590 348 1 
ECL1 TGME49_027660 DNA methyltransferase 2, putative 90211 834 0 
ECL1 TGME49_009220 hypothetical protein 75638 671 0 
ECL1 TGME49_116680 RNA pseudouridylate synthase domain-containing protein 289808 2780 0 
ECL1 TGME49_026320 hypothetical protein 72508 698 0 
ECL2 TGME49_015720 hypothetical protein 22634 201 2 
ECL2 TGGT1_027950 conserved hypothetical protein 64228 610 0 
ECL2 TGGT1_028070 conserved hypothetical protein 85264 799 0 
ECL2 TGME49_017960 hypothetical protein 88351 830 0 
ECL2 TGME49_087630 hypothetical protein 103529 975 0 
ECL2 TGME49_020280 SCP-like domain-containing protein 47796 434 0 
ECL2 TGME49_055900 hypothetical protein, conserved 27781 248 6 
ECL2 TGME49_065430 hypothetical protein 10883 101 0 
ECL2 TGVEG_088510 hypothetical protein 14236 122 1 
ECL2 TGME49_053110 kinesin motor domain-containing protein 70584 645 0 
ECL2 TGME49_030430 hypothetical protein 26382 236 0 
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ECL2 TGME49_062660 hypothetical protein 75308 701 7 
ECL2 TGME49_060630 DnaJ domain-containing protein 76803 675 3 
ECL2 TGME49_024780 SRS domain-containing protein 23720 218 0 
ECL2 TGME49_011040 Sec61beta family protein 10104 99 1 
ECL2 TGME49_066600 serine proteinase inhibitor, putative 12769 121 0 
C-terminus TGME49_013290 hypothetical protein 35483 320 0 
C-terminus TGME49_059900 hypothetical protein, conserved 81632 720 1 
C-terminus TGME49_112980 hypothetical protein, conserved 19688 162 0 
C-terminus TGME49_121390 hypothetical protein, conserved 42787 388 0 
C-terminus TGME49_009840 hypothetical protein 37722 307 0 
C-terminus TGGT1_036010 DHHC domain-containing protein, putative 96056 873 5 
C-terminus TGME49_003770 hypothetical protein 31965 291 0 
C-terminus TGME49_111750 hypothetical protein 28084 250 0 
C-terminus TGME49_058850 hypothetical protein 32750 276 0 
C-terminus TGME49_004100 Wee kinase 261583 2445 0 
C-terminus TGME49_074160 hypothetical protein 58727 525 0 
C-terminus TGME49_105860 CAM kinase, CDPK family TgCDPK1_2 (TGTPK4) 60431 537 0 
C-terminus TGME49_109400 chromosome segregation protein, putative 216856 1967 0 
C-terminus TGGT1_057060 NBP2B protein, putative 27327 251 0 
C-terminus TGME49_067310 myosin heavy chain, putative 51766 443 0 
C-terminus TGME49_016480 NMD3 protein 79320 721 0 
C-terminus TGME49_036090 hypothetical protein 18602 159 0 
C-terminus TGME49_114230 general transcription factor IIIC, putative 78275 695 0 
C-terminus TGME49_033430 hypothetical protein 101604 935 0 
C-terminus TGME49_052440 GPI-anchor transamidase, putative 66484 604 0 
C-terminus TGME49_021500 dual specificity protein phosphatase, catalytic domain-containing protein 109090 982 0 
C-terminus TGME49_053160 hypothetical protein 47298 433 0 
C-terminus TGME49_046140 hypothetical protein 111732 1033 0 
C-terminus TGME49_073970 corA-like Mg2+ transporter domain-containing protein 59769 537 2 
C-terminus TGME49_005050 hypothetical protein 133820 1207 0 
C-terminus TGME49_047000 TPR domain-containing protein 96859 888 1 
C-terminus TGME49_042860 plectin, putative 61535 544 0 
C-terminus TGME49_042750 hypothetical protein 445183 3900 0 
C-terminus TGME49_050720 intraflagellar transport protein component IFT74/72, putative 69502 606 0 
C-terminus TGME49_088270 hypothetical protein 45389 421 0 
C-terminus TGME49_044470 viral A-type inclusion protein repeat family 290408 2595 0 
C-terminus TGME49_037870 hypothetical protein, conserved 59175 538 0 
C-terminus TGME49_116630 hypothetical protein 98122 861 0 
C-terminus TGME49_075330 hypothetical protein 49391 456 0 
C-terminus TGME49_049520 hypothetical protein 21440 189 0 
C-terminus TGME49_042790 trichohyalin, putative 254916 2238 1 
C-terminus TGME49_084170 zinc finger DHHC domain-containing protein 96632 880 3 
C-terminus TGME49_050330 hypothetical protein 30475 263 0 
C-terminus TGME49_012880 hypothetical protein 560139 4817 0 
C-terminus TGME49_043930 hypothetical protein 101349 943 0 
C-terminus TGME49_091000 PHD-finger domain-containing protein 57115 527 0 
C-terminus TGME49_056060 nucleosome assembly protein, putative 89466 812 0 
C-terminus TGME49_053380 hypothetical protein 165275 1670 0 
C-terminus TGME49_097300 hypothetical protein 11997 107 0 
C-terminus TGME49_112070 hypothetical protein 43777 379 0 
C-terminus TGME49_087520 hypothetical protein 19609 167 0 
C-terminus TGME49_002250 hypothetical protein 98751 930 2 
C-terminus TGME49_003900 hypothetical protein, conserved 112395 951 0 
C-terminus TGME49_094790 hypothetical protein 37700 351 0 
C-terminus TGGT1_107350 conserved hypothetical protein 62632 547 0 
C-terminus TGGT1_056130 conserved hypothetical protein 42369 370 0 
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C-terminus TGME49_055700 hypothetical protein 389376 3552 0 
C-terminus TGME49_090620 hypothetical protein 291935 2617 0 
Whole TGME49_081590 hypothetical protein 13874 116 2 
Whole TGME49_116550 hypothetical protein 12988 113 2 
Whole TGME49_119850 hypothetical protein, conserved 56662 538 0 
Whole TGME49_036540 RRM domain-containing protein 53440 513 0 
Whole TGME49_119890 hypothetical protein 25535 236 0 
Whole TGME49_013290 hypothetical protein 35483 320 0 
Whole TGME49_025830 hypothetical protein 104168 989 0 
Whole TGME49_064610 heterogeneous nuclear ribonucleoprotein A3, putative 44975 430 0 
Whole TGME49_062620 Gbp1p protein, putative 31761 293 0 
Whole TGME49_036650 DEAD/DEAH box helicase, putative 59969 550 0 
Whole TGME49_012850 hypothetical protein 43503 414 0 
Whole TGME49_112980 hypothetical protein, conserved 19688 162 0 
Whole TGME49_035930 KH domain-containing protein 64265 570 0 
Whole TGME49_059900 hypothetical protein, conserved 81632 720 1 
Whole TGME49_121390 hypothetical protein, conserved 42787 388 0 
Whole TGME49_009840 hypothetical protein 37722 307 0 
Whole TGME49_064150 hypothetical protein 31441 307 0 
Whole TGGT1_068110 conserved hypothetical protein 15149 120 0 
Whole TGME49_069690 hypothetical protein 94305 865 1 
Whole TGME49_072010 nucleolar protein family A, putative 20932 210 0 
Whole TGGT1_002130 conserved hypothetical protein 47404 433 0 
Whole TGME49_003770 hypothetical protein 31965 291 0 
Whole TGME49_111750 hypothetical protein 28084 250 0 
Whole TGME49_013850 hypothetical protein 15644 147 1 
Whole TGGT1_020450 conserved hypothetical protein 32034 255 0 
Whole TGGT1_094450 conserved hypothetical protein 106483 932 0 
Whole TGME49_004100 Wee kinase 261583 2445 0 
Whole TGME49_074160 hypothetical protein 58727 525 0 
Whole TGME49_105860 CAM kinase, CDPK family TgCDPK1_2 (TGTPK4) 60431 537 0 
Whole TGGT1_077210 conserved hypothetical protein 390621 3561 0 
Whole TGGT1_036010 DHHC domain-containing protein, putative 96056 873 5 
Whole TGME49_109400 chromosome segregation protein, putative 216856 1967 0 
Whole TGGT1_057060 NBP2B protein, putative 27327 251 0 
Whole TGME49_005050 hypothetical protein 133820 1207 0 
Whole TGGT1_026910 conserved hypothetical protein 111220 1030 0 
Whole TGME49_067310 myosin heavy chain, putative 51766 443 0 
Whole TGME49_070170 hypothetical protein 21290 223 0 
Whole TGME49_036090 hypothetical protein 18602 159 0 
Whole TGME49_058850 hypothetical protein 32750 276 0 
Whole TGGT1_020470 conserved hypothetical protein 543156 5074 1 
Whole TGME49_091930 nucleolar phosphoprotein nucleolin, putative 73118 705 0 
Whole TGME49_062950 enterophilin-2L, putative 79898 717 0 
Whole TGME49_052440 GPI-anchor transamidase, putative 66484 604 0 
Whole TGME49_033430 hypothetical protein 101604 935 0 
Whole TGGT1_024770 conserved hypothetical protein 120268 1124 0 
Whole TGME49_025320 hypothetical protein, conserved 54459 504 0 
Whole TGGT1_047160 conserved hypothetical protein 445037 3900 0 
Whole TGME49_021500 dual specificity protein phosphatase, catalytic domain-containing protein 109090 982 0 
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